Form 8-K

8-K — Integer Holdings Corp

Accession: 0000950103-26-011881

Filed: 2026-08-04

Period: 2026-08-02

CIK: 0001114483

SIC: 3845 (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS)

Item: Entry into a Material Definitive Agreement

Item: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Item: Financial Statements and Exhibits

Documents

8-K — dp251220_8k.htm (Primary)

EX-2.1 — EXHIBIT 2.1 (dp251220_ex0201.htm)

EX-2.2 — EXHIBIT 2.2 (dp251220_ex0202.htm)

EX-3.1 — EXHIBIT 3.1 (dp251220_ex0301.htm)

EX-3.2 — EXHIBIT 3.2 (dp251220_ex0302.htm)

GRAPHIC (image_001.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: dp251220_8k.htm · Sequence: 1

false

--12-31

0001114483

2026-08-02

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________________________

FORM 8-K

_____________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities

Exchange Act of 1934

Date of report (Date of earliest event reported):

August 2, 2026

INTEGER HOLDINGS CORPORATION

(Exact name of registrant as specified in its

charter)

_____________________________________

Delaware

1-16137

16-1531026

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

5830 Granite Parkway,

Suite 1150

Plano,

Texas

75024

(Address of principal executive offices)

(Zip Code)

(214) 618-5243

Registrant’s telephone number, including

area code

_____________________________________

Check the appropriate box below if the Form 8-K filing is intended

to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction

A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities

Act (17 CFR 230.425)

☒ Soliciting material pursuant to Rule 14a-12 under the Exchange

Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under

the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under

the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001 par value per share

ITGR

New York Stock Exchange

Indicate by check mark whether the registrant is an

emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities

Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant

has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant

to Section 13(a) of the Exchange Act. ☐

Item 1.01. Entry into a Material Definitive Agreement.

On August 2, 2026, Integer Holdings Corporation, a Delaware corporation (the “Company”) entered into an Agreement and Plan

of Merger (the “Merger Agreement,” and the transactions contemplated thereby, the “Transaction”), by and among

the Company, Armstrong Parent, Inc., a Delaware corporation (“Parent”), and Armstrong Bidco, Inc., a Delaware corporation

and a wholly owned subsidiary of Parent (“Merger Sub”). Pursuant to the Merger Agreement, and upon the terms and subject to

the conditions therein, Merger Sub will merge with and into the Company (the “Merger”), with the Company surviving the Merger

as a wholly owned subsidiary of Parent. Parent and Merger Sub are each affiliates of investment funds managed by Kohlberg Kravis Roberts

& Co. L.P., a leading global investment firm.

Subject to the terms and conditions of the Merger

Agreement, at the effective time of the Merger (the “Effective Time”), each share of common stock of the Company, par value

$0.001 per share (the “Company Common Shares”) issued and outstanding immediately prior to the Effective Time (other than

Company Common Shares (i) held by the Company as a treasury share or owned by Parent, Merger Sub or any other Subsidiary of Parent immediately

prior to the Effective Time, (ii) held by any subsidiary of the Company immediately prior to the Effective Time and (iii) held by any

person who is entitled to demand, and has properly demanded, appraisal in respect of such Company Common Shares pursuant to applicable

law), will automatically be converted into the right to receive $127 in cash, without interest (the “Merger Consideration”).

Treatment of Company Equity Awards

With respect to the outstanding equity awards of the Company, at the

Effective Time, such awards will generally be treated as follows:

· RSU Awards: Each restricted stock unit (“RSU”) award that is vested or vests upon the

Transaction in accordance with its terms will be canceled and converted into the right to receive a cash amount equal to (i) the number

of shares of Company common stock subject to such RSU award, multiplied by (ii) the Merger Consideration. Each unvested RSU award will

be canceled and converted into a cash amount equal to (a) the number of shares of Company common stock subject to such RSU award, multiplied

by (b) the Merger Consideration, 50% of which will be paid as soon as practicable after the Effective Time (assessed on a tranche-by-tranche

basis) and the remaining 50% of which will be paid subject to satisfaction of the same vesting conditions that applied to the corresponding

RSU award, with vesting protections upon a qualifying termination of employment.

· PSU Awards: Each performance stock unit (“PSU”)

award for which the performance period has been completed but that has not yet been settled will be canceled and converted into the right

to receive a cash amount equal to (i) the number of shares of Company common stock subject to such PSU award based on actual performance,

multiplied by (ii) the Merger Consideration. Each PSU award for which the performance period has not been completed will be canceled and

converted into a cash amount equal to (a) the number of shares of Company common stock subject to such PSU award based on the greater

of (x) target performance and (y) actual performance, multiplied by (b) the Merger Consideration, 50% of which will be paid as soon as

practicable after the Effective Time (assessed on a tranche-by-tranche basis) and the remaining 50% of which will be paid subject to satisfaction

of the same service vesting conditions (without regard to any performance conditions) that applied to the corresponding PSU award, with

vesting protections upon a qualifying termination of employment.

· Options: Each option to purchase Company Common Shares

(“Company Option”) will be fully vested and converted into the right to receive a cash amount equal to (i) the excess, if

any, of the Merger Consideration over the applicable exercise price per share of Company common stock subject to such award of Company

Options, multiplied by (ii) the number of shares of Company common stock subject to such Company Option. If the exercise price of the

Company Option is equal or greater to the Merger Consideration, such Company Option will be cancelled for no consideration.

Financing

Parent and Merger Sub have obtained equity and debt financing commitments for the Transaction. Pursuant to an equity commitment letter

delivered to Parent (the “Equity Commitment Letter”), KKR Core II Holding Company LLC, a Cayman Islands limited liability

company (“Fund”), has committed to invest in Parent, directly or indirectly, the cash amounts set forth therein for the purpose

of enabling Parent to pay the Merger Consideration at the Closing, subject to the terms and conditions set forth therein. The Company

is an express third-party beneficiary of the Equity Commitment Letter. The Fund has also provided the Company with a limited guarantee,

which guarantees the payment of certain monetary obligations that may be owed by Parent to the Company pursuant to the Merger Agreement,

including any reverse termination fee that may become payable by Parent (described further below), in each case, pursuant to and in accordance

with the terms and conditions of the limited guarantee and Merger Agreement. In addition, pursuant to a debt commitment letter delivered to Parent, certain lenders have agreed to provide debt financing to Parent on the terms and subject

to the conditions set forth therein.

Closing Conditions

The consummation of the Merger is subject to

certain customary closing conditions set forth in the Merger Agreement, including: (i) the approval and adoption of the Merger Agreement

by the holders of a majority of the outstanding Company Common Shares (the “Company

Stockholder Approval”); (ii) the absence of any

order issued by any governmental authority (whether temporary, preliminary or permanent) of competent jurisdiction, or applicable law

prohibiting, rendering illegal or enjoining the consummation of the Merger; (iii) the expiration or termination of any waiting periods

applicable to the consummation of the Merger under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and certain other

applicable antitrust and foreign direct investment laws of certain jurisdictions; (iv) each party’s performance of and compliance

with its covenants, obligations and agreements contained in the Merger Agreement in all material respects; (v) no Company Material Adverse

Effect (as defined in the Merger Agreement) having occurred since the date of the Merger Agreement and (vi) the accuracy of the representations

and warranties of the parties in the Merger Agreement (subject to customary materiality qualifiers). The Merger is not subject to any

financing condition.

Representations, Warranties and Covenants

The Company, Parent and Merger Sub have each made customary representations,

warranties and covenants in the Merger Agreement. Subject to certain exceptions, the Company has agreed, among other things, to customary

covenants regarding the operation of the business of the Company and its subsidiaries during the interim operating period between the

execution of the Merger Agreement and the consummation of the Merger.

In addition, the Company, Parent and Merger Sub have each agreed to

use its respective reasonable best efforts to, as soon as reasonably practicable, consummate the transactions contemplated by the Merger

Agreement and obtain all approvals, consents, registrations, permits, authorizations, and other confirmations from any governmental authority

or third party that are necessary, proper or advisable to consummate the transactions contemplated by the Merger Agreement. The Company

and Parent have also agreed to take all actions that are necessary to secure the expiration or termination of any applicable waiting period

or obtain any consent or approval under any applicable competition or foreign investment law.

No-Shop; Intervening Events

Subject to certain exceptions, the Company has agreed not to solicit

alternative acquisition proposals, engage in discussions with any third party regarding alternative acquisition proposals or change its

recommendation to its stockholders in favor of the Merger.

The Merger Agreement also provides that, notwithstanding

the foregoing, if prior to receipt of the Company Stockholder Approval, the Company receives a bona fide alternative acquisition proposal

from a third party that did not result from a breach of the Company’s non-solicitation obligations, and the Board of Directors (as

defined in the Merger Agreement) determines in good faith that the alternative acquisition proposal constitutes, or would reasonably be

expected to lead to, a Superior Proposal (as defined in the Merger Agreement), the Company may provide information to, and engage in negotiations

and discussions with, such person making the alternative acquisition proposal.

Prior to obtaining the Company Stockholder Approval, the Board of Directors

has the right, in connection with (i) the receipt of a Superior Proposal or (ii) an Intervening Event (as defined in the Merger

Agreement) to change its recommendation in favor of the Merger or, in the case of a Superior Proposal, to terminate the Merger Agreement,

in each case, subject to complying with notice requirements and other specified conditions (including giving Parent the opportunity to

propose changes to the Merger Agreement in response to such Superior Proposal or Intervening Event, as applicable), if the Board of Directors

determines in good faith that the failure to take such action would be inconsistent with its fiduciary duties under applicable law, and

provided that, in the case of a termination of the Merger Agreement, the Company pays to Parent the Company Termination Fee (as described

below).

Termination

The Merger Agreement contains certain customary

termination rights for each of the Company and Parent, including, (i) by mutual written agreement of the Company and Parent, (ii) if the

Merger has not been consummated on or before May 2, 2027 (the “Outside Date”), (iii) any applicable order, writ, injunction,

judgment or decree of any governmental authority (an “Order”) issued by any governmental authority of competent jurisdiction

rendering illegal, or restraining, enjoining or otherwise prohibiting the consummation of the Merger and such Order has become final and

nonappealable, (iv) the Company Stockholder Approval shall not have been obtained at a meeting of holders of the Company Common Shares

(the “Company Stockholders Meeting”) or (v) the other party is in breach of any representation or warranty or failure to perform

any covenant or agreement on the part of the respective parties in a manner that would result in a failure of an applicable closing condition

and such breach cannot be cured or, if curable, has not been cured within 20 business days after notice to the other party of such breach

(or, if earlier, five business days prior to the Outside Date).

In addition, prior to receipt of the Company Stockholder Approval,

(i) the Company may also terminate the Merger Agreement to (A) accept a Superior Proposal, subject to Parent’s right to match such

Superior Proposal and payment to Parent of the Company Termination Fee (as described below), or (B) in circumstances relating to Parent’s

breach of the Merger Agreement or failure to consummate the Merger when it is required to do so under the Merger Agreement, subject to

payment to the Company of the Parent Termination Fee (as defined below) and (ii) Parent may terminate the Merger Agreement if the Board

of Directors changes its recommendation to the Company’s stockholders regarding the Merger Agreement (an “Adverse Recommendation

Change”).

Termination Fees

The Merger Agreement provides for the payment of termination fees upon

termination of the Merger Agreement under certain specified circumstances. The Company will be obligated to pay Parent a termination fee

of $154,000,000 (the “Company Termination Fee”) if the Merger Agreement is terminated (i) by the Company to accept a Superior

Proposal, (ii) by Parent following an Adverse Recommendation Change, or (iii) in certain circumstances by either Parent or the Company

and prior to such termination a bona fide acquisition proposal is publicly announced or publicly disclosed and not publicly withdrawn

or otherwise abandoned at least five business days prior to such termination of the Merger Agreement or the date of the Company Stockholders

Meeting and the Company enters into a definitive agreement for, or consummates, a transaction involving a Superior Proposal within twelve

months of such termination.

Parent will

be obligated to pay the Company a termination fee of $307,000,000 (the “Parent Termination

Fee”) if the Merger Agreement is terminated by the Company in certain circumstances relating

to Parent’s breach of the Merger Agreement or failure to consummate the Merger when

it is required to do so under the Merger Agreement.

The foregoing description of the Merger Agreement and the transactions

contemplated thereby does not purport to be complete, and is subject to, and qualified in its entirety by reference to, the full text

of the Merger Agreement, which is attached hereto as Exhibit 2.1.

The Merger Agreement has been included to provide investors and security

holders with information regarding its terms. It is not intended to provide any other factual information about the Company, Parent or

any of their respective subsidiaries or affiliates. The representations, warranties and covenants contained in the Merger Agreement were

made by the parties thereto only for purposes of that agreement and as of specific dates; were made solely for the benefit of the parties

to the Merger Agreement; may be subject to limitations agreed upon by the contracting parties, including being qualified by confidential

disclosures exchanged between the parties in connection with the execution of the Merger Agreement (such disclosures include information

that has been included in the Company’s public disclosures, as well as additional non-public information); may have been made for

the purposes of allocating contractual risk between the parties to the Merger Agreement instead of establishing these matters as facts;

and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors. Investors

should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state

of facts or condition of the Company or Parent or any of their respective subsidiaries or affiliates. Additionally, the representations,

warranties, covenants, conditions and other terms of the Merger Agreement may be subject to subsequent waiver or modification. Moreover,

information concerning the subject matter of the representations, warranties and covenants may change after the date of the Merger Agreement,

which subsequent information may or may not be fully reflected in the Company’s public disclosures.

Indemnification Agreement

The Board of Directors has approved a Company form of indemnification

agreement (the “Indemnification Agreement”) and entered into an Indemnification Agreement with each of the Company’s

directors and executive officers. The Indemnification Agreement provides for indemnification of the indemnitee to the full

extent allowed by Delaware law and conforms to prevailing market practices regarding availability and scope of indemnification, advancement

and the availability of directors and officers liability insurance. For example, the Indemnification Agreement clarifies, among

other items, the definitions of Change of Control, Continuing Director and Expenses. The Indemnification Agreement also contains

provisions with respect to matters, such as, treatment of expenses when the indemnitee is a witness, the mechanics for determinations

of entitlement to indemnification, and clarifies the types of matters that are outside the scope of indemnification.

The foregoing description of the Indemnification Agreement is qualified

in its entirety by reference to the full text of the Indemnification Agreement, which is attached hereto as Exhibit 2.2 and incorporated

herein by reference.

Item 5.03. Amendment to Bylaws.

On August 2, 2026, the Board of Directors amended and restated

the Company’s bylaws (as amended, the “A&R Bylaws”), which became effective immediately. The A&R Bylaws

provide that, unless the Company consents in writing to the selection of an alternative forum, (i) the sole and exclusive forum for

certain legal actions involving the Company will be the Delaware Court of Chancery (or, in the event that the Delaware Court of

Chancery lacks subject matter jurisdiction over any such actions, the federal district court for the District of Delaware) and (ii)

the sole and exclusive forum for certain legal actions arising under the Securities Act of 1933, as amended (the “Securities

Act”), the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or for which there is exclusive

federal or concurrent federal or state jurisdiction, in each case, shall, to the fullest extent permitted by applicable law, be the

federal district courts of the United States of America.

The foregoing description of the A&R Bylaws is qualified in its

entirety by reference to the full text of the A&R Bylaws, a copy of which is attached hereto as Exhibit 3.1 and is incorporated herein

by reference, along with a copy marked to show changes from the prior version as Exhibit 3.2.

Cautionary Statement Regarding Forward-Looking

Statements

Some of the statements contained in this communication

and other written and oral statements made from time to time by us and our representatives are not statements of historical or current

fact. As such, they are “forward-looking statements” within the meaning of Section 27A of the Securities Act, and Section

21E of the Exchange Act, and are subject to the safe harbor created thereby under the Private Securities Litigation Reform Act of 1995.

We have based these forward-looking statements on our current expectations, and these statements are subject to known and unknown risks,

uncertainties and assumptions. Forward-looking statements include, but are not limited to, statements relating to: our goals, plans, and

strategic initiatives; long-term growth prospects; maximizing value for our stockholders; and other events, conditions or developments

that will or may occur in the future; and timing of any of the foregoing. You can identify forward-looking statements by terminology such

as “may,” “will,” “should,” “could,” “expects,” “intends,” “plans,”

“anticipates,” “believes,” “estimates,” “predicts,” “projects,” “forecast,”

“outlook,” “assume,” “potential” or “continue” or variations or the negative counterparts

of these terms or other comparable terminology. These statements are only predictions and are no guarantee of future performance, and

investors should not place undue reliance on forward-looking statements as predictive of future results. Actual events or results may

differ materially from those stated or implied by these forward-looking statements. In evaluating these statements and our prospects,

you should carefully consider the factors set forth below. All forward-looking statements attributable to us or persons acting on our

behalf are expressly qualified in their entirety by these cautionary factors and to others contained throughout this communication.

Forward-looking statements by their nature address

matters that are, to different degrees, uncertain, such as statements regarding the Transaction. All such forward-looking statements are

based upon current plans, estimates, expectations, opportunities and ambitions that are subject to risks, uncertainties, assumptions,

and other important factors, many of which are beyond the control of the Company, that could cause actual results to differ materially

from those expressed in such forward-looking statements. Key factors that could cause actual results to differ materially include, but

are not limited to, the expected timing and likelihood of completion of the Transaction, including the timing, receipt and terms and conditions

of any required governmental and regulatory approvals; the occurrence of any event, change or other circumstances that could give rise

to the termination of the Merger Agreement; the possibility that the Company’s stockholders may not approve the Transaction; the

risk that the parties may not be able to satisfy the conditions to the Transaction in a timely manner or at all; risks related to disruption

of management time from ongoing business operations due to the Transaction; the risk that any announcements relating to the Transaction

could have adverse effects on the market price of the Company’s common stock; the risk that the Transaction and its announcement

could have an adverse effect on the parties’ business relationships and business generally, including the ability of the Company

to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers, and on their operating

results and businesses generally; the risk of unforeseen or unknown liabilities; customer, stockholder, regulatory and other stakeholder

approvals and support; the risk of unexpected future capital expenditures; the risk of potential litigation relating to the Transaction

that could be instituted against the Company or its directors and/or officers; the risk associated with third-party contracts containing

material consent, anti-assignment, transfer or other provisions that may be related to the Transaction which are not waived or otherwise

satisfactorily resolved; significant costs, or expenses incurred in connection with the Transaction; the Parent’s ability to obtain

the necessary financing arrangements set forth in the commitment letters received in connection with the Transaction; certain restrictions

contained in the Agreement and Plan of Merger that may impact the Company’s ability to pursue certain business opportunities or

strategic transactions; the risk of various events that could disrupt operations, including pandemics, epidemics or other public health

crises or severe weather (such as droughts, floods, avalanches and earthquakes), cybersecurity attacks, security threats and governmental

response to them, and technological changes; the risks of labor disputes, changes in labor costs and labor difficulties; and the risks

resulting from other effects of industry, market, economic, legal or legislative, political or regulatory conditions outside of the Company’s

control. All such factors are difficult to predict and are beyond our control, including those detailed in the Company’s annual

report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the Securities Exchange Commission (the “SEC”)

on February 23, 2026 (the “Form 10-K”), quarterly reports on Form 10-Q and other documents subsequently filed by the Company

with the SEC. The Company’s forward-looking statements are based on assumptions that the Company believes to be reasonable but that

may not prove to be accurate. Other unpredictable or factors not discussed in this communication could also have material adverse effects

on forward-looking statements. The Company does not assume an obligation to update any forward-looking statements, except as required

by applicable law. These forward-looking statements speak only as of the date hereof.

Additional Information and Where to Find It

In connection with the Transaction, the Company

will file with the SEC a proxy statement on Schedule 14A. The definitive proxy statement will be sent to the stockholders of the Company

seeking their approval of the Transaction and other related matters.

BEFORE MAKING ANY INVESTMENT OR VOTING DECISION,

INVESTORS AND SECURITY HOLDERS OF THE COMPANY ARE URGED TO READ THE PROXY STATEMENT ON SCHEDULE 14A WHEN IT BECOMES AVAILABLE, AS WELL

AS ANY OTHER RELEVANT DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC IN CONNECTION WITH THE TRANSACTION OR INCORPORATED BY REFERENCE

INTO THE PROXY STATEMENT, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION REGARDING THE COMPANY, THE TRANSACTION AND RELATED MATTERS.

Investors and security holders may obtain free

copies of these documents, including the proxy statement, and other documents filed with the SEC by the Company through the website maintained

by the SEC at https://www.sec.gov. Copies of documents filed

with the SEC by the Company will be made available free of charge by accessing the Company’s website at https://investor.integer.net/financial-information/sec-filings/default.aspx

or by contacting the Company via email by sending a message to ir@integer.net.

Participants in the Solicitation

The Company, Parent and their respective directors

and executive officers may be deemed to be participants in the solicitation of proxies from the stockholders of the Company in connection

with the Transaction under the rules of the SEC. Information about the directors and executive officers of the Company and other persons

who may be deemed to be participants in the solicitation of stockholders of the Company in connection with the Transaction and a description

of their direct and indirect interests, by security holdings or otherwise, will be included in the proxy statement and other relevant

material related to the Transaction, which will be filed with the SEC when they become available, and may be found in the Company’s

definitive proxy statement in connection with its 2026 Annual Meeting of Stockholders, as filed with the SEC on April 6, 2026 (the “2026

Proxy Statement”), and in the Form 10-K, and subsequently filed statements of beneficial ownership on Form 4. Information about

the directors and executive officers of the Company, their ownership of the Company common stock, and the Company’s transactions

with related persons is set forth in the sections entitled “Directors, Executive Officers and Corporate Governance,” “Security

Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters,” and “Certain Relationships and Related

Transactions, and Director Independence” included in the Form 10-K, and in the sections entitled “Corporate Governance and

Board Matters,” and “Security Ownership of Certain Beneficial Owners and Management,” included in the Company’s

definitive proxy statement in connection with its 2026 Proxy Statement. Additional information regarding the interests of such participants

in the solicitation of proxies in respect of the Transaction will be included in the proxy statement and other relevant materials to be

filed with the SEC when they become available. These documents can be obtained free of charge from the SEC’s website at www.sec.gov.

No Offer or Solicitation

This communication is not intended to and shall

not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities or the solicitation

of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would

be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be

made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number

Description of Exhibit

2.1+^

Agreement and Plan of Merger by and among Integer Holdings Corporation, Armstrong Parent, Inc., and Armstrong Bidco, Inc., dated August 2, 2026

2.2

Form of Indemnification Agreement

3.1

By-laws of Integer Holdings Corporation (Amended and Restated as of August 2, 2026)

3.2

Marked By-laws of Integer Holdings Corporation (Amended and Restated as of August 2, 2026)

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

In accordance with Item 601(a)(5) of Regulation S-K, certain schedules

to this agreement have been omitted (as marked by asterisks).

In accordance with Item 601(b)(2) of Regulation S-K, portions of the exhibit have been omitted because it is both not material and is of the type the registrant treats as private or confidential.

SIGNATURES

Pursuant to the requirements of the Securities

Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date:

August 4, 2026

INTEGER HOLDINGS CORPORATION

By:

/s/ Lindsay K.

Blackwood

Lindsay K.

Blackwood

General Counsel & Secretary

EX-2.1 — EXHIBIT 2.1

EX-2.1

Filename: dp251220_ex0201.htm · Sequence: 2

Exhibit 2.1

Execution Version

AGREEMENT AND

PLAN OF MERGER

dated as of

August 2, 2026

among

INTEGER HOLDINGS

CORPORATION,

ARMSTRONG PARENT, INC.

and

ARMSTRONG BIDCO,

INC.

TABLE OF CONTENTS

Page

Article 1

Definitions

Section 1.01. Definitions

Section 1.02. Other

Definitional and Interpretative Provisions

Article 2

The Merger

Section 2.01. The

Merger

Section 2.02. Conversion

of Shares

Section 2.03. Surrender

and Payment

Section 2.04. Dissenting

Section 2.05. Treatment

of Equity Awards

Section 2.06. Adjustments

Section 2.07. Withholding

Rights

Section 2.08. Lost

Certificates

Article 3

The Surviving Corporation

Section 3.01. Certificate

of Incorporation

Section 3.02. Bylaws

Section 3.03. Directors

and Officers

Article 4

Representations and Warranties of the Company

Section 4.01. Corporate

Existence and Power

Section 4.02. Corporate

Authorization

Section 4.03. Governmental

Authorization

Section 4.04. Non-Contravention

Section 4.05. Capitalization

Section 4.06. Subsidiaries

Section 4.07. SEC

Filings; Internal Control

Section 4.08. Financial

Statements

Section 4.09. Disclosure

Documents

Section 4.10. Absence

of Certain Changes

Section 4.11. No

Undisclosed Material Liabilities

Section 4.12. Compliance

with Laws; Permits

Section 4.13. Litigation

Section 4.14. Properties

Section 4.15. Intellectual

Property

Section 4.16. Taxes

Section 4.17. Employee

Benefit Plans

Section 4.18. Employee

and Labor Matters

Section 4.19. Environmental

Matters

Section 4.20. Material

Contracts

Section 4.21. Trade

Controls; FCPA

Section 4.22. Healthcare

and FDA Regulatory Matters

Section 4.23. Insurance

Section 4.24. Finders’

Fees

Section 4.25. Opinion

of Financial Advisor

Section 4.26. Antitakeover

Statutes

Section 4.27. Related

Party Transactions

Section 4.28. Acknowledgement

of No Other Representations and Warranties

Article 5

Representations and Warranties of Parent and Merger Sub

Section 5.01. Corporate

Existence and Power

Section 5.02. Corporate

Authorization

Section 5.03. Governmental

Authorization

Section 5.04. Non-Contravention

Section 5.05. Disclosure

Documents

Section 5.06. Compliance

with Laws

Section 5.07. Litigation

Section 5.08. Finders’

Fees

Section 5.09. Financing

Section 5.10. Solvency

Section 5.11. Guarantee

Section 5.12. No

Prior Operations; Capitalization

Section 5.13. Ownership

of Common Shares

Section 5.14. Acknowledgement

of No Other Representations and Warranties

Article 6

Covenants of the Company

Section 6.01. Conduct

of the Company

Section 6.02. Company

Stockholders Meeting

Section 6.03. Access

to Information

Section 6.04. No-Shop;

Other Offers

Section 6.05. Stock

Exchange Delisting

Section 6.06. Company

Financing Cooperation.

Section 6.07. Resignation

Section 6.08. Treatment

of Certain Indebtedness

Article 7

Covenants of Parent

Section 7.01. Conduct

of Parent

Section 7.02. Director

and Officer Liability

Section 7.03. Employee

Matters

Section 7.04. Debt

Financing Covenants

iii

Article 8

Covenants of Parent and the Company

Section 8.01. Regulatory

Undertakings

Section 8.02. Certain

Filings

Section 8.03. Public

Announcements

Section 8.04. Merger

Sub Approval

Section 8.05. Further

Assurances

Section 8.06. Section 16

Matters

Section 8.07. Notices

of Certain Events

Section 8.08. Litigation

and Proceedings

Section 8.09. Takeover

Statutes

Section 8.10. Convertible

Notes; Capped Calls

Article 9

Conditions to the Merger

Section 9.01. Conditions

to the Obligations of Each Party

Section 9.02. Conditions

to the Obligations of Parent and Merger Sub

Section 9.03. Conditions

to the Obligations of the Company

Article 10

Termination

Section 10.01. Termination

Section 10.02. Effect

of Termination

Article 11

Miscellaneous

Section 11.01. Notices

Section 11.02. No

Survival of Representations and Warranties

Section 11.03. Amendments

and Waivers

Section 11.04. Expenses

& Fees

Section 11.05. Disclosure

Schedule and SEC Document References

Section 11.06. Binding

Effect; Third Party Beneficiaries; Assignment

Section 11.07. Governing

Law

Section 11.08. Jurisdiction

Section 11.09. WAIVER

OF JURY TRIAL

Section 11.10. Counterparts;

Effectiveness

Section 11.11. Entire

Agreement

Section 11.12. Severability

Section 11.13. Specific

Performance

Section 11.14. Debt

Financing Sources

Section 11.15. No

Recourse.

‎Exhibit

A Certificate of Incorporation of Surviving Corporation

AGREEMENT AND

PLAN OF MERGER

AGREEMENT

AND PLAN OF MERGER (as may be amended in accordance with the terms and conditions hereof, this “Agreement”)

dated as of August 2, 2026, among Integer Holdings Corporation, a Delaware corporation (the “Company”),

Armstrong Parent, Inc., a Delaware corporation (“Parent”), and Armstrong

Bidco, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”).

W I T N E S

S E T H:

WHEREAS, the boards of directors of

Parent and Merger Sub have each approved this Agreement, declared it advisable for Parent and Merger Sub, respectively, to enter into

this Agreement and recommended that Parent, in its capacity as sole stockholder of Merger Sub, approve and adopt this Agreement following

the execution and delivery of this Agreement;

WHEREAS, the board of directors of the

Company (the “Board of Directors”) has unanimously (a) determined that

this Agreement and the transactions contemplated by this Agreement, including the Merger, on the terms and subject to the conditions

set forth herein, are advisable, fair to and in the best interests of the Company and its stockholders, (b) declared this Agreement and

the transactions contemplated by this Agreement, including the Merger, advisable, (c) approved this Agreement, the execution and delivery

by the Company of this Agreement, the performance by the Company of the covenants and agreements contained herein and the consummation

of the transactions contemplated by this Agreement, including the Merger, on the terms and subject to the conditions contained herein

and (d) subject to ‎Section 6.04, resolved to

recommend adoption and approval of this Agreement and the transactions contemplated by this Agreement, including the Merger, to the stockholders

of the Company (such recommendation, the “Company Recommendation”); and

WHEREAS, prior to or concurrently with

the execution of this Agreement, and as a condition to the willingness of, and material inducement to, the Company to enter into this

Agreement, Parent has delivered to the Company (i) the Equity Commitment Letter between Parent and KKR Core II Holding Company LLC (collectively,

the “Sponsor”) and (ii) the limited guarantee in favor of the Company with

respect to the performance by Parent of certain of its obligations hereunder, duly executed by Sponsor and dated as of the date hereof

(the “Guarantee”).

NOW, THEREFORE, in consideration of

the foregoing and the representations, warranties, covenants and agreements contained herein, and for other good and valuable consideration,

the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows:

Article 1

Definitions

Section 1.01.

Definitions. As used herein, the following terms have the following meanings:

“1933

Act” means the Securities Act of 1933.

“1934

Act” means the Securities Exchange Act of 1934.

“2028

Convertible Notes” means those certain 2.125% convertible senior notes due 2028, issued by the Company pursuant to the

2028 Convertible Notes Indenture.

“2028

Convertible Notes Indenture” means the Indenture, dated as of February 3, 2023, by and between the Company and Wilmington

Trust, National Association, as trustee (the “2028 Convertible Notes Trustee”).

“2030

Convertible Notes” means those certain 1.875% convertible senior notes due 2030, issued by the Company pursuant to the

2030 Convertible Notes Indenture.

“2030

Convertible Notes Indenture” means the Indenture, dated as of March 18, 2025, by and between the Company and Wilmington

Trust, National Association, as trustee (the “2030 Convertible Notes Trustee”

and, together with the 2028 Convertible Notes Trustee, the “Trustees” and each, a “Trustee”).

“Acceptable

Confidentiality Agreement” means an agreement with the Company that is either (a) in effect as of the date hereof; or

(b) executed, delivered and effective after the date hereof, in either case (i) containing provisions that require any counterparty thereto

(and any of its Affiliates and Representatives named therein) that receive non-public information of or with respect to the Company to

keep such information confidential (subject to customary exceptions), (ii) containing confidentiality provisions not less favorable in

any material respect to the Company than the terms of the Confidentiality Agreement and (iii) that does not prohibit the Company from

providing any information to Parent in accordance with, or otherwise complying with, ‎Section 6.04.

“Acquisition

Proposal” means, other than the transactions contemplated by this Agreement, any Third Party indication of interest,

offer or proposal relating to (i) any acquisition or purchase, direct or indirect, of 20% or more of the consolidated assets of the Company

and its Subsidiaries or 20% or more of any class of equity or voting securities of the Company or any of its Subsidiaries whose assets,

individually or in the aggregate, constitute 20% or more of the consolidated net revenues, net income or assets of the Company and its

Subsidiaries, (ii) any tender offer (including a self-tender offer) or exchange offer that, if consummated, would result in such Third

Party beneficially owning 20% or more of any class of equity or voting securities of the Company or any of its Subsidiaries, (iii) a

merger, consolidation, joint venture, partnership, share exchange, business combination, sale of all or substantially all of the assets,

reorganization, recapitalization, liquidation, dissolution or other similar transaction involving the Company or any of its Subsidiaries

whose assets, individually or in the aggregate, constitute 20% or more of the consolidated net revenues, net income or assets of the

Company and its Subsidiaries or (iv) any combination of the foregoing.

“Actual

Performance” has the meaning set forth in Section 2.05(d).

“Adverse

Recommendation Change” has the meaning set forth in ‎‎Section 6.04(a).

“Affiliate”

means, with respect to any Person, any other Person directly or indirectly controlling, controlled by or under common control with such

Person; provided that, for purposes

this Agreement, Parent, Merger Sub and Kohlberg Kravis Roberts & Co. L.P. (“KKR”) shall be deemed not to be Affiliates

of the Company and vice versa. As used in this definition, “control” (including, with its correlative meanings, “controlled

by” and “under common control with”) shall mean the possession, directly or indirectly, of the power to direct or cause

the direction of management or policies of a Person, whether through the ownership of securities or partnership or other ownership interests,

by contract or otherwise.

“Agreement”

has the meaning set forth in the Preamble.

“Alternative

Financing” has the meaning set forth in ‎Section 7.04(d).

“Alternative

Financing Commitment Letter” has the meaning set forth in ‎Section 7.04(d).

“Anti-Corruption

Laws” has the meaning set forth in ‎Section 4.21(a).

“Antitrust

Division” has the meaning set forth in ‎‎Section 8.01(b).

“Applicable

Law” means, with respect to any Person, any domestic or foreign federal, state or local law (including common law),

constitution, treaty, act, statute, code, rule, regulation, order, injunction, judgment, decree, directive, determination, ruling or

other similar requirement enacted, adopted, promulgated or applied by a Governmental Authority in any relevant jurisdiction that is binding

upon or applicable to such Person.

“Balance

Sheet Date” has the meaning set forth in ‎‎‎Section 4.10.

“Board

of Directors” has the meaning set forth in the Recitals.

“Business

Day” means a day, other than Saturday, Sunday or other day on which commercial banks in New York, New York are authorized

or required by Applicable Law to close.

“Capitalization

Date” has the meaning set forth in ‎‎Section 4.05(a).

“Capped

Call Transactions” means, collectively, the call option transactions documented in connection with (i) the 2028 Convertible

Notes by those certain (A) letter agreements regarding the Base Call Option Transactions, dated as of January 31, 2023, and (B) letter

agreements regarding the Additional Call Option Transactions, dated as of February 1, 2023, and (ii) the 2030 Convertible Notes by those

certain (A) letter agreements regarding the Base Call Option Transactions, dated as of March 13, 2025, and (B) letter agreements regarding

the Additional Call Option Transactions, dated as of March 14, 2025, in each case of the foregoing, by and between the Company and each

applicable dealer party thereto.

“Cash Out PSU Award”

has the meaning set forth in Section 2.05(d).

“Cash Out RSU Award”

has the meaning set forth in Section 2.05(b).

“Cause” has the meaning

set forth in the Company’s 2026 Omnibus Incentive Plan (as in effect on the date hereof).

“CBA”

has the meaning set forth in ‎‎Section 4.18(a).

“Certificate

of Merger” has the meaning set forth in ‎‎‎Section 2.01(c).

“Certificates”

has the meaning set forth in ‎‎‎Section 2.03(a).

“Chosen

Courts” has the meaning set forth in ‎‎‎Section 11.08.

“Closing”

has the meaning set forth in ‎‎‎Section 2.01(b).

“Closing

Date” has the meaning set forth in ‎‎‎Section 2.01(b).

“Closing

Year Bonus” has the meaning set forth in ‎Section 7.03(e).

“Code”

means the U.S. Internal Revenue Code of 1986.

“Collection Cap”

has the meaning set forth in ‎‎‎Section 11.04(e).

“Collection Obligations”

has the meaning set forth in ‎‎‎Section 11.04(e).

“Company”

has the meaning set forth in the Preamble.

“Company

Balance Sheet” means the consolidated balance sheet of the Company as of April 3, 2026, and the footnotes thereto set

forth in the Company’s quarterly report on Form 10-Q for the quarter ended April 3, 2026.

“Company

Bylaws” means the By-Laws of the Company, as amended and restated.

“Company

Certificate of Incorporation” means the Restated Certificate of Incorporation of the Company, as amended.

“Company

Common Shares” has the meaning set forth in ‎‎‎Section 4.05(a).

“Company

Credit Agreement” means the Credit Agreement, dated as of September 2, 2021, among the Company, as parent, Greatbatch

Ltd., as the borrower, Wells Fargo Bank, National Association, as administrative agent, and the other agents and lenders parties there

to, as amended.

“Company

Credit Facility” means the Company’s credit facilities under the Company Credit Agreement.

“Company

Disclosure Schedule” means the disclosure schedule, dated the date hereof, regarding this Agreement that has been provided

by the Company to Parent and Merger Sub or their Representatives.

“Company

Employee” means any employee of the Company or any of its Subsidiaries.

“Company

Equity Award” means any Company RSU, Company PSU or Company Option.

“Company

Material Adverse Effect” means any event, change, circumstance, effect, occurrence, condition, state of facts or development

that, individually or in the aggregate, has or would reasonably be expected to have a material adverse effect on the financial condition,

business, assets or results of operations of the Company and its Subsidiaries, taken as a whole, excluding any event, change, circumstance,

effect, occurrence, condition, state of facts or development directly or indirectly arising out of, attributable to or resulting from

any of the following, alone or in combination, (A) changes in GAAP or changes in the regulatory accounting requirements applicable to

any industries in which the Company and its Subsidiaries operate, (B) changes, developments or conditions after the date hereof generally

in financial or securities markets or in the general economic or political conditions globally or in any jurisdiction in which the Company

and its Subsidiaries operate, including the imposition or adjustment of tariffs, (C) changes or conditions affecting generally the industries

in which the Company and its Subsidiaries operate, (D) changes in geopolitical conditions (including with respect to the current conflict

in Iran or between the Russian Federation and Ukraine and any evolutions thereof and any sanctions or other Applicable Laws, directives

or policies promulgated by any Governmental Authority in connection therewith), the outbreak or escalation of hostilities, any actual

or threatened acts of war, sabotage, terrorism, cyberterrorism, global health conditions (including any epidemic, pandemic or disease

outbreak (including SARS-CoV-2 or COVID-19, monkeypox (or similar viruses in the orthopoxvirus genus) and any evolutions or mutations

thereof)), or natural disaster (including any hurricane, tornado, flood, earthquake and weather-related event), (E) changes in Applicable

Law after the date hereof, (F) the execution, delivery, performance or public announcement of this Agreement or pendency or consummation

of the transactions contemplated hereby, including the impact of any of the foregoing on the relationships, contractual or otherwise,

of the Company and its Subsidiaries with third parties (provided that this clause (F) shall be disregarded for

purposes of the representations and warranties in Section 4.04 and determining the satisfaction of the conditions in ‎Section 9.02(b)

with respect to the representations and warranties in ‎Section 4.04),

(G) any failure of any of the Company or any of its Subsidiaries to meet, with respect to any period or periods following the date hereof,

any internal or published budgets, projections, forecasts, estimates of earnings or revenues or business plans (it being understood that

any underlying facts giving rise or contributing to such failure that are not otherwise excluded from the definition of a “Company

Material Adverse Effect” may be taken into account in determining whether there has been a Company Material Adverse Effect), (H)

any action taken by the Company at the written request of Parent or its Affiliates, and (I) any action taken by the Company or any of

its Subsidiaries that is expressly required pursuant to this Agreement (including any action required under this Agreement to obtain

any authorization or approval from the FTC or the Antitrust Division or any other Governmental Authority for the consummation of the

Merger and the other transactions contemplated hereby), except, in the case of clauses (A), (B), (C), (D) and (E),

to the extent the business of the Company and its Subsidiaries, taken as a whole, is disproportionately affected thereby relative to

other participants in the industry or industries in which the Company and its Subsidiaries operate, in which case the incremental disproportionate

adverse impact may be taken into account in determining whether there has occurred or would reasonably be expected to occur a Company

Material Adverse Effect.

“Company

Option” means an option to purchase Company Common Shares granted under a Company Stock Plan.

“Company

Plan” means (a) each “employee benefit plan” as defined in Section 3(3) of ERISA (whether or not subject

to ERISA), and (b) each employment, consulting, bonus, commission, incentive, termination, severance, separation, change in control,

retention, profit-sharing, pension, retirement, deferred compensation, stock purchase, equity or equity-based, medical, health, life

insurance, dental, vision, drug, legal, cafeteria, spending account, vacation, sick time, paid time off, welfare, disability (long-term

or short-term), post-employment, fringe benefit or other compensation or benefit plan, program, policy or agreement, whether or not subject

to ERISA, in each case, that is sponsored, maintained, contributed to or required to be contributed to by the Company or any of its Subsidiaries,

including for the benefit of the Company Employees or with respect to which the Company or any of its Subsidiaries has any liability

or obligation (direct or indirect, contingent or otherwise), other than, in each case, any such plan, program, policy or agreement that

(i) is sponsored or operated by any Governmental Authority, or (ii) is a “multiemployer plan” within the meaning of Section

3(37) or 4001(a)(3) of ERISA.

“Company

Preferred Shares” has the meaning set forth in ‎Section 4.05(a).

“Company

PSU” means each restricted stock unit award granted under a Company Stock Plan that is subject, in whole or in part,

to performance-based vesting.

“Company

Recommendation” has the meaning set forth in ‎the

recitals.

“Company

Related Parties” has the meaning set forth in ‎‎Section 11.04(d).

“Company

RSU” means each restricted stock unit award granted under a Company Stock Plan that is subject solely to time-based

vesting.

“Company

SEC Documents” has the meaning set forth in ‎‎‎Section 4.07(a).

“Company

Securities” has the meaning set forth in ‎Section 4.05(b).

“Company

Service Provider” means any employee, director or individual independent contractor of the Company or any of its Subsidiaries

(including each Company Employee).

“Company

Stock Plans” means the Company’s 2009 Stock Incentive Plan, 2011 Stock Incentive Plan, 2016 Stock

Incentive Plan, 2021 Plan, and the 2026 Plan, in each case, as may be amended from time to time.

“Company

Stockholder Approval” has the meaning set forth in ‎‎‎Section 4.02(a).

“Company

Stockholders Meeting” has the meaning set forth in ‎‎‎Section 6.02.

“Company

Subsidiary Securities” has the meaning set forth in ‎‎‎Section 4.06(b).

“Company

Termination Fee” has the meaning set forth in ‎‎Section 11.04(b)(i).

“Company-Owned

Intellectual Property” means any and all Intellectual Property owned or purported to be owned by the Company or any

of its Subsidiaries.

“Competition

Laws” means the HSR Act and all other Applicable Laws that are designed or intended to govern competition, trade regulation

or foreign investment, or to prohibit, restrict or regulate actions having the purpose or effect of monopolization, lessening of competition

or restraint of trade.

“Confidentiality

Agreement” has the meaning set forth in ‎Section 6.03(b).

“Continuing

Employee” has the meaning set forth in ‎Section 7.03(b).

“Contract”

means any agreement, contract, subcontract, lease, sub-lease, occupancy agreement, binding understanding, obligation, promise, instrument,

indenture, mortgage, note, option, warranty, purchase order, license, sublicense, commitment or undertaking of any nature, which, in

each case, is legally binding upon a party or on any of its Affiliates.

“Converted

PSU Award” has the meaning set forth in Section 2.05(d).

“Converted

RSU Award” has the meaning set forth in Section 2.05(b).

“Convertible

Notes” means, collectively, the 2028 Convertible Notes and the 2030 Convertible Notes.

“D&O

Insurance” has the meaning set forth in ‎‎Section 7.02(d).

“Debt

Commitment Letter” has the meaning set forth in ‎Section 5.09(a).

“Debt

Financing” has the meaning set forth in ‎Section 5.09(a).

“Debt

Financing Sources” means the Persons that have committed to provide or arrange the Debt Financing in connection with

the transactions contemplated hereunder, including the parties to any commitment letters (including the Debt Commitment Letter), engagement

letters, joinder agreements, indentures or credit agreements entered into pursuant thereto or relating thereto, together with their respective

Affiliates, and their and their respective Affiliates’ officers, directors, employees, attorneys, agents and representatives and

their respective permitted successors and permitted assigns.

“Debt Financing Sources Related

Parties” means the Debt Financing Sources, their affiliates and their and their affiliates’ respective former, current

and future directors, officers, managers, members, stockholders, partners, employees, advisors, agents and representatives and their

successors and assigns.

“Deferred

Cash Award” has the meaning set forth in Section 2.05(d).

“Deferred

PSU Award” has the meaning set forth in Section 2.05(d).

“Deferred

RSU Award” has the meaning set forth in Section 2.05(b).

“DGCL”

means the Delaware General Corporation Law.

“Dissenting

Company Shares” has the meaning set forth in ‎‎Section 2.04(a).

“DPA”

has the meaning set forth in ‎Section 5.04.

“Effective

Time” has the meaning set forth in ‎‎‎Section 2.01(c).

“Enforceability

Exceptions” has the meaning set forth in ‎‎‎Section 4.02(a).

“Environmental

Laws” means any Applicable Laws that have as their principal purpose pollution, human health or safety (solely as related

to exposure to Hazardous Substances), or the protection of the environment or natural resources.

“Equity

Commitment Letter” has the meaning set forth in ‎Section 5.09(a).

“Equity

Financing” has the meaning set forth in ‎Section 5.09(a).

“ERISA”

means the Employee Retirement Income Security Act of 1974.

“ERISA

Affiliate” means any Person, trade or business (whether or not incorporated) that, together with the Company or any

of its Subsidiaries, is treated at any relevant time as a single employer under Section 414 of the Code or Section 4001(a)(14) of ERISA.

“Excluded

Benefits” has the meaning set forth in ‎Section 7.03(b).

“FCPA”

means the Foreign Corrupt Practices Act of 1977.

“Financing”

has the meaning set forth in ‎Section 5.09(a).

“Financing

Commitment Letters” has the meaning set forth in ‎Section 5.09(a).

“FTC”

has the meaning set forth in ‎Section 8.01(b).

“GAAP”

means generally accepted accounting principles in the United States.

“Good Reason” shall

be as defined in a Continuing Employee’s employment, termination of employment or severance protection agreement, as applicable,

and if not so defined, shall mean the occurrence of any of the following events without the written consent of the Continuing Employee:

(i) a diminution in annual base salary from that in effect immediately prior to the Effective Time or (ii) the relocation of the principal

office at which the Continuing Employee performs services by more than 35 miles from the location of such office immediately prior to

the Effective Time; provided that such relocation results in a material increase in commuting time; and provided, further,

that “Good Reason” shall not be deemed to exist unless: (A) such Continuing Employee has provided written notice of the existence

of one or more of the conditions listed in clauses (i) or (ii) above within 90 days after the initial existence of such

condition or conditions; (B) such condition or conditions have not been cured within 30 days after receipt of delivery of such notice

and (C) such Continuing Employee terminates employment within 30 days following the expiration of such cure period in clause (B).

“Governmental

Authority” means any transnational, domestic or foreign federal, state, provincial or local governmental, regulatory

or administrative authority, arbitral body (public or private), department, court, agency or official, or NYSE or any self-regulatory

organization.

“Governmental

Health Program” means any “federal health care program” as defined in 42 U.S.C. § 1320a-7b(f), including

Medicare, Medicaid, TRICARE, CHAMPVA, and “state healthcare programs” (as defined therein), and any health insurance program

for the benefit of federal employees, including those under chapter 89 of title 5, United States Code, and comparable foreign healthcare

programs such as national health insurance systems.

“Guarantee”

has the meaning set forth in the recitals.

“Hazardous

Substance” means any (i) material, substance or waste that is listed, defined or regulated as “hazardous”

or “toxic,” or as a “pollutant” or “contaminant” (or words of similar meaning and regulatory effect),

or for which liability or standards of conduct may be imposed, under Environmental Laws and (ii) petroleum, petroleum products or byproducts,

per- and polyfluoroalkyl substances, polychlorinated biphenyls (PCBs), asbestos and asbestos-containing materials, radioactive materials,

radon and toxic mold or fungi.

“Healthcare

Laws” means Applicable Laws relating to healthcare or the regulation, provision, consultation, management, administration

of, and payment for, healthcare items and services to the extent applicable to the business of the Company or its Subsidiaries, including:

(i) Title XVIII of the Social Security Act, 42 U.S.C. §§ 1395-1395hhh and Title XIX of the Social Security Act, 42 U.S.C. §§

1396-1396v; (ii) the Exclusion Laws, 42 U.S.C. § 1320a-7, the Federal Civil Monetary Penalties Law, 42 U.S.C. § 1320a-7a, and

the Federal Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b), the Federal False Claims Act (31 U.S.C. §§ 3729-3733), the

Federal Program Fraud Civil Remedies Act (31 U.S.C. §§ 3801-3812); (iii) HIPAA (as defined herein); and (iv) any similar Applicable

Laws; and any and all amendments or modifications made from time to time to the items referenced in this definition.

“HIPAA”

means the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and

Clinical Health Act (Title XIII of the American Recovery and Reinvestment Act of 2009), and their implementing regulations set forth

at 45 C.F.R. Parts 160, 162, and 164 and any similar Applicable Laws regulating the privacy and security of healthcare records.

“HSR

Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976.

“Indemnified

Person” has the meaning set forth in ‎Section 7.02(a).

“Indentures”

means, collectively, the 2028 Convertible Notes Indenture and the 2030 Convertible Notes Indenture.

“Intellectual

Property” means all intellectual property in any jurisdiction anywhere in the world, and the following and all rights

therein and thereto: (i) trademarks, service marks, logos, trade dress, and trade names (including any and all goodwill related

thereto); (ii) domain names and social media accounts and handles; (iii) mask works, inventions, patents, and patent applications (whether

provisional or non-provisional), including divisionals, continuations,

continuations-in-part,

substitutions, reissues, reexaminations, extensions, or restorations of any of the foregoing; (iv) trade secrets, know-how, methods,

processes, and techniques, and other confidential or proprietary information; (v) copyrights and any other rights in works of authorship;

(vi) software, including all source code, object code, application programming interfaces, data files, databases, protocols,

specifications, and other documentation thereof; (vii) any other similar type of proprietary intellectual property rights; and (viii)

any registrations or applications for registration of any of the foregoing clauses (i) – (viii) or any other intellectual

property.

“Internal

Controls” has the meaning set forth in ‎‎ ‎Section 4.07(e).

“Intervening

Event” has the meaning set forth in ‎Section 6.04(b)(ii).

“IRS”

means the U.S. Internal Revenue Service.

“IT Systems” means

all software, computer systems, servers, network equipment and other computer hardware and information technology assets or equipment,

in each case, owned by, licensed or sublicensed to, or otherwise controlled by, the Company or any of its Subsidiaries.

“Knowledge”

means (i) with respect to the Company, the actual knowledge of the individuals listed on ‎Section 1.01(a)(i)

of the Company Disclosure Schedule and (ii) with respect to Parent, the actual knowledge of the individuals listed on ‎Section 1.01(a)(ii)

of the Parent Disclosure Schedule.

“Lease”

means all leases, subleases, licenses, and other Contracts pursuant to which the Company or any of its Subsidiaries holds any Leased

Real Property.

“Leased

Real Property” means all leasehold or subleasehold estates and other rights to use or occupy any land, buildings, structures,

improvements, fixtures, or other interest in real property held by the Company or any of its Subsidiaries.

“Lien”

means, with respect to any property or asset, any mortgage, pledge, charge, security interest, license, encumbrance or other lien or

similar adverse restriction of any kind in respect of such property or asset.

“Material

Contract” has the meaning set forth in ‎Section 4.20.

“Medical

Device Laws” means those Applicable Laws administered and enforced by the FDA and comparable local, state, federal and

foreign Governmental Authorities including the federal Food, Drug, and Cosmetic Act of 1938 (21 U.S.C. §§ 301 et seq.),

the Medical Devices Directive 93/42/EEC, the Active Implantable Medical Devices Directive 90/385/EEC, the Medical Devices Regulation

(EU) 2017/745, and similar local, state, federal and foreign Applicable Laws.

“Medical

Device Permits” has the meaning set forth in Section 4.22(d).

“Merger”

has the meaning set forth in ‎‎Section 2.01(a).

“Merger

Consideration” has the meaning set forth in ‎‎‎Section 2.02(a).

“Merger

Sub” has the meaning set forth in the Preamble.

“NYSE”

means the New York Stock Exchange.

“Order”

means any order, writ, injunction, judgment or decree of any Governmental Authority.

“Outside

Date” has the meaning set forth in ‎‎‎Section 10.01(b)(i).

“Owned

Real Property” means all land, together with buildings, structures, improvements and fixtures located thereon, and all

easements and other rights and interests appurtenant thereto, owned by the Company or any of its Subsidiaries.

“Parent”

has the meaning set forth in the Preamble.

“Parent Disclosure Schedule”

means the disclosure schedule dated the date hereof regarding this Agreement that has been provided by Parent to the Company or its Representatives.

“Parent

Material Adverse Effect” means any event, change, circumstance, effect, occurrence, condition, state of facts or development

that, individually or in the aggregate, would be reasonably expected to prevent, or materially impair, interfere with, hinder or delay

the consummation of, or materially adversely affect the ability of Parent or Merger Sub to consummate, the Merger or the other transactions

contemplated by this Agreement on a timely basis, and in any event, prior to the Outside Date.

“Parent

Related Parties” has the meaning set forth in ‎‎Section 11.04(d).

“Parent

Termination Fee” has the meaning set forth in ‎Section 11.04(b)(iii).

“Paying

Agent” has the meaning set forth in ‎‎‎Section 2.03(a).

“Payoff

Letter” has the meaning set forth in ‎Section 6.08.

“Pension

Plan” means (a) an employee pension benefit plan within the meaning of Section 3(2) of ERISA that is subject to Title

IV of ERISA and/or is subject to the minimum funding standards under Sections 412 or 430 of the Code or Section 302 of ERISA, or (b)

a “multiemployer plan” within the meaning of Section 3(37) or 4001(a)(3) of ERISA.

“Permit”

means each governmental license, franchise, certificate, approval, clearance, registration, consent, order, decree or other similar authorization

of a Governmental Authority relating to the assets or business of the Company or its Subsidiaries which is necessary for the conduct

of the business.

“Permitted

Liens” means (a) carriers’, warehousemen’s, mechanics’, materialmen’s, landlords’, laborers’,

suppliers’ and vendors’ liens and other similar Liens, if any, arising or incurred in the ordinary course of business for

amounts that are not yet due and payable or are being contested in good faith by appropriate actions or that are adequately reserved

for as of the date hereof in the applicable financial statements of the Company in accordance with GAAP; (b)

Liens

for Taxes not yet delinquent or, if delinquent, that are being contested in good faith by appropriate actions and that are adequately

reserved for as of the date hereof in the applicable financial statements of the Company in accordance with GAAP; (c) applicable zoning,

planning, entitlement, conservation restrictions, land use restrictions, building codes and other governmental rules and regulations

regulating the use or occupancy of real property or the activities conducted thereon which are imposed by a Governmental Authority having

jurisdiction over such real property, which are not violated in any material respect by the current use or occupancy of such real property

or the operation of the Company or any of its Subsidiaries as currently conducted; (d) the terms and conditions of the Leases (other

than in connection with any breach thereof by the Company or any of its Subsidiaries) that do not materially interfere with the use or

operation of the real property subject thereto as currently used or operated by the Company or any of its Subsidiaries; (e) with respect

to real property, minor defects, irregularities or imperfections of title, easements or claims of easements, servitudes, permits, covenants,

rights of way, flowage rights, restrictions, title to any portion of the premises lying within the right of way or boundary of any public

road or private road and similar restrictions of record affecting title to such real property, in each case, that do not materially interfere

with, or impair the business and use of such real property as presently conducted by the Company and its Subsidiaries; (f) matters that

would be disclosed by an accurate survey or inspection of the real property to which they relate; (g) licenses or sublicenses of Intellectual

Property granted in the ordinary course of business by the Company or any of its Subsidiaries; (h) Liens to be released on or prior to

the Closing Date; and (i) any other Liens which would not, individually or in the aggregate, interfere materially with the ordinary course

of the business of the Company or any of its Subsidiaries.

“Person”

means an individual, corporation, partnership, limited liability company, association, trust or other entity or organization, including

a Governmental Authority.

“Personal

Information” means any information that (i) whether alone or in combination with any other data or information, identifies

or is reasonably capable of identifying a natural Person, or (ii) is considered “personally identifiable information”, “personal

information”, or “personal data” under Applicable Law.

“Privacy

Requirement” means, collectively, all of the following to the extent relating to Personal Information or otherwise relating

to data privacy, data security, or security breach notification requirements: (i) the Company’s or any of its Subsidiaries’

own published or public rules, policies and procedures (whether physical or technical in nature, or otherwise), (ii) Applicable Laws,

(iii) binding industry standards applicable to the Company or any of its Subsidiaries, including the Payment Card Industry Data Security

Standard (PCI-DSS) and (iv) Contracts into which the Company or any of its Subsidiaries has entered or by which it is otherwise bound.

“Proceeding”

means any action, claim, charge, complaint, investigation, arbitration, mediation, litigation, suit or other similarly formal legal proceeding

commenced, brought, conducted, or heard by or before, any Governmental Authority or arbitrator.

“Proxy

Statement” has the meaning set forth in ‎Section 8.02(a)‎.

“Registered

Company-Owned Intellectual Property” means all issued patents and patent applications, trademark registrations and applications,

copyrights registrations and applications, and domain names, in each case, that are owned by the Company or any of its Subsidiaries as

of the date hereof.

“Reimbursement Cap”

has the meaning set forth in ‎Section 6.06(r)‎.

“Reimbursement

Obligations” has the meaning set forth in ‎Section 6.06(r)‎.

“Release” means any

spilling, leaking, pumping, pouring, emitting, emptying, discharging, injecting, escaping, leaching, dumping, or disposing into the environment.

“Representatives”

means, with respect to a Person, such Person’s directors, managers, officers, employees, investment bankers, attorneys, accountants

and other advisors acting on such Person’s behalf.

“Sanctioned

Person” means at any time any Person who is the target of Sanctions, including by virtue of being: (i) listed

on any Sanctions-related list of designated or blocked persons; (ii) a Governmental Authority of, ordinarily resident in or organized

under the laws of a country or territory that is the subject of comprehensive Sanctions (as of the date of this Agreement, Cuba, Iran,

North Korea, the Crimea, Donetsk, Luhansk, Kherson and Zaporizhzhia regions of Ukraine) or Venezuela; or (iii) owned directly or indirectly,

50% or more (in the aggregate) or otherwise controlled by any of the foregoing.

“Sanctions”

means, collectively, the sanctions administered or enforced by the United States Government (including the U.S. Department of the Treasury’s

Office of Foreign Assets Control), the United Nations Security Council, the European Union and its member states, and His Majesty’s

Treasury.

“Sarbanes-Oxley

Act” has the meaning set forth in ‎Section 4.07(b).

“SEC”

means the U.S. Securities and Exchange Commission.

“Security

Incident” means any actual or suspected (i) breach of security, successful phishing incident, or ransomware or malware

attack, or other security incident with respect to any IT System or (ii) incident in which any data or information owned, held, or processed

by or for the Company or any of its Subsidiaries or Personal Information was accessed, collected, disclosed, shared, transferred, destroyed,

lost, stolen or exfiltrated in an unauthorized manner.

“Solvent”

has the meaning set forth in ‎‎‎Section 5.10.

“Sponsor”

has the meaning set forth in the recitals.

“Subsidiary”

means, with respect to any Person, (i) any entity of which such person, directly or indirectly, owns (A) securities or other ownership

interests having ordinary voting power to elect a majority of the board or other governing body of directors or other Person or body

performing similar functions or (B) more than 50% of the outstanding equity or financial interests

(ii) any entity in which such Person is or any of its Subsidiaries is a general partner or managing member of such other Person.

“Superior

Proposal” has the meaning set forth in ‎ ‎Section 6.04(f).

“Surviving

Corporation” has the meaning set forth in ‎‎Section 2.01(a).

“Tax”

means any tax, fee, levy or other like governmental assessment or charge, in each case, in the nature of a tax, including all income,

excise, gross receipts, ad valorem, profits, gains, property, capital, sales, transfer, use, registration, license, payroll, employment,

social security, severance, unemployment, withholding, duties, windfall profits, intangibles, franchise, backup withholding, value added,

alternative or add-on minimum and, estimated tax, together with all penalties and additions to tax and interest thereon.

“Tax

Return” means any return, declaration, report, or information return or statement relating to Taxes, including any schedule

or attachment thereto, and including any amendment thereof, supplied or required to be supplied to any Taxing Authority.

“Taxing

Authority” means the IRS or any Governmental Authority responsible for the imposition or collection of any Tax.

“Third

Party” means any Person, including as defined in Section 13(d) of the 1934 Act, other than the Company, Parent

or any of their respective Affiliates.

“Trade

Control Laws” has the meaning set forth in ‎Section 4.21(a).

“Trustee”

has the meaning set forth in the definition of “2030 Convertible Notes Indenture.”

“Uncertificated

Shares” has the meaning set forth in ‎‎Section 2.03(a).

“Union”

means any labor or trade union, works council, labor organization or other employee representative body.

“Unvested

PSU Award” has the meaning set forth in Section 2.05(d).

“Unvested

RSU Award” has the meaning set forth in Section 2.05(b).

“Vested

PSU Award” has the meaning set forth in Section 2.05(c).

“Vested

RSU Award” has the meaning set forth in Section 2.05(a).

“WARN

Act” has the meaning set forth in ‎Section 4.18(b).

Section 1.02.

Other Definitional and Interpretative Provisions. Unless context requires otherwise, the words “hereof,”

“herein” and “hereunder” and words of like import used in this Agreement will refer to this Agreement as a whole

and not to any particular provision of this Agreement. The captions herein are included for convenience of reference only

and will be ignored in the construction or interpretation hereof. References to “Articles,” “Sections,”

“Exhibits,”

“Annexes” and “Schedules” are to Articles, Sections, Exhibits, Annexes and Schedules of this Agreement unless

otherwise specified. All Exhibits, Annexes and Schedules annexed hereto or referred to herein are hereby incorporated in and

made a part of this Agreement as if set forth in full herein. Any capitalized terms used in any Exhibit, Annex or Schedule but not otherwise

defined therein will have the meaning as defined in this Agreement. Any singular term in this Agreement will be deemed to

include the plural, and any plural term the singular. Whenever the words “include,” “includes” or

“including” are used in this Agreement, they will be deemed to be followed by the words “without limitation,”

whether or not they are in fact followed by those words or words of like import. “Writing,” “written”

and comparable terms refer to printing, typing and other means of reproducing words (including electronic media) in a visible form. The

word “or” will not be deemed to be exclusive. The word “extent” and the phrase “to the extent”

when used in this Agreement will mean the degree to which a subject or other thing extends, and such word or phrase will not simply mean

“if.” References to any statute, law or other Applicable Law will be deemed to refer to such statute, law or other

Applicable Law as amended from time to time and, if applicable, to any rules, regulations or interpretations promulgated thereunder. References

to any agreement or contract are to that agreement or contract as amended, modified or supplemented from time to time in accordance with

the terms hereof and thereof. References to any Person include the successors and permitted assigns of that Person. References

to a “party” or the “parties” mean a party or the parties to this Agreement unless the context otherwise requires. References

from or through any date mean, unless otherwise specified, from and including or through and including, respectively. Any deadline or

time period set forth in this Agreement that by its terms ends on a day that is not a Business Day shall be automatically extended to

the next succeeding Business Day. Except as otherwise expressly set forth herein, all amounts required to be paid hereunder will be paid

in United States currency in the manner and at the times set forth herein. Whenever this Agreement requires Merger Sub to

take any action, such requirement will be deemed to include an undertaking on the part of Parent to cause Merger Sub to take such action. The

parties hereto have participated jointly in the negotiation and drafting of this Agreement, and each has been represented by counsel

of its choosing and, in the event an ambiguity or question of intent or interpretation arises, this Agreement will be construed as if

drafted jointly by such parties and no presumption or burden of proof will arise favoring or disfavoring any party due to the authorship

of any provision of this Agreement. Prior drafts of this Agreement or the fact that any clauses have been added, deleted or

otherwise modified from any prior drafts of this Agreement will not be used as an aide of construction or otherwise constitute evidence

of the intent of the parties, and no presumption or burden of proof will arise favoring or disfavoring any party by virtue of any such

prior drafts. Unless otherwise specifically indicated, all references to “dollars” and “$” will be deemed references

to the lawful money of the United States of America. Any dollar or percentage thresholds set forth herein shall not be used as a benchmark

for the determination of what is or is not “material” or a “Company Material Adverse Effect” under this Agreement. References

to documents or information “made available” or “provided” to Parent or similar terms will mean documents or

information (a) publicly available on the SEC EDGAR database (without redaction or omission) at least two Business Days prior to the

execution of this Agreement, (b) delivered by or on behalf of the Company to Parent or Parent’s representatives via e-mail or in

hard copy form prior to the execution of this Agreement or (c) uploaded at least 24 hours prior to the execution of this Agreement in

the “Project Armstrong” dataroom hosted on Datasite and available to Parent and its Representatives.

Article 2

The Merger

Section 2.01.

The Merger. (a) Upon the terms and subject to the conditions set forth in this Agreement, at the Effective

Time, Merger Sub will merge with and into the Company (the “Merger”) in accordance

with the DGCL, whereupon the separate existence of Merger Sub will cease, and the Company will be the surviving corporation as a wholly

owned Subsidiary of Parent (the “Surviving Corporation”).

(b)

Subject to the provisions of ‎‎Article 9,

the closing of the Merger (the “Closing”) will take place through the electronic

exchange of the applicable documents, using PDFs or electronic signatures as soon as possible, but in any event no later than two Business

Days after the date the last of the conditions set forth in ‎‎‎Article 9

(other than conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or, to the extent permissible,

waiver of those conditions at the Closing) has been satisfied or, to the extent permissible, waived by the party or parties entitled

to the benefit of such conditions, or at such other place, at such other time or on such other date as Parent and the Company may mutually

agree in writing. The date on which the Closing actually occurs is referred to herein as the “Closing

Date”.

(c)

At the Closing, the Company and Merger Sub shall file a certificate of merger (the “Certificate

of Merger”), executed in accordance with the relevant provisions of the DGCL, with the Delaware Secretary of State and

make all other filings or recordings required by the DGCL in connection with the Merger. The Merger will become effective

at such time as the Certificate of Merger is duly filed with the Delaware Secretary of State (or at such later time as may be specified

in the Certificate of Merger) (the “Effective Time”).

(d)

Without limiting the generality of the foregoing, from and after the Effective Time, the Surviving Corporation will possess all

the rights, powers, privileges and franchises and be subject to all of the obligations, liabilities and restrictions of the Company and

Merger Sub, all as provided under the DGCL.

Section 2.02.

Conversion of Shares. Except as set forth in ‎‎Section 2.05, as of the Effective Time:

(a)

Except as otherwise provided in ‎‎‎Section 2.02(b),

‎‎‎Section 2.02(c) or ‎‎‎Section 2.04,

each Company Common Share outstanding immediately prior to the Effective Time will automatically be converted into the right to receive

$127.00 in cash, without interest (the “Merger Consideration”). As

of the Effective Time, all such Company Common Shares will no longer be outstanding and will automatically be canceled and retired and

will cease to exist, and will thereafter represent only the right to receive the Merger Consideration to be paid in accordance with ‎Section 2.03,

without interest.

(b)

Each Company Common Share held by the Company as a treasury share or owned by Parent, Merger Sub or any other Subsidiary of Parent

immediately prior to the Effective Time will be canceled and cease to exist, and no payment will be made with respect thereto.

(c)

Each Company Common Share held by any Subsidiary of the Company immediately prior to the Effective Time will be converted into

such number of common shares of the Surviving Corporation such that each such Person owns the same percentage of the outstanding capital

stock in the Surviving Corporation immediately following the Effective Time as such Person owned in the Company immediately prior to

the Effective Time.

(d)

Each common share of Merger Sub outstanding immediately prior to the Effective Time will be converted into and become one common

share of the Surviving Corporation and, except as provided in ‎‎Section 2.02(c),

will constitute the only outstanding shares of capital stock of the Surviving Corporation.

Section 2.03.

Surrender and Payment. (a) Prior to the Closing Date, Parent shall appoint a nationally recognized bank,

trust company or other agent reasonably acceptable to the Company to act as the paying agent for the Merger (the “Paying

Agent”) and enter into a paying agent agreement, reasonably acceptable to the Company, with such agent for the purpose

of exchanging for the Merger Consideration as promptly as practicable after the Effective Time (i) certificates representing Company

Common Shares (the “Certificates”) or (ii) uncertificated Company Common

Shares (the “Uncertificated Shares”). Prior to the Effective Time,

Parent shall make available to the Paying Agent the aggregate Merger Consideration to be paid in respect of the Certificates and the

Uncertificated Shares, and such aggregate Merger Consideration shall not be used for any purpose other than to fund payments due pursuant

to ‎Section 2.02 and this ‎‎Section 2.03. Except as set forth in ‎‎Section 2.05,

as promptly as practicable after the Effective Time (but no later than two Business Days thereafter), Parent shall send, or shall cause

the Paying Agent to send, to each holder of Company Common Shares at the Effective Time a letter of transmittal and instructions (which

will be in a form reasonably acceptable to the Company and finalized prior to the Effective Time and which will specify that the delivery

will be effected, and risk of loss and title will pass, only upon proper delivery of the Certificates or transfer of the Uncertificated

Shares to the Paying Agent) for use in such exchange.

(b)

Each holder of Company Common Shares that have been converted into the right to receive the Merger Consideration in accordance

with ‎Section 2.02 will be entitled to receive,

upon (i) surrender to the Paying Agent of a Certificate, together with a properly completed letter of transmittal in customary form reasonably

acceptable to Parent, or (ii) receipt of an “agent’s message” by the Paying Agent (or such other evidence, if any,

of transfer as the Paying Agent may reasonably request) in the case of a book-entry transfer of Uncertificated Shares, the Merger Consideration

payable for each Company Common Share represented by a Certificate or for each Uncertificated Share (less any applicable

and permitted withholding). Until so surrendered or transferred, as the case may be, each such Certificate or Uncertificated

Share will represent from and after the Effective Time for all purposes only the right to receive the Merger Consideration. No

interest will be paid or will accrue on the Merger Consideration payable upon surrender of any such Company Common Shares.

(c)

If any portion of the Merger Consideration is to be paid to a Person other than the Person in whose name the surrendered Certificate

or the transferred Uncertificated Share is registered, it will be a condition to such payment that (i) either such Certificate shall

be properly endorsed or shall otherwise be in proper form for transfer or such Uncertificated Share shall be properly transferred and

(ii) the Person requesting such payment shall pay to the Paying Agent any

stock

transfer or other similar Taxes required as a result of such payment to a Person other than the registered holder of such Certificate

or Uncertificated Share or establish to the satisfaction of the Paying Agent that any such Taxes have been paid or are not payable.

(d)

At the Effective Time, the share transfer books of the Company will be closed, and there will be no further registration of transfers

of Company Common Shares. If, after the Effective Time, Certificates or Uncertificated Shares are presented to the Surviving

Corporation or the Paying Agent, they will be canceled and exchanged for the Merger Consideration provided for, and in accordance with

the procedures set forth, in this ‎‎‎Article 2,

including subject to applicable Law in the case of Dissenting Company Shares.

(e)

Any portion of the Merger Consideration made available to the Paying Agent pursuant to ‎‎Section 2.03(a)

(and any interest or other income earned thereon) that remains unclaimed by the holders of Company Common Shares twelve (12) months after

the Effective Time will be returned to Parent, and any such holder who has not exchanged any Company Common Share for the Merger Consideration

in accordance with this ‎‎‎Section 2.03

prior to that time will thereafter look only to Parent for payment of the Merger Consideration in respect of such Company Common Share

without any interest thereon (subject to abandoned property escheat or similar Applicable Law). Notwithstanding the foregoing,

none of Parent, the Surviving Corporation or the Paying Agent will be liable, including to any holder of Company Common Shares for Merger

Consideration delivered to a Governmental Authority pursuant to any applicable abandoned property, escheat or similar Applicable Law. If

any Certificate shall not have been surrendered or Uncertificated Share shall not have been transferred prior to the date on which any

Merger Consideration would otherwise escheat to or become the property of any Governmental Authority, then any such Merger Consideration

will, to the extent permitted by Applicable Law, become the property of Parent, free and clear of all claims or interest of any Person

previously entitled thereto.

Section 2.04.

Dissenting Shares. (a) Notwithstanding anything to the contrary set forth in this Agreement, all Company

Common Shares that are issued and outstanding as of immediately prior to the Effective Time and held by the Company’s stockholders

who are entitled to demand and shall have neither voted in favor of the adoption of this Agreement nor consented thereto in writing and

who shall have properly and validly demanded their statutory rights of appraisal in respect of such Company Common Shares in accordance

with Section 262 of the DGCL (the “Dissenting Company Shares”) will

not be converted into, or represent the right to receive, the Merger Consideration pursuant to ‎‎‎Section 2.02(a). Such

Company stockholders will be entitled to receive payment of the appraised value of such Dissenting Company Shares in accordance with

the provisions of Section 262 of the DGCL, except that all Dissenting Company Shares held by Company stockholders who shall have

failed to perfect or who shall have effectively withdrawn or lost their rights to appraisal of such Dissenting Company Shares pursuant

to Section 262 of the DGCL will thereupon be deemed to have been converted into, and to have become exchangeable for, as of the

Effective Time, the right to receive the Merger Consideration, without interest thereon, upon surrender of the Certificates or transfer

of Uncertificated Shares that formerly evidenced such Company Common Shares in the manner provided in ‎‎Section 2.03

(or in the case of a lost, stolen or destroyed Certificate, upon delivery of an affidavit (and bond, if required) in accordance with

the provisions of ‎‎‎Section 2.08).

(b)

The Company shall give Parent prompt notice of any demands for appraisal received by the Company, withdrawals of such demands,

and any other instruments served pursuant to the DGCL and received by the Company in respect of Dissenting Company Shares. Parent

shall have the right to participate in all negotiations and Proceedings with respect to demands for appraisal pursuant to the DGCL in

respect of Dissenting Company Shares. The Company may not, except with the prior written consent of Parent, make any payment

with respect to any demands for appraisal, settle or offer to settle any such demands in respect of Dissenting Company Shares or waive

any failure to timely deliver a written demand for appraisal.

Section 2.05.

Treatment of Equity Awards. (a) At the Effective Time, each award of Company RSUs that is outstanding and

vested but not yet settled in accordance with the existing terms of such award (after giving effect to any single-trigger vesting provisions

set forth in the applicable award agreement in effect as of the date hereof) as of the Effective Time (each, a “Vested

RSU Award”) shall be automatically canceled without any action on the part of the holder thereof and converted into

the right to receive an amount in cash (without interest and subject to applicable Tax withholdings) equal to the product

of (A) the Merger Consideration, multiplied by (B ) the number of shares of Company Common Shares subject to

such Vested RSU Award at the Effective Time.

(b)

At the Effective Time, each award of Company RSUs that is outstanding and not a Vested RSU Award as of immediately prior to the

Effective Time (each, an “Unvested RSU Award”) shall be automatically canceled

without any action on the part of the holder thereof and converted into a restricted cash award representing the right to receive an

amount in cash (without interest and subject to applicable Tax withholdings) equal to the product of (i) the Merger

Consideration, multiplied by (ii) the number of shares of Company Common Shares subject to such Unvested RSU Award

(each, a “Converted RSU Award”). With respect to each Converted RSU Award,

50% of such Converted RSU Award (determined on a tranche-by-tranche basis) shall vest and become payable at the Effective Time (together

with the Vested RSU Awards, the “Cash Out RSU Awards”), and the remaining 50% of each Converted RSU Award (each, a

“Deferred RSU Award”) shall vest and become payable after the Effective Time at the same time as the Unvested RSU

Award for which such Deferred RSU Award was exchanged would have vested and been paid pursuant to its terms and shall otherwise be subject

to the same terms and conditions (including as to vesting and termination protection) as applied to such corresponding Unvested RSU Award

as of immediately prior to the Effective Time, except for terms rendered inoperative by reason of the transactions contemplated by this

Agreement or administrative or ministerial changes; provided that, in addition to any other vesting protections that a holder

of Deferred RSU Awards has, if the employment of such holder is terminated by Parent or its Affiliates without Cause or by such holder

for Good Reason, in each case, within one year following the Effective Time, all of such holder’s Deferred RSU Awards shall immediately

vest and be paid.

(c)

At the Effective Time, each award of Company PSUs for which the performance period has been completed but not yet settled in accordance

with the terms of such award as of immediately prior to the Effective Time (each, a “Vested

PSU Award”) shall automatically be canceled without any action on the part of the holder thereof and be converted into

the right to receive an amount in cash (without interest and subject to applicable Tax withholdings) equal to the product

of (i) the Merger Consideration, multiplied by (ii) the number of shares of Company Common Shares subject to

such Vested PSU Award at the Effective Time (with the number of

Company

Common Shares determined based on actual performance as determined by the Board of Directors (or committee thereof) in the ordinary course

of business consistent with past practice).

(d)

At the Effective Time, each award of Company PSUs that is outstanding and not a Vested PSU Award as of immediately prior to the

Effective Time (each, an “Unvested PSU Award”) shall be automatically canceled

without any action on the part of the holder thereof and converted into a restricted cash award representing the right to receive an

amount in cash (without interest and subject to applicable Tax withholdings) equal to (i) the Merger Consideration,

multiplied by (ii) the number of Company Common Shares subject to such Unvested PSU Award (calculated based on the

greater of (A) target performance and (B) Actual Performance (defined below) for Unvested PSU Awards) (each, a “Converted

PSU Award”). With respect to each Converted PSU Award, 50% of such Converted PSU Award (determined on a tranche-by-tranche

basis) shall vest and become payable at the Effective Time (together with the Vested PSU Awards, the “Cash Out PSU Awards”),

and the remaining 50% of each Converted PSU Award (each, a “Deferred PSU Award,” and, together with each Deferred

RSU Award, the “Deferred Cash Awards”) shall vest and become payable after

the Effective Time at the same time as the Unvested PSU Award for which such Deferred PSU Award was exchanged would have vested and been

paid pursuant to its terms and will be subject to the same terms and conditions (including as to vesting and termination protection,

but excluding, for the avoidance of doubt, any performance conditions) as applied to such corresponding Unvested PSU Award as of immediately

prior to the Effective Time, except for terms rendered inoperative by reason of the transactions contemplated by this Agreement or administrative

or ministerial changes; provided that, in addition to any other vesting protections that a holder of Deferred PSU Awards has,

if the employment of such holder is terminated by Parent or its Affiliates without Cause or by such holder for Good Reason, in each case,

within one year following the Effective Time, all of such holder’s Deferred PSU Awards shall immediately vest and be paid. For

purposes of Section 2.05, “Actual Performance” shall be determined

by the Board of Directors (or a committee thereof) prior to the Effective Time as follows: (x) with respect to relative total shareholder

return, the Merger Consideration shall be used as the “Ending Stock Price” (as defined in the applicable award agreement);

and (y) with respect to organic sales growth, (I) actual performance shall be used for any year during the applicable performance

period that is completed prior to the Effective Time and (II) projected performance as determined by the Board of Directors (or a committee

thereof) prior to the Effective Time for any other year during the applicable performance period.

(e)

At the Effective Time, (i) each award of Company Options that is outstanding immediately prior to the Effective Time shall

fully vest, to the extent not vested previously, and (ii) each award of Company Options that is vested and outstanding (after giving

effect to the foregoing clause (i)) shall automatically be canceled without any action on the part of the holder thereof

and converted into the right to receive an amount in cash (without interest and subject to applicable Tax withholdings) equal to (A) the

excess, if any, of the Merger Consideration over the applicable exercise price per share of Company Common Shares subject to such award

of Company Options, multiplied by (B) the number of shares of Company Common Shares subject to such award of Company

Options at the Effective Time; provided that if the applicable exercise price per share of Company Common Shares of an award of

Company Options is equal to or greater than the Merger Consideration, such award of Company Options shall be canceled at the Effective

Time for no consideration.

(f)

Prior to the Effective Time, the Board of Directors (or a committee thereof) shall adopt resolutions approving, and shall take

such other actions, including any such actions under any Company Stock Plan, as may be reasonably required or necessary to effectuate

the provisions of this ‎‎Section 2.05 prior

to, and contingent upon, the Effective Time.

(g)

Any payments under this ‎‎‎‎Section 2.05(a)

through (e) shall be made by the Surviving Corporation or any of its Subsidiaries, as applicable, through its payroll system at

or as soon as practicable after (i) the Effective Time (and in no event later than the later of (A) the next regularly scheduled

payroll run of the Surviving Corporation or its Subsidiary, as applicable, following the Effective Time, and (B) three Business

Days following the Effective Time) for payments made in respect of the Company Options, Cash Out RSU Awards and Cash Out PSU Awards,

and (ii) the date on which the Deferred Cash Award (or portion thereof) vests (and in no event later than the later of (A) the

next regularly scheduled payroll run of the Surviving Corporation or its Subsidiary, as applicable, following the applicable vesting

date, and (B) 30 Business Days following the applicable vesting date), pursuant to the Surviving Corporation’s or its

Subsidiary’s, as applicable, ordinary payroll practices, and will be subject to any applicable Tax withholding. Notwithstanding

the foregoing, any payments contemplated by this ‎‎Section 2.05

that constitute nonqualified deferred compensation subject to Section 409A of the Code and that are not permitted to be paid or settled

in accordance with the timing set forth in the preceding sentence without triggering a Tax or penalty under Section 409A of the Code

shall be made at the earliest time permitted under the terms of such award that will not trigger a Tax or penalty under Section 409A

of the Code.

Section 2.06.

Adjustments. Without limiting any rights or obligations otherwise set forth in this Agreement, if, during

the period between the date of this Agreement and the Effective Time, the outstanding shares of capital stock, or securities convertible

into or exchangeable into or exercisable for shares of such capital stock, of the Company shall have changed into a different number

or class of shares or other securities by reason of any reclassification, recapitalization, share split or combination, exchange or readjustment

of shares, or any share dividend thereon with a record date during such period, or any merger, consolidation or other event or similar

transaction, but excluding (i) any change that results from settlement or exercise (as applicable) of Company Equity Awards as described

above in ‎‎Section 2.05, or (ii) the issuance of Company Common Shares or Company Equity Awards in accordance with

the terms of this Agreement, the Merger Consideration and any other amounts payable pursuant to this Agreement shall be equitably adjusted

to reflect such event so as to provide Parent and the holders of Company Securities the same economic effect as contemplated by this

Agreement prior to such event.

Section 2.07.

Withholding Rights. Notwithstanding anything to the contrary herein, Parent, the Company, the Surviving

Corporation, the Paying Agent and any of their respective Affiliates or agents shall be entitled to deduct and withhold (or cause to

be deducted and withheld) from any amounts otherwise payable pursuant to this Agreement such amounts as are required to be deducted or

withheld under the Code or any other Applicable Law in respect of Taxes. Any amounts so deducted or withheld shall, to the extent timely

paid over to the appropriate Taxing Authority, be treated for all purposes of this Agreement as having been paid to the Person in respect

of which such deduction or withholding was made. Parent shall use commercially reasonable efforts to cooperate with the Company to obtain

any affidavits, certificates or other documentation as would reasonably be expected to afford to the Company and any holder of Company

Common Shares reduction of or relief from such deduction or withholding.

Section 2.08.

Lost Certificates. If any Certificate shall have been lost, stolen or destroyed, upon the making of an affidavit

of that fact by the Person claiming such Certificate to be lost, stolen or destroyed and, if required by the Surviving Corporation, an

agreement to indemnify the Surviving Corporation against any claim that may be made with respect to such Certificate (including, if required

by the Surviving Corporation, the posting by such Person of a bond, in such reasonable amount as the Surviving Corporation may direct),

the Paying Agent shall pay, in exchange for such lost, stolen or destroyed Certificate, the Merger Consideration to be paid in respect

of the Company Common Shares represented by such Certificate, as contemplated by this ‎‎Article 2.

Article 3

The Surviving Corporation

Section 3.01.

Certificate of Incorporation. Subject to ‎‎Section 7.02, at the Effective Time, the

certificate of incorporation of the Surviving Corporation shall be amended and restated as set forth in ‎Exhibit A, and, as

so amended and restated, shall be the certificate of incorporation of the Surviving Corporation until further amended in accordance with

Applicable Law.

Section 3.02.

Bylaws. Subject to ‎‎Section 7.02, the bylaws of Merger Sub in effect at the Effective

Time will be the bylaws of the Surviving Corporation (except that references to the name of Merger Sub shall be replaced by reference

to the name of the Surviving Corporation) until thereafter amended in accordance with Applicable Law.

Section 3.03.

Directors and Officers. From and after the Effective Time, until successors are duly elected or appointed

and qualified in accordance with Applicable Law, (a) the directors of Merger Sub at the Effective Time shall be the directors of the

Surviving Corporation and (b) the officers of the Company at the Effective Time shall be the officers of the Surviving Corporation.

Article 4

Representations and Warranties of the Company

Except (a) as disclosed in any Company

SEC Document filed on or after January 1, 2024 and at least two (2) Business Days before the date of this Agreement (but excluding any

forward-looking disclosures set forth in any “risk factors” section or “forward-looking statements” section under

the heading “Quantitative and Qualitative Disclosures About Market Risk” or any other statements that are similarly predictive,

cautionary or forward-looking in nature; it being understood that any factual information contained within such sections shall not be

excluded), and it being further understood that (i) any matter disclosed in any Company SEC Document will be deemed to be disclosed in

a section of the Company Disclosure Schedule only to the extent that it is reasonably apparent on the face of such disclosure in such

Company SEC Document that it is applicable to such section of the Company Disclosure Schedule; and (ii) nothing disclosed in the Company

SEC Documents will be deemed to modify or qualify the representations and warranties set forth in Section 4.01, 4.02, 4.04,

4.05, 4.06 or 4.24); or (b) subject to ‎‎‎Section 11.05,

as set forth in the Company Disclosure Schedule, the Company represents and warrants to Parent and Merger Sub as follows:

Section 4.01.

Corporate Existence and Power. (a) The Company (i) is a corporation, duly incorporated, validly existing

and in good standing under the laws of the State of Delaware and (ii) has all corporate powers required to carry on its business as now

conducted and to own, lease or operate its properties and assets, except in the case of this clause (ii) as has not had, and would

not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.

(b)

The Company is duly qualified or licensed to do business as a foreign corporation and is in good standing in each jurisdiction

where the properties or assets owned, operated or leased by it or the conduct of its business in such jurisdiction, as currently conducted,

requires such qualification or licensing, except for those jurisdictions where failure to be so qualified or in good standing has not

had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. The

Company has made available to Parent true, complete and correct copies of the Company Certificate of Incorporation and the Company Bylaws,

which are in effect as of the date hereof. The Company is not in violation of any of the provisions of the Company Certificate

of Incorporation or the Company Bylaws.

Section 4.02.

Corporate Authorization. (a) The execution, delivery and performance by the Company of this Agreement and

the consummation by the Company of the transactions contemplated hereby are within the Company’s corporate powers and, except for

obtaining the Company Stockholder Approval and the filing of the Certificate of Merger with the Secretary of State of the State of Delaware,

no other corporate action not previously taken on the part of the Company is necessary to authorize the execution and delivery by the

Company of this Agreement, the performance by the Company of its covenants and obligations hereunder and the consummation of the transactions

contemplated hereby. The affirmative vote of the holders of a majority of the outstanding Company Common Shares entitled to

vote at the Company Stockholders Meeting on the adoption of this Agreement (the “Company Stockholder

Approval”) is the only vote of the holders of any of the Company’s capital stock required by Applicable Law or

under the organizational documents of the Company or any of its Subsidiaries necessary to consummate the transactions contemplated hereby

(including the Merger). The Company has duly executed and delivered this Agreement, and, assuming due authorization, execution

and delivery by each of Parent and Merger Sub, this Agreement constitutes a valid and binding agreement of the Company, enforceable against

the Company in accordance with its terms (except insofar as such enforceability may be limited by bankruptcy, insolvency, fraudulent

transfer, reorganization, moratorium or other Applicable Laws of general applicability relating to or affecting creditors’ rights,

or by principles governing the availability of equitable remedies, whether at law or in equity (collectively, the “Enforceability

Exceptions”)).

(b)

The Board of Directors has unanimously (i) determined that this Agreement and the transactions contemplated by this Agreement,

including the Merger, on the terms and subject to the conditions set forth herein, are advisable, fair to and in the best interests of

the Company and its stockholders, (ii) declared this Agreement and the transactions contemplated by this Agreement, including the Merger,

advisable, (iii) approved this Agreement, the execution and delivery by the Company of this Agreement, the performance by the Company

of the covenants and agreements contained herein and the consummation of the transactions contemplated by this Agreement, including the

Merger, on the terms and subject to the conditions contained herein and (iv) resolved, subject to ‎Section 6.04,

to make the Company Recommendation, and, as of the date of this

Agreement,

such Company Recommendation has not been subsequently rescinded, modified or withdrawn in any way.

Section 4.03.

Governmental Authorization. The execution, delivery and performance by the Company of this Agreement and

the consummation by the Company of the transactions contemplated hereby require no action by or in respect of, or filing by the Company

or any of its Subsidiaries with, any Governmental Authority, other than (a) compliance with any applicable requirements of the HSR Act

and any other applicable Competition Laws, (b) the filing with the SEC of such reports and other filings under, and compliance with any

applicable requirements of the 1933 Act, the 1934 Act and any other applicable securities laws (including filing, or causing to be filed,

the Proxy Statement and the clearance thereof by the SEC), (c) the filing of the Certificate of Merger with the Secretary of State of

the State of Delaware and appropriate documents with the relevant authorities of the other jurisdictions in which the Company is qualified

to do business, (d) compliance with the rules and regulations of NYSE and (e) any other actions or filings (i) required solely by reason

of the participation of Parent or Merger Sub (as opposed to any Third Party) in the transactions contemplated hereby or (ii) the absence

of which would not reasonably be expected to materially impair the ability of the Company to consummate the transactions contemplated

hereby on a timely basis, and in any event, prior to the Outside Date.

Section 4.04.

Non-Contravention. The execution, delivery and performance by the Company of this Agreement and, assuming

compliance with the matters referred to in ‎‎Section 4.03 and receipt of the Company Stockholder Approval, the consummation

of the transactions contemplated hereby do not and will not (a) contravene, conflict with, or result in any violation or breach of any

provision of the organizational documents of the Company or any of its Subsidiaries, (b) contravene, conflict with or result in a violation

or breach of any provision of any Applicable Law, (c) require any consent or other action by any Person under, violate, conflict with,

result in breach of, constitute a default (or an event that, with notice or lapse of time or both, would become a default) under, or

cause or permit the termination, acceleration of performance or cancellation of any agreement binding upon the Company or any of its

Subsidiaries or (d) result in the creation or imposition of any Lien on any properties, rights or asset of the Company or any of its

Subsidiaries, with only such exceptions, in the case of each of clauses ‎(b)‎ through ‎(d)‎, as would not

reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect or prevent, materially delay or materially

impair the ability of the Company to consummate the transactions contemplated hereby on a timely basis, and in any event, prior to the

Outside Date.

Section 4.05.

Capitalization. (a) The authorized capital stock of the Company consists of 100,000,000 shares of common

stock, par value $0.001 per share (“Company Common Shares”), and 100,000,000 shares of preferred stock, par value

$0.001 per share (“Company Preferred Shares”). As of July 30, 2026 (such date, the “Capitalization

Date”), there were outstanding (i) 34,768,334 Company Common Shares, (ii) no Company Preferred Shares, (iii) 340,855 Company

Common Shares subject to outstanding Company RSUs, (iv) 418,085 Company Common Shares subject to outstanding Company PSUs (assuming achievement

of the applicable performance measures at the maximum level), (v) 17,346 Company Common Shares subject to outstanding Company Options,

and (vi) 7,957,857 Company Common Shares reserved for issuance and available on the possible conversion of the 2028 Convertible Notes

outstanding and available for issuance under the Company Stock Plans. In addition, as of the Capitalization Date, (x) $116.3 million

aggregate principal amount of the 2028 Convertible Notes (with a conversion rate as of

the

date hereof equal to 11.4681 Company Common Shares per $1,000 principal amount, subject to adjustment as provided in the 2028 Convertible

Notes Indenture) were issued and outstanding, and 1,333,557 Company Common Shares were reserved for issuance upon conversion of the 2028

Convertible Notes, and (y) $1,000 million aggregate principal amount of the 2030 Convertible Notes (with a conversion rate as of the

date hereof equal to 6.6243 Company Common Shares per $1,000 principal amount, subject to adjustment as provided in the 2030 Convertible

Notes Indenture) were issued and outstanding, and 6,624,300 Company Common Shares were reserved for issuance upon conversion of the 2030

Convertible Notes. The Company has made available to Parent a true and complete list, as of the Capitalization Date, of all outstanding

Company RSUs and Company PSUs on an individual-by-individual basis, including with respect to each such award, (A) the name or employee

identification number of the holder, (B) the date of grant and (C) the Company Stock Plan under which the award was granted, (D) the

total number of Company Common Shares subject to such award and (E) the current vesting status; provided the Company shall otherwise

cooperate with Parent to provide information necessary to implement the Deferred Cash Awards. There are no outstanding dividend equivalent

rights that have accrued in respect of any award granted under the Company Stock Plans.

(b)

Except as set forth in ‎Section 4.05(a),

as of the Capitalization Date, there are no issued, reserved for issuance or outstanding (i) shares of capital stock or other voting

securities of or ownership interests in the Company, (ii) securities of the Company or its Subsidiaries convertible into or exchangeable

or exercisable for shares of capital stock or other voting securities of or ownership interests in the Company, (iii) warrants,

calls, options or other rights to acquire from the Company or its Subsidiaries, or other obligation of the Company or its Subsidiaries

to issue, any capital stock or other voting securities or ownership interests in or any securities convertible into or exchangeable or

exercisable for capital stock or other voting securities or ownership interests in the Company, (iv) share options, restricted shares,

restricted share units, share appreciation rights, “phantom” equity, profits interests, contingent value rights, performance

units or similar securities or rights issued by the Company or any of its Subsidiaries that are derivative of, or provide economic benefits

based, directly or indirectly, on the value or price of, any capital stock or voting securities or ownership interests of the Company

or (v) contractual obligations or commitments relating to any Company Securities, including any voting trusts, proxies or any other contracts

or understandings with respect to the voting of, or any agreements restricting transfer of, requiring the registration for sale of, or

granting any preemptive rights, subscription rights, anti-dilutive rights, rights of first refusal or any similar rights. (the items

in clauses ‎(i) through ‎(v)‎

being referred to collectively as the “Company Securities”). There

are no outstanding obligations of the Company or any of its Subsidiaries to repurchase, redeem or otherwise acquire any of the Company

Securities. There are no declared or accrued but unpaid dividends or distributions with respect to any Company Common Shares. None of

the Company Securities are owned by any Subsidiary of the Company.

Section 4.06.

Subsidiaries. (a) Each Subsidiary of the Company has been duly formed, is validly existing and (where applicable)

in good standing under the laws of its jurisdiction of organization and has all organizational powers required to carry on its business

as now conducted, except for those licenses, authorizations, permits, consents and approvals the absence of which would not reasonably

be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Each such Subsidiary is duly qualified

to do business as a foreign entity and (where applicable) is in good standing in each jurisdiction where such qualification is necessary,

except

for those jurisdictions where failure to be so qualified or in good standing has not had, and would not reasonably be expected to have,

individually or in the aggregate, a Company Material Adverse Effect. All “significant subsidiaries” (as defined

in Rule 1-02(w) of Regulation S-X promulgated by the SEC) of the Company and their respective jurisdictions of organizations as of the

date hereof are identified in the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2025. The Company

is not in material default under or in material violation of any of the provisions of, the articles of organization, bylaws or equivalent

documents of each of the Company’s Subsidiaries.

(b)

All of the outstanding capital stock or other voting securities of, or ownership interests in, each Subsidiary of the Company

has been duly authorized, validly issued, fully paid and non-assessable and is free of any preemptive or similar rights, and is owned

by the Company, directly or indirectly, free and clear of any Liens (other than Permitted Liens). As of the date hereof, there

are no issued, reserved for issuance or outstanding (i) securities of the Company or any of its Subsidiaries convertible into, or exchangeable

or exercisable for, shares of capital stock or other voting securities of, or ownership interests in, any Subsidiary of the Company,

(ii) warrants, calls, options or other rights to acquire from the Company or any of its Subsidiaries, or other obligations of the Company

or any of its Subsidiaries to issue, any capital stock or other voting securities of, or ownership interests in, or any securities convertible

into, or exchangeable or exercisable for, any capital stock or other voting securities of, or ownership interests in, any Subsidiary

of the Company or (iii) share options, restricted shares, share appreciation rights, phantom equity, profits interests, performance units

or similar securities or rights issued by the Company or any of its Subsidiaries that are derivative of, or provide economic benefits

based, directly or indirectly, on the value or price of, any capital stock or other voting securities of, or ownership interests in,

any Subsidiary of the Company or (iv) contractual obligations or commitments relating to any Company Subsidiary Securities, including

any voting trusts, proxies or any other contracts or understandings with respect to the voting of, or any agreements restricting transfer

of, requiring the registration for sale of, or granting any preemptive rights, subscription rights, anti-dilutive rights, rights of first

refusal or any similar rights (the items in clauses ‎(i)

through ‎(iv) being referred to collectively as the

“Company Subsidiary Securities”). There are no outstanding obligations

of the Company or any of its Subsidiaries to issue, transfer, exchange, register, repurchase, redeem or otherwise acquire or sell any

of the Company Subsidiary Securities. Except as set forth in ‎Section 4.06(b)

of the Company Disclosure Schedule, neither the Company nor any of its Subsidiaries owns, directly or indirectly, any shares of capital

stock or other voting securities of or ownership interests in, or securities convertible into, or exchangeable or exercisable for, shares

of capital stock or other voting securities of or ownership interests in, any other Person.

Section 4.07.

SEC Filings; Internal Control. (a) Since January 1, 2024, the Company has filed with or furnished to

the SEC on a timely basis all reports, schedules, forms, statements, prospectuses, registration statements and other documents required

to be filed with or furnished to the SEC by the Company pursuant to Applicable Laws (collectively, together with any exhibits and schedules

thereto and other information incorporated therein, the “Company SEC Documents”).

(b)

As of its filing or furnishing date (or, if amended or superseded by a filing prior to the date hereof, as of the date of such

amended or superseded filing), each Company SEC Document complied, and each Company SEC Document filed or furnished subsequent to the

date

hereof

will when so filed or furnished comply, as to form in all material respects with the applicable requirements of the 1933 Act, the 1934

Act and the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), as the

case may be.

(c)

As of its filing or furnishing date (or, if amended or superseded by a filing prior to the date hereof, as of the date of such

amended or superseded filing), each Company SEC Document did not, and each Company SEC Document filed or furnished subsequent to the

date hereof will not, contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the

statements made therein, in the light of the circumstances under which they were made, not misleading. Since January 1, 2024, the Company

has not received from the SEC or any other Governmental Authority any written comments or questions with respect to any of the Company

SEC Documents (including the financial statements included therein) that are not resolved, nor as of the date hereof has received any

written notice from the SEC or other Governmental Authority that such Company SEC Documents (including the financial statements included

therein) are being reviewed or investigated, and, to the Company’s Knowledge, there is not, as of the date hereof, any investigation

or review being conducted by the SEC or any other Governmental Authority of any Company SEC Documents (including the financial statements

included therein). No Subsidiary of the Company is required to file any schedule, form, report, statement, prospectus, registration statement

or other document with the SEC.

(d)

The Company and each of its officers are in compliance in all material respects with the applicable provisions of the Sarbanes-Oxley

Act and, with respect to the Company, the applicable listing and corporate governance rules of NYSE. Each Company SEC Document

containing financial statements that has been filed with or submitted to the SEC under the Exchange Act was accompanied by any certifications

required to be filed or submitted by the Company’s principal executive officer and principal financial officer pursuant to Rules

13a-14 and 15d-14 under the 1934 Act and Sections 302 and 906 of the Sarbanes-Oxley Act and, at the time of filing or submission of each

such certification, such certification complied in all material respects with the applicable provisions of the 1934 Act and the Sarbanes-Oxley

Act. As of the date hereof, none of the foregoing certifications has become incomplete or incorrect. As of the date hereof, neither the

Company nor its principal executive officer or principal financial officer has received written notice from any Governmental Authority

challenging or questioning the accuracy, completeness, form or manner of filing such certifications.

(e)

Since January 1, 2024, the Company has, in compliance with Rule 13a-15 under the 1934 Act, (i) designed, established and maintained

disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports that it files or

submits under the 1934 Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of

the SEC, and that all such information required to be disclosed by the Company is accumulated and communicated to the Company’s

management, including its chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required

disclosure, and (ii) designed, established and maintained internal controls over financial reporting (“Internal

Controls”), as defined in Section 13a-15 under the 1934 Act, to provide reasonable assurance regarding the reliability

of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. Since January

1, 2024, neither the Company nor, to the Knowledge of the Company, the Company’s independent auditors have identified or been made

aware of significant deficiencies or material weaknesses (as such

terms

are defined by the Public Company Accounting Oversight Board) in the design or operation of the Company’s Internal Controls and

have identified for the Company’s auditors any material weaknesses in Internal Controls. Since January 1, 2024, neither

the Company nor, to the Knowledge of the Company, the Company’s independent auditors have identified or been made aware of any

fraud, whether or not material, that involves management or other employees who have a significant role in the preparation of financial

statements or in the Company’s Internal Controls. Since January 1, 2024, neither the Company nor any of its Subsidiaries has received

any material unresolved complaint, allegation, assertion or claim regarding the accounting or auditing practices, procedures, methodologies

or methods of the Company or any of its Subsidiaries or their respective internal accounting controls.

Section 4.08.

Financial Statements. The audited consolidated financial statements (including any related notes and schedules)

and unaudited consolidated interim financial statements (including any related notes and schedules) of the Company included or incorporated

by reference in the Company SEC Documents (a) were prepared in accordance with GAAP applied on a consistent basis (except as may be indicated

in the notes thereto or as otherwise permitted by Form 10-Q with respect to any financial statements filed on Form 10-Q) and (b) fairly

present in all material respects, in conformity with GAAP applied on a consistent basis throughout the periods covered thereby (except

as may be indicated in the notes thereto), the consolidated financial position of the Company and its consolidated Subsidiaries as of

the dates thereof and their consolidated results of operations and cash flows for the periods then ended (subject to, in the case of

any unaudited consolidated interim financial statements, normal year-end audit adjustments, which are not material, either individually

or in the aggregate).

Section 4.09.

Disclosure Documents. The Proxy Statement will, with respect to information regarding the Company, when

filed, comply as to form in all material respects with the applicable requirements of the 1934 Act. At the time (a) of such filing, (b)

the Proxy Statement and any amendments or supplements thereto are first mailed to the stockholders and (c) of the Company Stockholders

Meeting, the Proxy Statement as supplemented or amended (if applicable) will not contain any untrue statement of a material fact or omit

to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances

under which they were made, not misleading, except that no representation or warranty is made by the Company with respect to statements

made or incorporated by reference therein based on information supplied to the Company by Parent or Merger Sub or any of their respective

Representatives in writing specifically for use or incorporation by reference therein.

Section 4.10.

Absence of Certain Changes. Since December 31, 2025 (the “Balance

Sheet Date”) through the date of this Agreement, (a) the business of the Company and its Subsidiaries has been conducted

in the ordinary course except as has not had, or would not reasonably be expected to have, individually or in the aggregate, a Company

Material Adverse Effect and (b) there has not been any change, circumstance, effect, occurrence or development that has had or would

reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.

Section 4.11.

No Undisclosed Material Liabilities. (a) There are no liabilities or obligations of the Company or any of its

Subsidiaries of a type required to be reflected on a balance sheet prepared in accordance with GAAP, other than: (i) liabilities

or obligations to the extent

disclosed

and provided for in the Company Balance Sheet (or notes thereto); (ii) liabilities or obligations to the extent incurred in the ordinary

course of business since the Balance Sheet Date (none of which relates to a breach of Contract, breach of warranty, tort, misappropriation,

infringement or violation of Applicable Law); (iii) liabilities or obligations incurred in connection with the transactions contemplated

hereby; and (iv) liabilities or obligations which have not had, and would not reasonably be expected to have, individually or in the

aggregate, a Company Material Adverse Effect.

(b)

Neither the Company nor any of its Subsidiaries is a party to, or has any Contract to become a party to, any joint venture, off-balance

sheet partnership or any similar Contract, including any Contract relating to any transaction or relationship between or among the Company

or any of its Subsidiaries, on the one hand, and any unconsolidated affiliate, including any structured finance, securitization, special

purpose or limited purpose entity or Person, on the other hand, or any off-balance sheet arrangements (as contemplated by Instruction

8 to Item 303(b) of Regulation S-K of the SEC).

Section 4.12.

Compliance with Laws; Permits. Except as has not had, and would not reasonably be expected to have, individually

or in the aggregate, a Company Material Adverse Effect, (i) the Company and each of its Subsidiaries are, and since January 1, 2024 have

been, in compliance with all Applicable Laws and (ii) neither the Company nor any of its Subsidiaries nor any of their respective

assets is, to the Knowledge of the Company, under investigation with respect to or has been threatened in writing to be charged with

or given notice of, nor has any Governmental Authority notified the Company or any of its Subsidiaries in writing of its intent to conduct

an investigation of, any violation of any Applicable Law.

Section 4.13.

Litigation. As of the date hereof, there is no (a) Proceeding pending, or, to the Knowledge of the

Company, threatened, against the Company or any of its Subsidiaries or any officer, director or employee of the Company or any of its

Subsidiaries in such capacity by or before any Governmental Authority or (b) Order outstanding against the Company or any of its Subsidiaries,

in each case, except as has not been, and would not reasonably be expected to be, material to the Company and its Subsidiaries, taken

as a whole.

Section 4.14.

Properties.

(a)

Except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse

Effect, the Company and its Subsidiaries have good title to, or valid leasehold interests in, all real property and assets reflected

on the Company Balance Sheet or acquired after the Balance Sheet Date, in each case free and clear of all Liens other than Permitted

Liens, except as have been disposed of since the Balance Sheet Date in the ordinary course of business.

(b)

The Company and its Subsidiaries have good and marketable (or the equivalent title in the applicable jurisdiction) to all Owned

Real Property, free and clear of all Liens other than Permitted Liens. Except as has not had, and would not reasonably be expected to

have, individually or in the aggregate, a Company Material Adverse Effect, or, as set forth on ‎‎Section 4.14(b)

of the Company Disclosure Schedule, to the Company’s Knowledge, (i) neither the Company nor any of its Subsidiaries is in material

breach or material default under any material restrictive, affirmative

other covenant or restriction encumbering any Owned Real Property, (ii) neither the Company nor any of its Subsidiaries has leased or

otherwise granted to any Person the right to use or occupy any Owned Real Property or any portion thereof, (iii) other than the right

of Parent pursuant to this Agreement, there are no outstanding options, rights of first offer or rights of first refusal to purchase

any Owned Real Property or any portion thereof or interest therein, and (iv) neither the Company nor any of its Subsidiaries is a party

to any agreement or option to purchase any real property or interest therein.

(c)

To the Company’s Knowledge, the Company has made available to Parent a current, complete and accurate copy of each Lease

and all amendments thereto. Except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a

Company Material Adverse Effect, or, as set forth on ‎‎Section 4.14(c)

of the Company Disclosure Schedule, (i) to the Company’s Knowledge, each Lease is legal, valid, binding, enforceable, and in full

force and effect and no event has occurred that, with notice, lapse of time or both, would constitute a default by the Company or any

of its Subsidiaries or any other party under any Lease, (ii) to the Company’s Knowledge, neither the Company nor any of its

Subsidiaries, nor any other party to a Lease, is in violation of any provision of any Lease or is in default under any Lease, and (iii)

neither the Company nor any of its Subsidiaries has (x) subleased, licensed, or otherwise granted any Person the right to use or occupy

any Leased Real Property or any portion thereof or (y) collaterally assigned or granted any security interest in any Lease or any interest

therein.

(d)

The Owned Real Property and Leased Real Property comprise all of the real property used in, or otherwise related to, the business

of the Company and its Subsidiaries. Except, as has not had, and would not reasonably be expected to have, individually or in the aggregate,

a Company Material Adverse Effect, (i) there is no condemnation or other proceeding in eminent domain pending or, to the Company’s

Knowledge, otherwise threatened, affecting any Owned Real Property, and (ii) all buildings, structures, improvements, fixtures, building

systems and equipment included in or located on the Owned Real Property are good condition and repair, and sufficient for the operation

of the business of the Company and its Subsidiaries.

Section 4.15.

Intellectual Property. (a) Except as has not had, and would not reasonably be expected to have, individually

or in the aggregate, a Company Material Adverse Effect: (i) to the Company’s Knowledge, neither the Company or any of

its Subsidiaries nor the conduct of the business of the Company or any of its Subsidiaries as currently or previously conducted is or

has been in the last six years infringing, misappropriating or violating the Intellectual Property rights of any Person, and (ii) there

is no (and has not in the last three years been any) claim or Proceeding pending or, to the Company’s Knowledge, threatened in

writing, against the Company or any of its Subsidiaries alleging any of the foregoing.

(b)

Except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse

Effect: (i) to the Knowledge of the Company, no Person is, or in the past six years has been, infringing, misappropriating, or violating

the Company-Owned Intellectual Property, and (ii) in the past three years, neither the Company nor any of its Subsidiaries have sent

a written notice or claim or initiated any Proceeding alleging the same.

(c)

Except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse

Effect: (i) none of the Registered Company-Owned Intellectual Property has been adjudged invalid or unenforceable in whole or in part,

(ii) there is no pending or, to the Company’s Knowledge, threatened Proceeding challenging or contesting the validity or enforceability

of any Company-Owned Intellectual Property, and (iii) the Registered Company-Owned Intellectual Property is subsisting and, to the Company’s

Knowledge, valid and enforceable.

(d)

Except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse

Effect, either the Company or one of its Subsidiaries: (i) exclusively owns the Company-Owned Intellectual Property, or (ii) to the Company’s

Knowledge, has a valid, enforceable, and sufficient right to all Intellectual Property used in or necessary for the operation of the

business of the Company or any of its Subsidiaries, in each case of (i) and (ii), free and clear of any Liens (other than Permitted Liens).

(e)

Except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse

Effect: (i) the Company and its Subsidiaries have taken reasonable measures to protect the confidentiality of trade secrets and confidential

information owned by the Company or any of its Subsidiaries, and (ii) no such trade secrets or other confidential information have been

disclosed or authorized to be disclosed to any Person other than in the ordinary course of business pursuant to a reasonable, written

confidentiality and non-disclosure agreement.

(f)

Except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse

Effect: (i) the IT Systems are adequate and sufficient for the operation of the business of the Company and its Subsidiaries as currently

conducted, (ii) the Company and its Subsidiaries have implemented commercially reasonable technical and physical safeguards designed

to protect the IT Systems (and any Personal Information stored therein) against unauthorized access, collection, disclosure, destruction,

loss, theft or exfiltration, (iii) to the Company’s Knowledge, no IT Systems contain any “virus”, “back door,”

“time bomb”, “Trojan horse” or other malicious code, and (iv) to the Company’s Knowledge, there have not

been any Security Incidents.

(g)

Except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse

Effect, to the Knowledge of the Company, the Company and its Subsidiaries are in compliance, and during the past three years have been

in compliance, with all Applicable Laws with respect to Privacy Requirements. To the Company’s Knowledge, no claims have been threatened

against the Company or any of its Subsidiaries alleging a violation of any Person’s privacy or personal information or data rights,

except for claims that would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Except

as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, neither

the Company nor any of its Subsidiaries are, or during the past three years have, (i) received any notice of any audit, investigation,

complaint or other Proceeding by any Person, or (ii) sent or been required to send to any Person any notice, in each case of (i) and

(ii), concerning any Security Incident or any actual or potential violation of any Privacy Requirements.

Section 4.16.

Taxes. Except as has not had, and would not reasonably be expected to have, individually or in the aggregate,

a Company Material Adverse Effect:

(a)

All Tax Returns required by Applicable Law to be filed with any Taxing Authority by, or on behalf of, the Company or any of its

Subsidiaries have been filed when due in accordance with all Applicable Law (taking into account all extensions), and all such Tax Returns

are true, correct and complete.

(b)

The Company and each of its Subsidiaries has paid (or has had paid on its behalf) to the appropriate Taxing Authority all Taxes

due and payable. The Company and its Subsidiaries have deducted, withheld and timely paid to the appropriate Taxing Authority all Taxes

required to be deducted, withheld or paid in connection with amounts paid or owing to any employee, former employee, independent contractor,

creditor, stockholder or other third party.

(c)

There is no Proceeding now pending or, to the Company’s Knowledge, threatened in writing against or with respect to the

Company or its Subsidiaries in respect of any Tax.

(d)

There are no Liens on any of the assets of the Company or any of its Subsidiaries with respect to Tax, other than Permitted Liens.

(e)

With respect to any tax years open for audit as of the date of this Agreement, neither the

Company nor any of its Subsidiaries has entered into a written agreement waiving or extending any statute of limitations with respect

to Taxes.

(f)

Other than with respect to a Tax Return for which the statute of limitations has expired, neither the Company nor any of its Subsidiaries

has any liability for the Taxes of any Person (other than the Company or its Subsidiaries) under Treasury Regulations Section 1.1502-6

or any similar provision of state, local or non-U.S. Applicable Law or as a successor or transferee.

(g)

Neither the Company nor any of its Subsidiaries has participated in any “listed transactions” within the meaning of

Treasury Regulations Section 1.6011-4(b)(2).

Notwithstanding anything else in this

Agreement to the contrary, the representations and warranties set forth in this Section 4.16 and those portions of Section

4.17 that relate to Taxes are the only representations and warranties of the Company being made hereunder with respect to Tax matters.

The representations in this Section 4.16 may be relied upon only with respect to tax periods ending on or prior to the Closing

Date. The Company and its Subsidiaries make no representation or warranty in this Section 4.16 or otherwise as to the amount or

availability of, or as to the existence or non-existence of limitations (or the extent of any such limitations) on, the Tax attributes

of the Company or any Subsidiary, including Tax basis, net operating losses, capital losses, Tax credits or other Tax assets or attributes.

Section 4.17.

Employee Benefit Plans. (a) ‎Section 4.17(a) of the Company Disclosure Schedule sets forth

list of all material Company Plans. The Company has made available to Parent a current, accurate and complete copy of each material Company

Plan and all amendments thereto as of the date hereof and, to the extent applicable: (i) any related trust agreement, insurance

policy or other funding instrument and all amendments thereto, (ii) any summary plan description or summary of material modifications,

(iii) for the most recent plan year, the filed Form 5500 annual

report

(with applicable schedules and attachments thereto); (iv) the most recent favorable determination letter from the IRS or opinion issued

to the prototype sponsor with respect to each such Company Plan intended to qualify under Section 401 of the Code; and (v) any material

non-routine communication with any Governmental Authority since January 1, 2024.

(b)

Each Company Plan has been established, funded, maintained, operated and administered in accordance with its terms and in compliance

with ERISA, the Code and other Applicable Law, except as has not had, and would not reasonably be expected to have, individually or in

the aggregate, a Company Material Adverse Effect. Each Company Plan intended to be “qualified” under Section 401(a)

of the Code has received or is eligible to rely upon a favorable determination or opinion letter from the IRS or has applied to the IRS

for such a letter within the applicable remedial amendment period that the Company Plan is so qualified and the trusts maintained thereunder

are exempt from taxation under Section 501(a) of the Code; and, nothing has occurred, and, to the Knowledge of the Company, no condition

exists, that would reasonably be expected to cause the loss of such qualified status of such Company Plan or result in the loss of qualified

or tax-exempt status of each trust intended to qualify under Section 501(a) of the Code.

(c)

Except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse

Effect, each Company Plan that constitutes in any part a “nonqualified deferred compensation plan” within the meaning of

Section 409A of the Code has been operated and administered in all respects in operational compliance with, and is in all respects in

documentary compliance with, Section 409A of the Code and all IRS guidance promulgated thereunder.

(d)

The Company has no current or contingent obligation to indemnify, gross-up, reimburse or otherwise make whole any Person for any

Taxes, including those imposed under Section 409A or 4999 of the Code (or any corresponding provisions of state, local or foreign

Tax law).

(e)

There is no pending or, to the Knowledge of the Company, threatened assessment, complaint, Proceeding or investigation of any

kind in any court, by any Governmental Authority or otherwise with respect to any Company Plan (in each case, other than routine claims

for benefits), in each case, except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a

Company Material Adverse Effect.

(f)

Neither the execution of this Agreement nor the consummation of the transactions contemplated hereby could, either alone or in

conjunction with any other event, (i) other than with respect to the treatment of Company RSUs, Company PSUs, and Company Options

in accordance with ‎‎‎Section 2.05, entitle

any Company Service Provider to any payment or benefit, or accelerate the time of payment, funding or vesting, or otherwise increase

the amount of, compensation due or payable or the level of benefits to be provided to any Company Service Provider under any Company

Plan, (ii) limit the right to merge, amend or terminate any Company Plan (except any limitations imposed by Applicable Law), or

(iii) result in the payment or funding of any amount or provision of any benefit that could, individually or in combination with

any other such payment or benefit, reasonably be expected to constitute an “excess parachute payment” under Section 280G(b)(1)

or 4999 of the Code.

(g)

Neither the Company nor any of its Subsidiaries has, in the past six years, sponsored, maintained, contributed to, been required

to contribute to, or had any liability or other obligation (contingent or otherwise), including as the result of any ERISA Affiliate,

with respect to, any (i) Pension Plan, (ii) a “multiple employer plan” within the meaning of Section 210 of ERISA or Section

413(c) of the Code, or (iii) a “multiple employer welfare arrangement” as defined in Section 3(40) of ERISA. No Company Plan

provides, and neither the Company nor any of its Subsidiaries has an obligation to provide, post-employment or post-service health or

life insurance benefits or coverage, or other retiree welfare benefits, to any Person (other than as required under Part 6 of Subtitle

B of Title I of ERISA, Section 4980B of the Code, or any other Applicable Laws (for which such Person pays the full cost of coverage)).

(h)

Except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse

Effect, neither the Company nor any of its Subsidiaries has incurred (whether or not assessed) any Tax or other penalty under Section

4980B, 4980D, 4980H, 6055, 6056, 6721, or 6722 of the Code. There has been no material “prohibited transaction” within the

meaning of Section 4975 of the Code or Section 406 of ERISA or breach of fiduciary duty (as determined under ERISA) with respect to any

Company Plan.

Section 4.18.

Employee and Labor Matters. (a) Except as set forth on ‎‎Section 4.18(a) of the Company

Disclosure Schedule, neither the Company nor any of its Subsidiaries is a party to, bound by, or subject to any collective bargaining

agreement or other labor-related contract with any Union (each, a “CBA”),

and none are currently being negotiated; and no employees of the Company or any of its Subsidiaries are represented by any Union with

respect to their employment with the Company or any of its Subsidiaries. The Company has timely satisfied and will timely

satisfy any legal or contractual requirement to provide notice or information to, bargain with, enter into any consultation procedure

with, or obtain consent from, any labor Union which is representing any employee of the Company or any of its Subsidiaries, or any applicable

labor tribunal, in connection with the execution of this Agreement or the transactions contemplated by this Agreement. Since January

1, 2024, (i) no Union or group of current or former Company Employees has made a written demand to the Company for recognition or certification,

(ii) to the Knowledge of the Company, there have been no labor organizing activities with respect to any current or former Company Employees

and no such activities have been threatened, and (iii) except as has not had, and would not reasonably be expected to have, a Company

Material Adverse Effect, there have been no unfair labor practice charges, labor grievances, labor arbitrations, strikes, lockouts, work

stoppages, slowdowns, picketing, hand billing or other labor disputes against the Company or its Subsidiaries.

(b)

Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, the Company and its Subsidiaries

are, and for the last three years have been, in compliance with all Applicable Laws respecting labor, employment and employment practices,

including all Applicable Laws respecting terms and conditions of employment, health and safety, wages and hours (including the classification

and treatment of independent contractors and exempt and non-exempt employees), immigration (including the completion of Forms I-9 for

all U.S. employees and the proper confirmation of employee visas), whistleblower protections, employment discrimination, harassment,

retaliation, restrictive covenants, pay transparency, disability rights or benefits, equal opportunity, plant closures and layoffs (including

the Worker Adjustment and Retraining Notification Act of 1988 or any similar laws (the “WARN

Act”)), labor

relations,

automated employment decision tools and other artificial intelligence, employee leave issues, employee trainings and notices, COVID-19,

affirmative action and unemployment insurance.

(c)

There are no currently pending, or to the Knowledge of the Company, threatened, employment-related Proceedings against the Company

or its Subsidiaries based on, arising out of, in connection with, or otherwise relating to the employment, application for employment,

or termination of any Company Service Provider by the Company or its Subsidiaries, in each case, except as has not had, and would not

reasonably be expected to have, a Company Material Adverse Effect.

(d)

The Company and its Subsidiaries have reasonably investigated all material sexual harassment allegations against officers, directors,

or executive-level employees of the Company or its Subsidiaries which have been reported in writing to the Company or its Subsidiaries.

With respect to each such allegation (except those the Company or its Subsidiaries reasonably deemed to not have merit), the Company

or its Subsidiaries have taken corrective action reasonably calculated to prevent further improper action.

Section 4.19.

Environmental Matters. Except as has not had, and would not reasonably be expected to have, a Company Material

Adverse Effect:

(a)

since January 1, 2024 through the Closing Date, no written notice, order, complaint or penalty has been received by the Company

or any of its Subsidiaries arising under any Environmental Laws, and there are no Proceedings pending or, to the Knowledge of the Company,

threatened which allege a violation by, or liability of, the Company or any of its Subsidiaries of any Environmental Laws;

(b)

the Company and each of its Subsidiaries have all material Permits necessary for their operations to comply with all Environmental

Laws and are now, and since January 1, 2024 have been, in compliance with the terms of such Permits;

(c)

the Company and each of its Subsidiaries are, and since January 1, 2024 have been, in compliance with all Environmental Laws;

(d)

neither the Company nor any of its Subsidiaries has received any written request for information pursuant to Section 104(e) of

the Comprehensive Environmental Response, Compensation and Liability Act or similar state statute, concerning any release or threatened

release of Hazardous Substances at any location except, with respect to any such request for information concerning any such release

or threatened release, to the extent such matter has been resolved with the appropriate foreign, federal, state or local regulatory authority

or otherwise;

(e)

neither the Company nor any of its Subsidiaries (or any other Person to the extent giving rise to liability for the Company or

any of its Subsidiaries) has Released any Hazardous Substance at, on, under, to, in or from any real property or facility currently or,

to the Knowledge of the Company, formerly owned, leased or operated by the Company or any of its Subsidiaries, in each case as would

give rise to liability for the Company or its Subsidiaries under any Environmental Laws;

(f)

neither the Company nor any of its Subsidiaries has assumed or provided an indemnity with respect to the liability of another

Person arising under Environmental Laws or relating to Hazardous Substances; and

(g)

the Company has made available to Parent copies of all material environmental audits, assessments and reports and other documents

relating to material environmental, health or safety liabilities relating to the current or former properties, facilities or operations

of the Company, in each case which are in the possession or reasonable control of the Company or any of its Subsidiaries.

Section 4.20.

Material Contracts.

(a)

Except as set forth on ‎Section 4.20

of the Company Disclosure Schedule (excluding any Contract that is or relates to a Company Plan), as of the date hereof, neither the

Company nor any of its Subsidiaries is a party to our bound by any:

(i)

Contract that is required to be filed by the Company as a “material contract” (as such term is defined in Item 601(b)(10)

of Regulation S-K of the SEC) but is not so filed;

(ii)

indenture, credit agreement, loan agreement, security agreement, guarantee, note, mortgage or other evidence of indebtedness for

borrowed money or any debt securities or agreement providing for indebtedness in excess of $20,000,000;

(iii)

Contract for the sale of any material portion of its assets after the date hereof (other than sales of inventory, product or obsolete

equipment in the ordinary course of business);

(iv)

Contract under which the Company or any Subsidiary of the Company has an ongoing obligation with respect to an “earn out,”

holdback, contingent purchase price or similar contingent payment obligation;

(v)

settlement agreement, conciliation or similar agreement with a Governmental Authority involving future performance by the Company

or any of its Subsidiaries, in any such case, that is material to the Company and its Subsidiaries, taken as a whole;

(vi)

Contract that restricts in any material respect the ability of the Company or any of its Subsidiaries to compete in any line of

business or geographic area and that is material to the Company and its Subsidiaries, taken as a whole;

(vii)

Contract with respect to a material joint venture, partnership agreement, strategic alliance or similar Contract relating to the

formation, creation, operation, management or control of any joint venture or partnership or the ownership of any equity interest in

any Person other than the Company’s Subsidiaries or securities held for investment by the Company or its Subsidiaries in the ordinary

course of business;

(viii)

other Contract that could reasonably be expected to involve aggregate payments by the Company or any of its Subsidiaries during

calendar year 2026 or any subsequent 12-month period of at least $20,000,000 and which is not terminable by either party on less than

60 days’ written notice without material penalty, except for any such Contract which is entered into in the ordinary course of

business;

(ix)

other Contract that could reasonably be expected to involve aggregate payments from a Third Party to the Company or any of its

Subsidiaries during calendar year 2026 or any subsequent 12-month period of at least $50,000,000 and which is not terminable by either

party on less than 60 days’ written notice without penalty;

(x)

Contract relating to the settlement of any litigation Proceeding that provides for any continuing material obligations on the

part of the Company or any of its Subsidiaries; or

(xi)

Contract to enter into any of the foregoing.

Each such contract

described in the foregoing clauses ‎(i) – ‎(xi)

is referred to herein as a “Material Contract.” The Company has

made available to Parent true, complete and correct (in all material respects) copies of the Material Contracts.

(b)

Except as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse

Effect, (i) neither the Company nor any of its Subsidiaries is (and, to the Knowledge of the Company, no other party is) in default under

any Material Contract, (ii) each of the Material Contracts is in full force and effect, and is a valid, binding and enforceable obligation

of the Company or its applicable Subsidiary, and to the Knowledge of the Company, of the other parties thereto, subject to the Enforceability

Exceptions, (iii) the Company and its Subsidiaries have performed all obligations required to be performed by them to date under the

Material Contracts and are not (with or without the lapse of time or the giving of notice, or both) in breach thereunder, and (iv) neither

the Company nor any of its Subsidiaries has received any written notice of termination from any other party to any Material Contract

that such other party intends to terminate, not renew or renegotiate in any material respects the terms of any such Material Contract.

Section 4.21.

Trade Controls; FCPA. (a) Since January 1, 2022, the Company, its Subsidiaries, and their respective directors,

officers, and, to the Knowledge of the Company, managers, employees, agents, or representatives, have, in all material respects, (i)

conducted their transactions and dealings in accordance with all applicable anti-money laundering laws of any jurisdiction to which the

Company or any Subsidiary is subject, (ii) not been in violation of any import, export, re-export, transfer, and re-transfer control

laws, rules, regulations, and statutes of any jurisdiction to which the Company or any Subsidiary is subject (“Trade

Control Laws”), and (iii) not been in violation of any anti-bribery or anti-corruption law of any jurisdictions to which

the Company or any Subsidiary is subject, including the U.S. Foreign Corrupt Practices Act of 1977 and the United Kingdom Bribery Action

2010 (“Anti-Corruption Laws”).

(b)

None of the Company, any Subsidiary thereof, nor any of their respective directors, officers or, to the Knowledge of the Company,

managers, employees, agents, or representatives,

(i)

has been or is a Sanctioned Person, or (ii) has, since January 1, 2022, acting for or on behalf of the Company or any Subsidiary, transacted

business with or for the benefit of a Sanctioned Person or otherwise violated, in any material respect, applicable Sanctions.

(c)

The Company and each of its Subsidiaries have implemented and maintain in effect written policies and procedures and internal

controls reasonably designed to prevent, deter and detect violations of applicable Trade Control Laws, Sanctions, and Anti-Corruption

Laws.

(d)

Since January 1, 2022, neither the Company nor any of its Subsidiaries has been the subject of any investigation by any Governmental

Authority, made any voluntary or involuntary disclosure to any Governmental Authority, received any notice or inquiry from any Governmental

Authority or internal or external allegation, or conducted any internal investigation or audit, in each case, relating to an actual or

potential violation of Trade Control Laws, Sanctions or Anti-Corruption Laws.

(e)

There are no pending or, to the Knowledge of the Company, threatened Proceedings against the Company of any of its Subsidiaries

alleging a violation of any Trade Control Laws, Sanctions or Anti-Corruption Laws.

Section 4.22.

Healthcare and FDA Regulatory Matters. (a) Except as has not had, and would not reasonably be expected to have,

a Company Material Adverse Effect, the Company and each of its Subsidiaries are, and since January 1, 2022 have been, in compliance with

all Healthcare Laws applicable to the business of the Company and its Subsidiaries.

(b)

Neither the Company, its Subsidiaries, nor any of their respective directors, officers or managers, or, to the Knowledge of the

Company, managing employees (as such term is defined in 42 U.S.C. § 1320a-5(b)) is or has been: (i) debarred, disqualified, excluded,

or suspended by any Governmental Authority (including the FDA pursuant to its authority under 21 U.S.C. § 335a and 21 C.F.R. §

812.119); (ii) subject to a civil monetary penalty assessed under Section 1128A of the Social Security Act in connection with any material

violation of any Governmental Health Program requirement; (iii) listed on the General Services Administration published list of parties

excluded from federal procurement programs and non-procurement programs; or (iv) charged with, convicted of or entered a plea of guilty

or nolo contendere to any criminal or civil offense relating to the delivery of any item or service under a Governmental Health Program.

Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, neither the Company, its Subsidiaries,

nor any of their respective directors, officers or managers, or, to the Knowledge of the Company, managing employees (as such term is

defined in 42 U.S.C. § 1320a-5(b)) has been or is a party to, nor has any ongoing reporting obligations pursuant to, any corporate

integrity agreements, deferred prosecution agreements, monitoring agreements, consent decrees, settlement agreements, criminal actions,

plans of correction or similar agreements or Orders with or imposed by any Governmental Authority concerning any Healthcare Law or Medical

Device Law.

(c)

Except as has not had, and would not reasonably be expected to have, a Company Material Adverse Effect, since January 1, 2022,

the Company and each of its Subsidiaries have implemented physical, technical and administrative safeguards to protect “protected

health information” or “PHI” (as defined under HIPAA). Except as has not had, and would not reasonably

expected to have, a Company Material Adverse Effect, since January 1, 2024, neither the Company, its Subsidiaries, nor any of their respective

directors, officers or employees have received notice, complaints, or audit requests from any Governmental Authority regarding uses or

disclosures of PHI or its alleged failure to comply with HIPAA or any other Healthcare Law applicable to PHI.

(d)

The Company and its Subsidiaries have, and for the past five years have maintained, all Permits required and issued by the FDA

and comparable local, state, and foreign Governmental Authorities (“Medical Device Permits”)

necessary for the conduct of the business by of the Company and its Subsidiaries as currently conducted, except as has not had, and would

not reasonably be expected to have, a Company Material Adverse Effect. The Company and its Subsidiaries are not in violation or breach

of any of the Medical Device Permits. In the past five years, neither the Company nor any Subsidiary has received notice of any Proceedings

pending or, to the Knowledge of the Company, threatened relating to the suspension, revocation or modification of any Medical Device

Permit.

(e)

Except as set forth on ‎Section 4.22

of the Company Disclosure Schedule, for the past five years, the operations of the Company and its Subsidiaries have been in material

compliance with Medical Device Laws. The operations of the Company and its Subsidiaries regarding the design, development, manufacturing,

testing, packaging, labeling, storage, handling, distribution, marketing, advertising, import, and export of medical devices have been

conducted in material compliance with Applicable Laws, including the requirements of current good manufacturing practices under 21 C.F.R.

Part 820, ISO 13485:2016, and applicable comparable local, state, and foreign Applicable Laws. As applicable, the medical device manufacturing

establishments are registered, and medical devices are listed, with the FDA and comparable local, state, and foreign Governmental Authorities

whenever legally required in the jurisdictions where the devices are designed, manufactured, distributed, and/or sold.

(f)

Except as set forth on ‎Section 4.22

of the Company Disclosure Schedule, for the past five years (i) there have been no recalls, field safety corrective actions, corrections,

or removals ordered (or, to the Knowledge of the Company, threatened) by the FDA or any comparable Governmental Authority with respect

to any products designed, manufactured, processed, marketed, or sold by the Company or its Subsidiaries, (ii) the Company and its Subsidiaries

have neither voluntarily nor at the request of any Governmental Authority initiated or participated in any recalls, field safety corrective

actions, corrections or removals of any products designed, manufactured, marketed, or sold by the Company or its Subsidiaries, and (iii)

to the Knowledge of the Company, no customer of the Company or its Subsidiaries has voluntarily, nor at the request of any Governmental

Authority, initiated or participated in any recalls, field safety corrective actions, corrections or removals of products designed, processed,

or manufactured by the Company or its Subsidiaries as a direct or indirect result of the services of the Company or any of its Subsidiaries.

To the Knowledge of the Company, there are no facts or circumstances reasonably likely to result in a recall, field safety corrective

action, correction, or removal of any product designed, manufactured, processed, marketed, or sold by the Company or any of its Subsidiaries.

(g)

In the past five years, no product designed, manufactured, processed, marketed or sold by the Company or any of its Subsidiaries

has been seized, withdrawn, detained, subject to a suspension, destruction order, safety alert or similar action, and there are no facts

or circumstances

reasonably

likely to cause (i) the seizure, denial, withdrawal, detention, public health notification, safety alert or suspension or termination

of manufacturing, testing, marketing, or other activity relating to any such product, or (ii) a change in the labeling of any such product

suggesting a compliance issue or risk. No Proceeding in the United States or any other jurisdiction seeking the withdrawal,

revocation, suspension, import refusal or import alert, or seizure of any product designed, manufactured, processed, marketed or sold

by the Company or any of its Subsidiaries is pending or, to the Knowledge of the Company, threatened against the Company or any of its

Subsidiaries.

(h)

For the past five years, all reports, statements, documents, registrations, filings, and submissions required to be filed by or

on behalf of the Company or any of its Subsidiaries with the FDA or any comparable local, state, or foreign Governmental Authority have

been filed, properly maintained, amended and supplemented as required by Medical Device Laws, except as has not had, and would not reasonably

be expected to have, individually or in the aggregate, a Company Material Adverse Effect. All such reports and filings were and are complete

and truthful and in material compliance with Medical Device Laws when filed or as amended or supplemented, and no deficiencies have been

asserted in writing by any Governmental Authority with respect to such reports and filings, except as has not had, and would not reasonably

be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Neither the Company, nor any Subsidiary, officer,

director, employee or, to the Knowledge of the Company, agent or subcontractor of the Company or any of its Subsidiaries made any untrue

statement of a material fact or a fraudulent statement to the FDA or any other Governmental Authority responsible for enforcement or

oversight with respect to applicable FDA Laws, or failed to disclose a material fact required to be disclosed to the FDA or such other

Governmental Authority that, at the time such disclosure was made, would reasonably be expected to provide a basis for the FDA to invoke

its policy respecting “Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities” set forth in 56 Fed.

Reg. 46191 (September 10, 1991), or for any other Governmental Authority to invoke a similar policy.

Section 4.23.

Insurance. Except as has not had, and would not reasonably be expected to have, individually or in the aggregate,

a Company Material Adverse Effect, (a) the Company and its Subsidiaries maintain insurance in such amounts and against such risks and

with such carriers as the Company reasonably has determined to be prudent, taking into account the industries in which the Company and

its Subsidiaries operate and as is sufficient to comply with Applicable Law, (b) all insurance policies of the Company and its Subsidiaries

are in full force and effect, except for any expiration thereof in accordance with the terms thereof, (c) neither the Company nor any

of its Subsidiaries is in breach of, or default under, any such insurance policy, and (d) no written notice of cancellation or termination

has been received with respect to any such insurance policy, other than in connection with ordinary renewals. All material insurance

policies of the Company and its Subsidiaries have been made available to Parent.

Section 4.24.

Finders’ Fees. Except for Goldman Sachs & Co. LLC, there is no investment banker, financial advisor,

broker, finder or other intermediary that has been retained by or is authorized to act on behalf of the Company or any of its Subsidiaries

who might be entitled to any material fee or commission from the Company or any of its Affiliates in connection with the transactions

contemplated by this Agreement. The Company has made available to Parent true and complete copies of all engagement letters

or other agreements with any broker, finder,

investment

banker or other similar Person engaged by or on behalf of the Company (including Goldman Sachs & Co. LLC) in connection with the

transactions.

Section 4.25.

Opinion of Financial Advisor. The Board of Directors has received the opinion of Goldman Sachs & Co. LLC, financial

advisor to the Company, that, as of the date of this Agreement, and subject to the qualifications, limitations and matters set forth

therein, the Merger Consideration to be received by the holders of Company Common Shares is fair to such holders (other than Parent and

its Affiliates) from a financial point of view. It is agreed and understood that such opinion is for the benefit of the Board

of Directors and may not be relied on by Parent or Merger Sub for any purpose. A signed, correct and complete copy of such opinion will

promptly be made available to Parent for informational purposes only, following receipt thereof by the Company.

Section 4.26.

Antitakeover Statutes. The Company has taken all necessary actions so that the restrictions on business

combinations set forth in Section 203 of the DGCL and any other similar applicable “anti-takeover” law will not be applicable

to the Merger.

Section 4.27.

Related Party Transactions. Neither the Company nor any of its Subsidiaries is party to any agreement, commitment,

arrangement or understanding that would be required to be disclosed under Item 404 of Regulation S-K of the SEC, in each case, that is

not so disclosed.

Section 4.28.

Acknowledgement of No Other Representations and Warranties. Except for the express representations and warranties

set forth in ‎‎ ‎Article 5 or in any certificate delivered pursuant to this Agreement, the Company acknowledges

and agrees that no representation or warranty of any kind whatsoever, express or implied, at law or in equity, is made or shall be deemed

to have been made by or on behalf of Parent or Merger Sub to the Company, and the Company hereby disclaims reliance on any such other

representation or warranty, whether by or on behalf of Parent or Merger Sub, and notwithstanding the delivery or disclosure to the Company,

or any of its Representatives or Affiliates, of any documentation or other information by Parent, Merger Sub or any of their respective

Representatives or Affiliates with respect to any one or more of the foregoing.

Article 5

Representations and Warranties of Parent and Merger Sub

Subject to ‎Section 11.05,

except to the extent set forth in the Parent Disclosure Schedule, Parent represents and warrants to the Company as follows:

Section 5.01.

Corporate Existence and Power. Each of Parent and Merger Sub (a) is a corporation, duly incorporated, validly

existing and in good standing under the laws of its jurisdiction of incorporation and (b) has all corporate powers required to carry

on its business as now conducted, except in the case of this clause ‎(b) where the failure to have such power or authority

has not had, and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect or prevent,

materially delay or materially impair the ability of Parent or Merger Sub to consummate the transactions contemplated hereby on a timely

basis, and in any event, prior to the Outside Date. Since the date of its incorporation, Merger Sub

has

not engaged in any activities other than in connection with or as contemplated by this Agreement. Merger Sub was incorporated

solely for the purpose of consummating the transactions contemplated by this Agreement. All of the outstanding shares of capital

stock of Merger Sub have been validly issued, are fully paid and nonassessable and are directly owned by, and at the Effective Time will

be directly owned by, Parent, free and clear of all Liens, excluding restrictions on transfer arising under applicable securities laws.

Section 5.02.

Corporate Authorization. The execution, delivery and performance by each of Parent and Merger Sub of this

Agreement and the consummation by Parent and Merger Sub of the transactions contemplated hereby are within the corporate powers of each

of Parent and Merger Sub and have been duly authorized by all necessary corporate action on the part of each of Parent and Merger Sub,

and no vote of the shareholders of Parent is necessary to authorize the execution, delivery or performance of this Agreement. Each

of Parent and Merger Sub has duly executed and delivered this Agreement, and, assuming due authorization, execution and delivery by the

Company, this Agreement constitutes a valid and binding agreement of each of Parent and Merger Sub, enforceable against each of Parent

and Merger Sub in accordance with its terms (except insofar as such enforceability may be limited by the Enforceability Exceptions).

Prior to the execution of this Agreement, Parent, as sole stockholder of Merger Sub, duly executed and delivered a written consent approving

and adopting this Agreement in accordance with Section 228 and Section 251 of the DGCL, which by its terms will be effective immediately

following execution of this Agreement and, when effective, will constitute the only approval of Merger Sub stockholders necessary to

adopt this Agreement.

Section 5.03.

Governmental Authorization. The execution, delivery and performance by each of Parent and Merger Sub of

this Agreement and the consummation by each of Parent and Merger Sub of the transactions contemplated hereby require no action by or

in respect of, or filing by Parent or Merger Sub with, any Governmental Authority, other than (a) compliance with any applicable requirements

of the HSR Act and any other applicable Competition Laws, (b) compliance with any applicable requirements of the 1933 Act, the 1934 Act

and any other applicable securities laws, (c) the filing of the Certificate of Merger with the Secretary of State of the State of Delaware

and appropriate documents with the relevant authorities of the other jurisdictions in which Merger Sub is qualified to do business and

(d) any other actions or filings the absence of which has not had, and would not reasonably be expected to have, individually or in the

aggregate, a Parent Material Adverse Effect or prevent, materially delay or materially impair the ability of Parent or Merger Sub to

consummate the transactions contemplated hereby on a timely basis, and in any event, prior to the Outside Date.

Section 5.04.

Non-Contravention. The execution, delivery and performance by each of Parent and Merger Sub of this Agreement

and, assuming compliance with the matters referred to in ‎‎Section 5.03, the consummation of the transactions contemplated

hereby do not and will not (a) contravene, conflict with, or result in any violation or breach of any provision of the organizational

documents of Parent or Merger Sub, (b) contravene, conflict with or result in a violation or breach of any provision of any Applicable

Law, (c) require any consent or other action by any Person under, violate, conflict with, result in breach of, constitute a default (or

an event that, with notice or lapse of time or both, would become a default) under, or cause or permit the termination, acceleration

of performance or cancellation of any agreement binding upon Parent or any of its Subsidiaries or (d) result in the creation or imposition

of any Lien on any properties, rights or asset

Parent or any of its Subsidiaries, with only such exceptions, in the case of each of clauses ‎(a) through ‎(d),

as has not had, and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect or prevent,

materially delay or materially impair the ability of Parent or Merger Sub to consummate the transactions contemplated hereby on a timely

basis, and in any event, prior to the Outside Date. Neither Parent nor Merger Sub is a “foreign person” as that

term is defined in Section 721 of the Defense Production Act of 1950, including all implementing regulations thereof (the “DPA”).

Section 5.05.

Disclosure Documents. None of the information supplied or to be supplied by or on behalf of Parent in writing

specifically for inclusion or incorporation by reference in the Proxy Statement will, at the date it (and any amendments or supplements

thereto) is first mailed to the stockholders of the Company and at the time of the Company Stockholders Meeting, contain any untrue statement

of a material fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances

under which they were made, not misleading, except that no representation or warranty is made by Parent with respect to statements made

or incorporated by reference therein based on information supplied by the Company or any of its Representatives in writing specifically

for use or incorporation by reference therein.

Section 5.06.

Compliance with Laws. Parent and each of

its Subsidiaries are, and since January 1, 2024 have been, in compliance with

all Applicable Laws, except for failure to comply or violations that would not reasonably be expected to have, individually or in the

aggregate, a Parent Material Adverse Effect.

Section 5.07.

Litigation. As of the date hereof, there is no Proceeding pending, or to the Knowledge of Parent, threatened,

against Parent, except as would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect,

and there is no Order outstanding that in any manner seeks to prevent, enjoin, materially impair or materially delay Parent’s or

Merger Sub’s ability to consummate the Merger or any of the other transactions contemplated hereby.

Section 5.08.

Finders’ Fees. There is no investment banker, financial advisor, broker, finder or other intermediary

that has been retained by or is authorized to act on behalf of Parent or any of its Subsidiaries who might be entitled to any fee or

commission from Parent or any of its Affiliates payable by the Company prior to the Closing in connection with the transactions contemplated

by this Agreement.

Section 5.09.

Financing. (a) Parent has delivered to the Company a true, complete and fully executed copy of (i) a debt commitment

letter, dated as of the date of this Agreement (including all related exhibits, schedules, annexes, supplements and term sheets thereto,

and including any related fee letter as described below and redacted in accordance with ‎Section 5.09(c), as each of

the foregoing may be amended, supplemented, replaced, substituted, terminated or otherwise modified or waived from time to time after

the date hereof in compliance with ‎Section 6.06, the “Debt Commitment Letter”),

from the Debt Financing Sources party thereto confirming their respective commitments to provide Parent with debt financing, subject

to the terms and conditions thereof, in connection with the transactions contemplated hereby in the amount set forth therein (the “Debt

Financing”) and (ii) an equity commitment letter (the “Equity Commitment

Letter” and together with the Debt Commitment Letter, the “Financing Commitment

Letters”)

from the Sponsor confirming its commitment to provide Parent with the equity financing, subject to the terms and conditions thereof,

in connection with the transactions contemplated hereby in the amount set forth therein (the “Equity

Financing” and together with the Debt Financing, the “Financing”).

(b)

The Equity Commitment Letter is in full force and effect and is a valid and binding obligation of Parent and the other parties

thereto, enforceable against Parent and the other parties thereto in accordance with its terms (subject to the Enforceability Exceptions). The

Debt Commitment Letter is in full force and effect and is a valid and binding obligation of Parent and, to the knowledge of Parent, the

other parties thereto, enforceable against Parent and, to the knowledge of Parent, the other parties thereto in accordance with its terms

(subject to the Enforceability Exceptions). As of the date hereof, none of Financing Commitment Letters have been amended

or modified, the respective commitments contained in the Financing Commitment Letters have not been withdrawn, rescinded or otherwise

modified, and no such amendment, modification, withdrawal or rescission of the Financing Commitment Letters is, to the Knowledge of Parent,

currently contemplated or the subject of current discussions (other than amendments to the Debt Commitment Letter to add additional lenders,

arrangers and agents). No event has occurred which, with or without notice, lapse of time or both, would or would reasonably

be expected to constitute a default or breach on the part of (x) Parent, Merger Sub or any of their respective Affiliates or any other

Person, under the Equity Commitment Letter or (y) Parent, Merger Sub or any of their respective Affiliates or, to the Knowledge of Parent,

any other Person, under the Debt Commitment Letter. All fees (if any) required to be paid under the Financing Commitment Letters

on or prior to the date hereof have been paid in full.

(c)

There are no conditions precedent directly or indirectly related to the funding of the full amount of the Financing other than

as expressly set forth in the Financing Commitment Letters. Other than the Financing Commitment Letters, there are no other

contracts, arrangements or understandings entered into by Parent or any Affiliate thereof related to the funding or investing, as applicable,

of the Financing (except for (i) customary fee letters relating to the commitments in the Debt Commitment Letter, a true, complete and

fully executed copy of each of which has been provided to the Company, with only the fee amounts, “market flex,” pricing

terms, pricing caps and other commercially sensitive terms redacted; provided that Parent represents and warrants that no such

redacted provisions in such fee letter permit the imposition of any new conditions (or the modification or expansion of any existing

conditions) or (ii) customary engagement letters or non-disclosure agreements which do not impact the conditionality or amount of the

Financing). As of the date hereof, assuming the satisfaction of the conditions to Parent’s obligation to consummate

the Merger, Parent has no reason to believe that any of the conditions to the Financing will not be satisfied or that the full amount

of the Financing will not be available in full to Parent on the Closing Date.

(d)

Assuming the Financing is funded on the Closing Date in accordance with the terms and conditions of the Financing Commitment Letters

and the Closing is consummated in accordance with the terms of this Agreement following satisfaction of the conditions precedent thereto,

the aggregate proceeds of the Financing (after giving effect to any market flex provisions with respect to the Debt Financing), will

be in an amount sufficient to enable Parent to (i) make the payment of the Merger Consideration and any other amounts to be paid by it

hereunder or under the Financing Commitment Letters and (ii) make any payments required to be made on or

after

the Closing under the Indentures in respect of the Convertible Notes as a result of the transactions contemplated hereby, including the

settlement of any conversions, without giving effect to any payments received pursuant to the Capped Call Transactions, of the Convertible

Notes pursuant to the terms of the Indentures (including any make-whole with respect thereto and assuming all conversions are settled

solely in cash) and, if applicable, the repurchase of the Convertible Notes as may be required pursuant the terms of the Indentures. Parent

acknowledges and agrees that the availability of funds (including the Financing) will not be a condition to the obligation of Parent

or Merger Sub to consummate the transactions contemplated hereby.

Section 5.10.

Solvency. Assuming (a) the satisfaction of the conditions to Parent’s obligation to consummate the

Merger (b) the accuracy of the representations and warranties set forth in ‎Article 4 of this Agreement and (c) the

Company and its Subsidiaries, on a consolidated basis, are Solvent immediately prior to the Effective Time, after giving effect to the

transactions contemplated by this Agreement (including any alternative financing, the payment of the aggregate Merger Consideration and

the payment of all related fees and expenses), the Surviving Corporation on a consolidated basis will be Solvent as of the Effective

Time and immediately after the consummation of the transactions contemplated hereby. For purposes of this Agreement, “Solvent”

when used with respect to any Person, means that as of any date of determination (i) the fair value of the assets of such Person

and its Subsidiaries on a consolidated basis, at a fair valuation, will exceed the debts and liabilities, contingent, subordinated or

otherwise, of such Person and its Subsidiaries on a consolidated basis, (ii) the present fair salable value of the property of such Person

and its Subsidiaries on a consolidated basis will be greater than the amount that will be required to pay the probable liability of such

Person and its Subsidiaries on a consolidated basis on their debts and liabilities as they become absolute and matured, (iii) such Person

and its Subsidiaries on a consolidated basis will be able to pay their debts and liabilities, subordinated, contingent or otherwise,

as they become absolute and matured and become due in the usual course of their affairs and (iv) such Person and its Subsidiaries on

a consolidated basis will not have unreasonably small capital with which to conduct the business in which they are engaged as such businesses

are now conducted and proposed to be conducted following the Closing Date.

Section 5.11.

Guarantee. Concurrently with the execution of this Agreement, Sponsor has delivered to the Company a duly

executed Guarantee. The Guarantee is in full force and effect and constitutes a valid and binding obligation of Sponsor, enforceable

against Sponsor in accordance with its terms (except insofar as such enforceability may be limited by the Enforceability Exceptions). As

of the date hereof, no event has occurred which, with or without notice, lapse of time or both, would constitute a default on the part

of Sponsor under such Guarantee.

Section 5.12.

No Prior Operations; Capitalization. Each of Parent and Merger Sub is a newly formed entity that was formed

specifically in connection with the transactions contemplated by this Agreement and, except as required in connection with the transactions

contemplated hereby, has not conducted any operations, owned an interest in any assets (including any ownership interest in any other

Person), incurred any liabilities of any nature or become party to any agreements. Sponsor is the indirect beneficial owner of 100% of

the outstanding ownership interests of Parent. Parent is the direct beneficial owner of 100% of the outstanding ownership interests of

Merger Sub.

Section 5.13.

Ownership of Common Shares. Neither Parent nor Merger Sub nor any of their respective Affiliates or “associates”

is the beneficial owner (within the meaning of Section 13 of the 1934 Act and the rules and regulations promulgated thereunder) of any

Company Common Shares or other Company Securities, and except as set forth in Section 5.13 of the Parent Disclosure Schedule,

neither Parent nor Merger Sub is a party to any agreement, arrangement or understanding (other than this Agreement) for the purpose of

acquiring, holding, voting, directing the voting of or disposing of any Company Common Shares or other Company Securities. Neither Parent

nor Merger Sub nor any of their respective Affiliates is, or has been within the past three years, an “associate” of the

Company. For purposes of this Section 5.13, the term “associate” shall have the meaning ascribed to it in Rule 12b-2

of the 1934 Act.

Section 5.14.

Acknowledgement of No Other Representations and Warranties. Except for the express representations and warranties

set forth in ‎‎‎Article 4 or in any certificate delivered pursuant to this Agreement, each of Parent and Merger

Sub acknowledges and agrees that no representation or warranty of any kind whatsoever, express or implied, at law or in equity, is made

or shall be deemed to have been made by or on behalf of the Company to Parent or Merger Sub, and each of Parent and Merger Sub hereby

disclaims reliance on any such other representation or warranty, whether by or on behalf of the Company, and notwithstanding the delivery

or disclosure to Parent or Merger Sub, or any of their respective Representatives or Affiliates, of any documentation or other information

by the Company or any of their respective Representatives or Affiliates with respect to any one or more of the foregoing.

Article 6

Covenants of the Company

Section 6.01.

Conduct of the Company. Except (w) with the prior written consent of Parent (which consent shall not be unreasonably

withheld, conditioned or delayed), (x) as required or contemplated or permitted by this Agreement, (y) as set forth in ‎‎‎Section 6.01

of the Company Disclosure Schedule or (z) as required by Applicable Law, from the date hereof until the Effective Time, the Company shall,

and shall cause each of its Subsidiaries to, use reasonable best efforts to conduct its business in accordance with Applicable Law and

in the ordinary course of business consistent with past practice to preserve intact the material components of its current business organizations

and relationships and goodwill with suppliers, customers, employees, Governmental Authorities and other material business relations and

not:

(a)

(i) amend the Company Certificate of Incorporation or Company Bylaws or (ii) amend the comparable organizational documents

of any of the Subsidiaries of the Company;

(b)

(i) adjust, split, combine, subdivide or reclassify any shares of its capital stock, (ii) declare, set aside, make or pay

any dividend or other distribution (whether in cash, shares or property or any combination thereof) in respect of its capital stock,

except for dividends or other such distributions by any of its Subsidiaries to the Company or to other Subsidiaries of the Company or

(iii) redeem, repurchase or otherwise acquire or offer to redeem, repurchase, or otherwise acquire any Company Securities or any Company

Subsidiary Securities, except as required by the terms of a Company Stock Plan;

(c)

(i) issue, deliver or sell, or authorize the issuance, delivery or sale of, any Company Securities or Company Subsidiary Securities,

other than (A) the issuance of any shares of Company Common Shares upon the settlement or exercise (as applicable) of Company Equity

Awards, and (B) any issuance, delivery or sale among the Company and any of its Subsidiaries or between any of such Subsidiaries or (ii)

amend any term of any Company Security or any Company Subsidiary Security;

(d)

acquire (by merger, consolidation, acquisition of shares or assets or otherwise), directly or indirectly, a material amount of

securities or any material business, division or other business organization in excess of $10,000,000 in the aggregate in any one transaction

or series of related transactions;

(e)

enter into any material new line of business outside the existing business of the Company and its Subsidiaries as of the date

of this Agreement (other than reasonably foreseeable extensions of the existing business of the Company and its Subsidiaries);

(f)

sell, lease, license, assign or otherwise transfer, encumber, abandon, let lapse or subject to any material Lien (in each case,

other than Permitted Liens) any material assets, businesses or properties of the Company or any of its Subsidiaries, including material

Company-Owned Intellectual Property and the Owned Real Property, other than (i) such sales, leases, assignments, transfers, Liens or

other dispositions of inventory or other assets (excluding Company-Owned Intellectual Property) that are in the ordinary course of business

consistent with past practice, (ii) pursuant to existing Contracts, (iii) among the Company and any of its Subsidiaries, (iv) non-exclusive

licenses of Company-Owned Intellectual Property granted in the ordinary course of business consistent with past practice or (v) the abandonment

or lapse of Company-Owned Intellectual Property in the ordinary course of business;

(g)

disclose to any Person any material trade secrets or other material confidential information of the Company or any of its Subsidiaries

(other than in the ordinary course of business pursuant to a reasonable, written confidentiality and non-disclosure agreement);

(h)

other than in connection with actions permitted by ‎Section 6.01(d),

make any material loans, advances or capital contributions to, or investments in, any other Person (other than loans or advances among

the Company and any of its wholly owned Subsidiaries and capital contributions to or investments in its wholly owned Subsidiaries in

the ordinary course of business), other than trade credit and similar loans and advances made to employees, customers and suppliers in

the ordinary course of business consistent with past practice;

(i)

other than (i) borrowings under the Company Credit Facilities or (ii) indebtedness incurred between the Company and any of

its wholly owned Subsidiaries or between any of such wholly owned Subsidiaries or guarantees by the Company of indebtedness of any wholly

owned Subsidiary of the Company, (A) incur any indebtedness for borrowed money or any debt securities (or, in each case, guarantees thereof)

or (B) assume, guarantee, endorse or otherwise become liable or responsible for any indebtedness for borrowed money of any other Person,

except with respect to obligations of wholly owned Subsidiaries of the Company, in the cases of the foregoing clauses ‎(A)

and ‎(B), in excess of $10,000,000 in the aggregate;

(j)

settle or compromise (i) any Proceeding (excluding any Proceeding relating to Taxes) involving or against the Company or any of

its Subsidiaries other than settlements that result solely in monetary obligations of the Company or its Subsidiaries (without the admission

of wrongdoing or a nolo contendere or similar plea, the imposition of injunctive or other equitable relief, or restrictions on the future

activity or conduct, by, of or on Parent, the Company or any of their respective Subsidiaries, except for confidentiality and similar

de minimis obligations) involving payment by the Company or any of its Subsidiaries of an amount not greater than $1,500,000 individually

or $5,000,000 in the aggregate or (ii) except in accordance with ‎Section 8.08,

any Proceeding (excluding any Proceeding relating to Taxes) that relates specifically to the transactions contemplated hereby;

(k)

(i) amend or modify in any material respect, waive any material rights under, or terminate (other than any termination in accordance

with the terms of an existing Material Contract) any Material Contract or (ii) enter into any contract which if entered into prior to

the date of this Agreement would have been a Material Contract, (A) in the case of clause (i), other than in the ordinary course

of business consistent with past practice and (B) in the case of clause (ii), other than Contracts of the type referred to in

‎Section 4.20(a)(viii) and ‎Section 4.20(a)(ix)

that are entered into in the ordinary course of business consistent with past practice;

(l)

other than as required by Applicable Law or a Company Plan existing as of the date of this Agreement, (i) increase or accelerate

or grant any increase or acceleration in the funding, payment or vesting of the compensation or benefits provided to any current or former

Company Service Provider, (ii) establish, adopt, amend or terminate any Company Plan or any other benefit or compensation plan, policy,

program, contract agreement or arrangement that would be a Company Plan if in effect on the date hereof, (iii) grant or announce any

cash or equity or equity-based incentive awards, bonuses, retention, change in control, transaction, severance or similar compensation,

(iv) hire, promote or engage any current or former Company Service Provider who is an Executive Vice President or higher or (v) terminate

any Company Service Provider other than for cause who is an Executive Vice President or higher;

(m)

adopt a plan of complete or partial liquidation, dissolution, restructuring, recapitalization or other reorganization of the Company

or any of its Subsidiaries (other than the Merger);

(n)

materially change the Company’s methods of financial accounting except as required or authorized by concurrent changes in

GAAP or in Regulation S-X of the 1934 Act, as agreed to by its independent public accountants;

(o)

make or revoke any material Tax election, file a material amendment with respect to a material tax return, adopt or change any

material Tax accounting period or methodology, waive any right to a material tax refund, settle or compromise any material Tax Liability

or Proceeding relating to Taxes, or consent to any extension or waiver of the statute of limitations, except, in each case, in the ordinary

course of business;

(p)

(i) (A) negotiate, modify, amend, extend, terminate or enter into any CBA or (B) recognize or certify any Union or group of employees

as the bargaining representative for any Company Employees; (ii) other than in the ordinary course of business consistent with past

practice

in consultation with Parent, implement or announce any employee layoffs, furloughs, reductions in force, plant closings, material reductions

in compensation or other similar actions that could implicate the WARN Act; or (iii) waive or release any noncompetition, nonsolicitation,

nondisclosure or other restrictive covenant obligation of any current or former Company Service Provider;

(q)

cancel, materially reduce, terminate or fail to use reasonable best efforts to maintain in effect without replacing material insurance

policies covering the Company and its Subsidiaries and their respective properties, assets and businesses;

(r)

make, or commit to make, any capital expenditures in amounts exceeding the capital expenditures budget of the Company

set forth on Section 6.01(r) of the Company Disclosure Schedule, other than any capital expenditures that do not exceed

$3,000,000 individually or in the aggregate during any fiscal quarter;

(o) enter

into any agreement, commitment, arrangement or understanding with, any Affiliate of the Company or any Person covered by Item 404 of

Regulation S-K of the SEC, in each case, that would be required to be disclosed pursuant to Item 404; or

(s)

agree, resolve or commit to do any of the foregoing.

Section 6.02.

Company Stockholders Meeting. The Company shall (a) as soon as reasonably practicable (and in any event

within five Business Days) following confirmation from the SEC that it will not review, or that it has completed review of, the Proxy

Statement, which confirmation will be deemed to occur if the SEC has not notified the Company on or prior to the tenth calendar day after

making the Company’s initial filing of the Proxy Statement, duly call (including establishing a record date for) and give notice

of, and commence mailing of the Proxy Statement to the holders of Company Common Shares as of the record date established for, a meeting

of holders of the Company Common Shares (together with any adjournments or postponements thereof, the “Company

Stockholders Meeting”) to take place within 35 days following the ﬁrst mailing of the Proxy Statement to the Company’s

stockholders for purposes of seeking the Company Stockholder Approval, (b) initiate or cause to be initiated a “broker search”

in accordance with Rule 14a-13 of the 1934 Act in order for the Company to comply with its obligations set forth in the foregoing clause

‎(a), and (c) as soon as reasonably practicable following the commencement of the mailing of the Proxy Statement pursuant to

the foregoing clause ‎ ‎(a), convene and hold the Company Stockholders Meeting in accordance with the DGCL and applicable

requirements of NYSE; provided that the Company may adjourn or postpone the Company Stockholders Meeting to a later date (i) with

the consent of Parent (not to be unreasonably withheld, conditioned or delayed) or (ii) to the extent the Company reasonably determines

in good faith (after consultation with outside legal counsel) that such adjournment or postponement is reasonably necessary (A) to ensure

that any required supplement or amendment to the Proxy Statement is provided to the holders of Company Common Shares within a reasonable

amount of time in advance of the Company Stockholders Meeting, (B) due to Applicable Law (including fiduciary duties) or a request from

the SEC or its staff, (C) to allow reasonable additional time to solicit additional proxies necessary to obtain the Company Stockholder

Approval or (D) to ensure that there are sufficient Company Common Shares represented (either in person or by proxy) and voting to constitute

a quorum necessary to conduct the business of the

Company

Stockholders Meeting; provided, that in the case of the foregoing clauses (ii)(A) – (D), the Company Stockholders

Meeting shall not be adjourned or postponed on more than two occasions and no such adjournment or postponement shall be for more than

five (5) Business Days per occasion; provided, further, that in no event shall the Company Stockholders Meeting be adjourned

or postponed beyond the date that is five Business Days prior to the Outside Date. The record date for the Company Stockholders Meeting

shall be selected after reasonable consultation with Parent. The Company agrees to use reasonable efforts to provide Parent periodic

updates concerning proxy solicitation results as reasonably requested by Parent (including, if requested, providing daily voting reports

to the extent reasonably practicable). Subject to ‎‎Section 6.04, the Board of Directors shall recommend that the

holders of the Company Common Shares adopt this Agreement, and the Company shall (x) include the Company Recommendation in the Proxy

Statement, (y) use its reasonable best efforts to obtain the Company Stockholder Approval and (z) otherwise comply in all material respects

with all legal requirements applicable to such meeting. In the event that the Board of Directors makes an Adverse Recommendation Change

pursuant to ‎‎Section 6.04 and this Agreement has not been terminated in accordance with its terms in connection

therewith, the Company will nevertheless submit this Agreement to the Company’s stockholders for the purpose of obtaining the Company

Stockholder Approval unless this Agreement shall have been terminated in accordance with its terms prior to the Company Stockholders

Meeting.

Section 6.03.

Access to Information. (a) From the date hereof until the Effective Time, subject to Applicable Law and

other than any such matters that relate to the negotiation and execution of this Agreement (including with respect to the consideration

or valuation of the Merger or any financial or strategic alternatives thereto), in each case, solely for the purpose of consummating

the Merger and integration planning, the Company shall (i) give Parent and its Representatives, upon reasonable written notice, reasonable

access during normal business hours to the offices, properties, assets, books and records and personnel (including employees and agents)

of the Company and its Subsidiaries and (ii) reasonably promptly furnish to Parent and its Representatives such existing financial and

operating data and other information as such Persons may reasonably request in writing (it being acknowledged and agreed that nothing

herein express or implied shall require the Company or any of its Subsidiaries to provide any data or information in any format other

than as it then exists, or otherwise manipulate or reconfigure any data or information regarding the Company and its Subsidiaries or

any of its or their assets, financial performance or conditions or operations); provided that, in each case, such access may be

limited to the extent that such access would jeopardize the health and safety of any of its Representatives; provided, further,

that the Company may, in its sole discretion, designate any competitively sensitive material as “Outside Counsel Only Material”

such that such materials and the information contained therein shall be furnished only to the outside counsel of Parent and will not

be disclosed to any other Persons unless express permission is obtained in advance from the Company or its legal counsel. The

Company shall have the right to have its Representatives present in any investigation pursuant to this ‎‎‎Section 6.03,

and such investigation shall be conducted in such manner as not to interfere unreasonably with the conduct of the business of the Company

and its Subsidiaries. Nothing in this ‎‎‎Section 6.03 shall require the Company to provide any access,

or to disclose any (A) information if providing such access or disclosing such information would violate any Applicable Law (including

Competition Laws and privacy laws) or binding agreement entered into prior to the date of this Agreement, (B) communications between

the Company and its investment bankers, attorneys, accountants and other advisors, (C) information protected by

attorney-client

privilege or other applicable legal privilege or (D) information related or reasonably pertinent to actual or potential threatened litigation

or disputes between the parties to this Agreement; provided that, in the case of clauses ‎ ‎(A) and ‎(C),

the Company shall use reasonable best efforts to allow for such access or disclosure in a manner that would not violate any such Applicable

Law or jeopardize the protection of the attorney-client privilege or other applicable legal privilege. Notwithstanding the foregoing,

Parent and its Representatives shall not be permitted to perform or cause to be performed any intrusive environmental sampling or assessment

with respect to any property of the Company or any of its Subsidiaries without the prior written consent of the Company.

(b)

All information exchanged or otherwise received pursuant to ‎‎‎Section 6.03(a)

will be subject to the confidentiality agreement dated as of May 22, 2026 between the Company and Parent (the “Confidentiality

Agreement”). No information or knowledge obtained in any investigation pursuant to this ‎‎Section 6.03

shall affect or limit or be deemed to modify any representation or warranty made by any party hereunder or any rights or remedies available

to any party under this Agreement. Parent will use its reasonable best efforts to minimize any disruption to the business of the Company

and its Subsidiaries that may result from requests for access under this ‎‎‎Section 6.03.

Section 6.04.

No-Shop; Other Offers. (a) No-Shop. Except as otherwise expressly permitted by the remainder of this

‎‎Section 6.04, from the execution of this Agreement until the earlier to occur of the termination of this Agreement

pursuant to ‎‎‎Article 10 and the Effective Time, the Company shall not, shall cause its Subsidiaries, officers

and directors not to, and shall instruct its other Representatives not to, directly or indirectly, (i) solicit, initiate or take any

action to knowingly induce the making, submission or announcement of, or knowingly facilitate (including by way of providing information)

or encourage the submission of any Acquisition Proposal or any inquiry or indication of interest that is reasonably likely to lead to

an Acquisition Proposal, (ii) engage in, enter into or participate in any discussions or negotiations with, furnish any material nonpublic

information relating to the Company or any of its Subsidiaries or afford access to the business, properties, assets, books or records,

or to any personnel of the Company or any of its Subsidiaries to, or otherwise cooperate with, any Third Party, in each case relating

to an Acquisition Proposal by such Third Party, (iii) (A) fail to make, withdraw, withhold, qualify or modify, or propose publicly

to withdraw, withhold, qualify or modify the Company Recommendation (or recommend an Acquisition Proposal), (B) adopt, approve or recommend,

or propose publicly to adopt, approve or recommend, or otherwise declare advisable, any Acquisition Proposal or proposal that would reasonably

be expected to lead to an Acquisition Proposal, (C) fail to publicly recommend against any Acquisition Proposal structured as a tender

offer or exchange offer within ten Business Days after the commencement (within the meaning of Rule 14d-2 under the 1934

Act) thereof or take any public position in connection with a tender or exchange offer other than a recommendation against such

offer or a “stop, look and listen” communication by the Board of Directors, (D) in the event of a publicly announced Acquisition

Proposal that is not covered by the foregoing clause (C), fail to publicly reaffirm the Company Recommendation within ten Business

Days after Parent so requests in writing, or (E) fail to include the recommendation of the Board of Directors in favor of approval and

adoption of this Agreement and the Merger in the Proxy Statement (any action described in this clause (iii), an “Adverse

Recommendation Change”), (iv) grant any waiver or amendment or release under any standstill or confidentiality agreement;

provided that the foregoing clause (iv) shall not prohibit the Company

any of its Subsidiaries from amending, modifying or granting any waiver or release under any standstill, confidentiality or similar agreement

of the Company or any of its Subsidiaries, in each case, solely to the extent the Board of Directors determines, in consultation with

its outside legal counsel, that the failure to do so would be inconsistent with its fiduciary duties, (v) enter into any agreement in

principle, letter of intent, indication of interest, term sheet, memorandum of understanding, merger agreement, acquisition agreement,

option agreement, share exchange agreement, joint venture agreement, other agreement or other similar instrument relating to or that

would reasonably be expected to lead to, an Acquisition Proposal or (vi) resolve, or agree to do any of the foregoing.

(b)

Exceptions. Notwithstanding anything contained in this ‎‎Section 6.04

to the contrary, at any time prior to the receipt of the Company Stockholder Approval:

(i)

the Company, directly or indirectly through its Representatives, may (a) engage in negotiations or discussions with any Third

Party and its Representatives that has made after the date of this Agreement a bona fide Acquisition Proposal that the Board of

Directors determines, in good faith, after consultation with outside counsel and a financial advisor, is or is reasonably likely to result

in a Superior Proposal and did not result from a breach of ‎Section 6.04(a),

and (b) furnish to such Third Party or its Representatives non-public information relating to the Company or any of its Subsidiaries

pursuant to an Acceptable Confidentiality Agreement (a copy of which shall be provided for informational purposes only to Parent, to

the extent not already made available or otherwise provided to Parent); provided that, (x) to the extent that any nonpublic information

relating to the Company or its Subsidiaries is provided to any such Third Party or any such Third Party is given access which was not

previously provided to or made available to Parent, such nonpublic information or access is provided or made available to Parent prior

to or substantially concurrently with it being shared with such Third Party and (y) any competitively sensitive information or data (as

determined by the Company’s legal counsel) provided to any such Third Party in accordance with this ‎Section 6.04

who is, or whose Affiliates include, a competitor, supplier or customer of the Company or any of its Subsidiaries will be provided in

a separate “clean data room” and subject to customary “clean team” arrangements regarding access to such information

or data; and

(ii)

subject to compliance with ‎Section 6.04(d),

the Board of Directors may make an Adverse Recommendation Change (a) following receipt of a Superior Proposal or (b) solely with

respect to clause (A) and (E) of the definition of Adverse Recommendation Change, in response to events, changes or developments

in circumstances that are material to the Company and its Subsidiaries, taken as a whole, that were not known to or reasonably foreseeable

by the Board of Directors as of or prior to the date hereof and that become known to the Board of Directors after the date hereof (or,

if known to the Board of Directors as of the date hereof, the consequences of which were not known or reasonably foreseeable to the Board

of Directors of the Company as of the date hereof) (an “Intervening Event”);

provided that in no event shall any of the following constitute or contribute to an Intervening Event: (i) the announcement or

pendency of this Agreement or the transactions contemplated by this Agreement; (ii) changes in the market price or trading volume of

Company Common Shares (it being understood that the underlying facts giving rise or contributing to such change may be taken into account

in determining whether there has

been

an Intervening Event); (iii) the Company meeting or exceeding any internal or published budgets, projections, forecasts or predictions

of financial performance for any period (it being understood that the underlying facts giving rise or contributing to such change may

be taken into account in determining whether there has been an Intervening Event); or (iv) the receipt, existence or terms of any Acquisition

Proposal or any inquiry, offer, request or proposal that would reasonably be expected to lead to an Acquisition Proposal, or the consequences

of any of the foregoing;

in each case referred

to in the foregoing clauses ‎(i) and ‎(ii)

only if the Board of Directors determines in good faith, after consultation with outside legal counsel, that the failure to take such

action would be reasonably likely to be inconsistent with its fiduciary duties under Delaware law. In addition, nothing contained

in this Agreement shall prevent the Company or the Board of Directors (or any committee thereof) from (1) taking and disclosing to the

Company’s stockholders a position contemplated by Rule 14d-9 and Rule 14e-2(a) promulgated under the 1934 Act (or any similar communication

to stockholders in connection with the making or amendment of a tender offer or exchange offer) or from making any legally required disclosure

to stockholders with regard to the transactions contemplated by this Agreement or an offer, inquiry, proposal or indication of interest

with respect to an Acquisition Proposal (provided that neither the Company nor the Board of Directors may make an Adverse Recommendation

Change unless permitted by this ‎‎‎Section 6.04(b)),

(2) issuing a “stop, look and listen” disclosure or similar communication of the type contemplated by Rule 14d-9(f) under

the 1934 Act or (3) contacting and engaging in discussions with any person or group and their respective Representatives who has

made an offer, inquiry, proposal or indication of interest with respect to an Acquisition Proposal that was not solicited in breach of

this ‎‎Section 6.04 for the purpose of clarifying

such offer, inquiry, proposal or indication of interest and the terms thereof or informing such Third Party of the restrictions imposed

by this ‎Section 6.04.

(c)

Required Notices. Prior to the earlier of the termination of this Agreement pursuant to ‎‎‎Article 10

and the Effective Time, the Company shall notify Parent promptly (and in any event within 24 hours) of the receipt by the Company of

any Acquisition Proposal or any request for material non-public information relating to the Company or any of its Subsidiaries or for

access to the business, properties, assets, books or records or personnel of the Company or any of its Subsidiaries by any Third Party

(which notice shall include the identity of the Third Party making such Acquisition Proposal and unredacted copies of the Acquisition

Proposal and all related documents (including all financing commitments and other documents relating to the financing), and if such Acquisition

Proposal or any portion thereof was not provided in writing, a summary of the material terms and conditions thereof) and keep Parent

reasonably informed, on a prompt basis, of the status and material terms and conditions of any Acquisition Proposal and any developments

which are not immaterial related thereto and the status of any discussions or negotiations, including promptly (but in no event later

than 24 hours after receipt) providing Parent summaries of all oral communications between the Company and Third Party and unredacted

copies of all material correspondence and written materials (including any amendments or modifications thereto) sent or provided to or

by the Company or any of its Subsidiaries or any of their respective Representatives in connection therewith.

(d)

Last Look. Neither the Board of Directors nor the Company shall be permitted to take any of the actions referred

to in ‎‎‎Section 6.04(b)(ii) unless (i)

the Company shall have notified

Parent,

in writing and at least five Business Days prior to taking such action, of its intention to take such action, specifying, in reasonable

detail, the reasons for the Adverse Recommendation Change, and (A) in the case of a Superior Proposal, including the identity of the

Person or group making such proposal and the material terms thereof or (B) in the case of an Intervening Event, reasonably detailed description

of the facts and circumstances relating to such Intervening Event, (ii) during such five Business Day period following the date on which

such notice is received, the Company shall have negotiated with Parent in good faith (to the extent Parent wishes to negotiate) to make

such adjustments to the terms and conditions of this Agreement as Parent may propose, (iii) upon the end of such notice period (or such

subsequent notice period as contemplated by clause ‎(iv) below),

the Board of Directors shall have considered in good faith any revisions to the terms of this Agreement proposed in writing by Parent

that, if accepted by the Company, would be binding upon Parent, and shall have determined in good faith, after consultation with its

outside legal counsel, that the failure of the Board of Directors to make such Adverse Recommendation Change would be inconsistent with

its fiduciary duties under Applicable Law, and, in the case of Superior Proposal, that such Acquisition Proposal continues to constitute

a Superior Proposal and (iv) in the event of any change to any of the financial terms or any other material terms (it being understood

that conditionality, termination and termination fees, regulatory efforts and financing are material terms) of such Superior Proposal,

the Company shall, in each case, have delivered to Parent an additional notice consistent with that described in clause ‎‎

‎(i) above and a new notice period under clause ‎‎

‎(i) shall commence (provided that the notice period thereunder shall only be three Business Days) during which

time the Company shall be required to comply with the requirements of this ‎‎‎Section 6.04(d)

with respect to such additional notice, including clauses ‎ ‎(i)

through ‎ ‎(iii) above.

(e)

Obligation to Terminate Discussions. Subject to this ‎Section 6.04,

the Company shall, and shall cause any of its Subsidiaries and its and their respective Representatives to cease immediately and cause

to be terminated (i) any and all existing activities, discussions, negotiations or solicitations of the foregoing, if any, with any Third

Party and its Representatives conducted prior to the date hereof with respect to any Acquisition Proposal and (ii) the Company shall

promptly (and in any event within two Business Days after the date hereof) terminate any data room access of such Third Party or any

of its Representatives and request in writing that each Third Party that has executed a confidentiality or similar agreement in connection

with any transaction or proposal involving the Company that could reasonably be expected to lead to an Acquisition Proposal or that relates

to a potential Acquisition Proposal promptly return to the Company or destroy all non-public information previously furnished or made

available to such Third Party or any of its Representatives by or on behalf of the Company or its Representatives. If at any time the

Company provides any non-public information to a Third Party, in compliance with ‎Section 6.04(b)

and the Board of Directors subsequently determines that the Acquisition Proposal made by such Third Party is not, or would not reasonably

be expected to lead to, a Superior Proposal, then the Company shall promptly (and in any event within 48 hours after the date thereof)

terminate any data room access of such Third Party or any of its Representatives and request in writing that each Third Party promptly

return to the Company or destroy all non-public information previously furnished or made available to such Third Party or any of its

Representatives by or on behalf of the Company or its Representatives.

(f)

Definition of Superior Proposal. For purposes of this Agreement, “Superior

Proposal” means a bona fide, written Acquisition Proposal (but substituting “more than 50%” for

all

references to “20% or more” in the definition of such term) that (i) the Board of Directors determines in good faith, after

consultation with its outside legal counsel and financial advisor, is more favorable from a financial point of view to the Company’s

stockholders (solely in their capacity as such) than the Merger and (ii) relative to the transactions contemplated by this Agreement

(after taking into account any changes to the terms of this Agreement proposed by Parent to the Company in response to such Acquisition

Proposal), is reasonably likely to be completed on the terms proposed, taking into consideration (A) the identity of the counterparty,

(B) the expected timing, conditionality and likelihood of consummation of the contemplated transaction(s), (C) any other legal, financial,

financing and regulatory aspects of such Acquisition Proposal and (D) any other factors determined by the Board of Directors to be relevant.

Section 6.05.

Stock Exchange Delisting and Deregistration. The Company and Parent shall cooperate to take, or cause to

be taken, all actions, and do or cause to be done all things, including making all necessary filings, reasonably necessary, proper or

advisable under Applicable Laws and the rules and policies of NYSE to enable the delisting by the Surviving Corporation of the Company

Common Shares under the 1934 Act and the suspension of the Company’s duty to file reports under Sections 13 and 15(d) of the 1934

Act, in each case as promptly as practicable after the Effective Time.

Section 6.06.

Company Financing Cooperation.

(a)

The Company shall use its reasonable best efforts to, and shall cause its Subsidiaries and its and their respective Representatives

to use their reasonable best efforts to, provide all cooperation in connection with the arrangement of the Debt Financing (including

with respect to any “market flex” to the extent exercised or any Alternative Financing) as may be reasonably requested by

Parent that is necessary and customary for financings of the type contemplated by the Debt Commitment Letter, including, without limitation,

the following:

(b)

participating in a reasonable number of meetings, due diligence sessions, presentations, lender meetings, “road shows”

and similar sessions with the Debt Financing Sources and other prospective financing sources, investors and ratings agencies, in each

case on reasonable advance notice and at mutually agreeable times;

(c)

assisting with the preparation of materials for rating agency presentations, bank information memoranda, marketing materials and

other similar documents, including executing customary authorization letters in connection with the distribution of such materials, in

each case only to the extent customarily needed for financings of the type contemplated by the Debt Commitment Letter;

(d)

furnishing, at least three Business Days prior to the Closing, such documentation and information as is reasonably requested in

writing by the Parent at least ten Business Days prior to the Closing to the extent required under applicable “know your customer”

and anti-money laundering rules and regulations, including the USA PATRIOT Act and 31 C.F.R. §1010.230, in order to satisfy

the conditions set forth in the Debt Commitment Letter;

(e)

(A) executing and delivering any credit agreements, pledge and security documents, guarantees, other definitive financing documents

and schedules thereto or other requested

certificates

or documents; provided that (x) none of the foregoing documents or certificates shall be executed and/or delivered, except in

connection with the Closing and (y) the effectiveness thereof shall be conditioned upon, or become operative only after or concurrently

with, the occurrence of the Closing and (B) facilitating the obtaining of guarantees and pledging of collateral, granting of security

interests and other similar matters ancillary to the Debt Financing, in each case as may be reasonably requested by Parent; and

(f)

cooperating with, and taking all actions required or otherwise reasonably requested by Parent in order to facilitate the termination

and payoff of the indebtedness under the Company Credit Agreement at Closing upon or simultaneously with the funding of the Debt Financing

(including, upon such funding, (w) the repayment in full of all obligations then outstanding thereunder, (x) the release of all encumbrances,

security interests and collateral, (y) the termination of all guaranties and the agreements evidencing subordination in connection therewith

and (z) the termination or replacement of all letters of credit outstanding thereunder, in each case at the Closing), and arranging for

delivery to Parent Payoff Letters, lien terminations and other instruments of discharge, in each case, in form and substance reasonably

satisfactory to Parent, from the administrative agent, trustees or other similar agents under the Company Credit Agreement.

(g)

Notwithstanding the foregoing, nothing in this ‎Section 6.06

shall require the Company or any of its Subsidiaries to:

(h)

take any action in respect of the Debt Financing to the extent that such action would cause any condition to Closing set forth

in ‎‎Article 9 to fail to be

satisfied by the Outside Date or otherwise result in a breach of this Agreement by the Company;

(i)

take any action in respect of the Debt Financing that would conflict with or violate the Company’s or any if its Subsidiary’s

organizational documents or any Applicable Law, or result in the contravention of, or violation of breach of, or default under, any contract

to which the Company or any of its Subsidiaries is a party;

(j)

take any action to the extent such action would (A) unreasonably interfere with the business or operations of the Company or its

Subsidiaries or (B) cause competitive harm to the Company or its Subsidiaries if the transactions contemplated by this Agreement are

not consummated;

(k)

execute and deliver any letter, agreement, document or certificate in connection with the Debt Financing (other than the customary

authorization letters described in clause (a)(ii) above) or take any corporate action that is not contingent on, or that would

be effective prior to, the occurrence of the Closing;

(l)

pay any commitment fee or other fee or payment to obtain consent or incur any liability with respect to or cause or permit any

Lien to be placed on any of their respective assets in connection with the Debt Financing prior to the Closing Date;

(m)

provide access to or disclose information where the Company determines that such access or disclosure would reasonably be expected

to jeopardize the attorney-client privilege or contravene any Applicable Law or contract;

(n)

subject the Company or any of its Subsidiaries, respective directors, managers, officers or employees to any actual or potential

personal liability;

(o)

cause the directors and managers of the Company and its Subsidiaries to adopt resolutions (or take other corporate action) approving

the agreements, documents and instruments pursuant to which the Debt Financing is obtained unless Parent shall have determined that such

directors and managers are to remain as directors and managers of the Company and the applicable Subsidiaries on and after the Closing

Date and such resolutions (or take other corporate action) are contingent upon the occurrence of, or only effective as of, the Closing;

(p)

waive or amend any terms of this Agreement or any other material contract to which the Company or its Subsidiaries is party; or

(q)

take any action that would subject it to actual or potential liability, to bear any cost or expense or to make any other payment

or agree to provide any indemnity in connection with the Debt Commitment Letter, the definitive documents related to the Debt Financing

or any information utilized in connection therewith (in each case, except following the Closing).

(r)

Parent shall promptly, upon written request by the Company, reimburse the Company for all reasonable and documented out-of-pocket

costs and expenses (including reasonable attorneys’ fees) incurred by the Company or any of its Subsidiaries in connection with

the cooperation of the Company and its Subsidiaries contemplated by this ‎Section 6.06

and shall indemnify and hold harmless the Company, its Subsidiaries and their respective Representatives from and against any and all

losses, damages, claims, costs or expenses actually suffered or incurred by any of them of any type in connection with the arrangement

of any Debt Financing and any information used in connection therewith, in each case, other than to the extent arising from any material

inaccuracy of any financial statements delivered by the Company or the fraud, bad faith or willful misconduct of the Company, its Subsidiaries

or any of its or their Representatives. The foregoing obligations shall be referred to herein as the “Reimbursement Obligations”

and shall survive the termination of this Agreement; provided that the Reimbursement Obligations payable pursuant to this Section

6.06(c) shall not exceed $1,000,000 in the aggregate (the “Reimbursement Cap”).

(s)

All material non-public information provided by the Company or any of its Subsidiaries or any of their Representatives pursuant

to this ‎Section 6.06 shall be kept confidential

in accordance with the Confidentiality Agreement; provided, such information may be disclosed (i) to prospective lenders, underwriters,

initial purchasers, arrangers, agents, other potential Debt Financing Sources, other potential sources of capital and rating agencies

during the arrangement, syndication and marketing of the Debt Financing that enter into confidentiality arrangements customary for financing

transactions of the same type as the Debt Financing (including customary “click-through” confidentiality undertakings and

through a notice and undertaking in a form customarily used in confidential information memoranda for senior credit facilities) and (ii)

on a confidential basis to rating agencies.

(t)

The Company hereby consents to the use of its and its Subsidiaries’ logos in connection with the Debt Financing; provided

that such logos are used solely in a manner that does

not

violate any existing contractual obligation of the Company and is not intended to, nor reasonably likely to, harm or disparage the Company.

(u)

Parent and Merger Sub acknowledge and agree that, notwithstanding anything in this Agreement to the contrary, the obligations

to perform their respective agreements hereunder, including to consummate the Closing subject to the terms and conditions hereof, are

not conditioned on obtaining of the Debt Financing or any alternative Debt Financing or on the performance of any party to the Debt Commitment

Letter.

(v)

Notwithstanding anything to the contrary in this Agreement, for all purposes of this Agreement (including the condition set forth

in ‎‎Section 9.02(a) as it applies to the

Company’s obligations under this ‎Section 6.06),

the Company’s obligations under this ‎Section 6.06

shall be deemed satisfied unless (i) the Company has willfully and materially breached its obligations under this ‎Section 6.06,

(ii) Parent has promptly notified the Company of such breach and (iii) such breach was the direct cause of Parent or Merger Sub’s

failure to receive any material portion of the proceeds of the Debt Financing.

Section 6.07.

Resignation. At the written request of Parent, the Company shall cause each director or officer of the Company or any

director or officer of any of the Company’s Subsidiaries to resign in such capacity, with such resignations to be effective as

of the Effective Time.

Section 6.08.

Treatment of Certain Indebtedness. Prior to the Closing, the Company shall use its reasonable best efforts to deliver

to Parent, an executed copy of all customary payoff letter in connection with the repayment of the indebtedness that is set forth on

‎Section 6.08 of the Company Disclosure Schedule, stating the aggregate amount of the indebtedness thereunder required

for payoff as of the date specified in such letter (together with a customary per diem for payment following such date), the instructions

for payment of the same to discharge such obligations and, if such indebtedness is secured by any Lien or other security interest, all

Lien terminations and instruments of discharge releasing and terminating such Lien or security interest, as applicable, upon the receipt

of the applicable payoff amounts (each, a “Payoff Letter”). At the Closing,

Merger Sub shall pay or shall cause to be paid, in full and in immediately available funds, any and all amounts outstanding and then

necessary to pay the amounts set forth in each Payoff Letter.

Article 7

Covenants of Parent

Section 7.01.

Conduct of Parent. Parent shall not, and shall cause its Subsidiaries not to, from the date of this Agreement

to the Effective Time, take any action or fail to take any action that is intended to, or could reasonably be expected to, individually

or in the aggregate, prevent, delay or impede the ability of Parent and Merger Sub to consummate the Merger or the other transactions

contemplated by this Agreement, including the financing thereof; provided, however, that this ‎Section 7.01

shall not apply to the matters covered by ‎Section 8.01, which shall be exclusively governed by ‎Section 8.01.

Section 7.02.

Director and Officer Liability. Parent shall cause the Surviving Corporation to do the following:

(a)

For a period of six years after the Effective Time, Parent shall, and shall cause the Surviving Corporation to, indemnify and

hold harmless the present and former directors, officers, managers, employees and agents of the Company and its Subsidiaries and their

respective successors and heirs and any individuals serving in such capacity at or with respect to other Persons at the Company’s

or its Subsidiaries’ request (each, an “Indemnified Person”) from and

against any losses, damages, liabilities, costs, expenses (including attorneys’ fees), judgments, fines, penalties and amounts

paid in settlement (including all interest, assessments and other charges paid or payable in connection with or in respect of any thereof)

in respect of acts or omissions prior to the Effective Time, in each case to the fullest extent permitted by the DGCL or any other Applicable

Law or provided under the Company’s certificate of incorporation and bylaws or other organizational documents of the Company or

any of its Subsidiaries in effect on the date hereof. If any Indemnified Person is made party to any claim, action, suit,

proceeding or investigation arising out of or relating to matters that would be indemnifiable pursuant to the immediately preceding sentence,

the Surviving Corporation shall (and Parent shall cause the Surviving Corporation to), advance fees, costs and expenses (including attorneys’

fees and disbursements) as incurred by such Indemnified Person in connection with and prior to the final disposition of such claim, action,

suit, proceeding or investigation; provided that such Indemnified Person agrees in advance to return any such funds to which it

is determined in a final, non-appealable judgment that such Indemnified Person is not ultimately entitled to indemnification. Any

determination required to be made with respect to whether the conduct of any Indemnified Person complies or complied with any applicable

standard will be made by independent legal counsel selected by the Surviving Corporation (which counsel will be reasonably acceptable

to such Indemnified Person), the fees and expenses of which shall be paid by the Surviving Corporation. At its own expense,

an Indemnified Person may, but will not be obligated to, employ separate counsel and participate in the defense of any action involving

such Indemnified Person and so controlled by the Surviving Corporation; provided that if (i) the named parties to any such action

include the Surviving Corporation and such Indemnified Person and such Indemnified Person is advised in writing by its own counsel that

there are legal defenses available to it that are different from or additional to those available to the Surviving Corporation or any

other Indemnified Person that is party thereto, (ii) a conflict of interest exists between such Indemnified Person and the Surviving

Corporation or (iii) the Surviving Corporation and such Indemnified Person shall have mutually agreed in writing to the retention

of such counsel for such Indemnified Person, then in each such case such Indemnified Person will be entitled to obtain its own separate

counsel and the Surviving Corporation shall pay the fees and expenses of such counsel. The Surviving Corporation shall not

settle any action that is indemnifiable pursuant to this ‎Section 7.02,

except (A) with the consent of the applicable Indemnified Persons, which consent shall not be unreasonably withheld, conditioned or delayed

or (B) if such settlement or compromise (1) includes an unconditional release thereof from all liability arising out of such action in

a form reasonably satisfactory to the applicable Indemnified Person and (2) does not include a statement or admissions of fault, culpability

or a failure to act, by or on behalf of such Indemnified Person. No Indemnified Person will be liable for any settlement entered into

in contravention of the foregoing sentence.

(b)

For a period of six years after the Effective Time, the Surviving Corporation shall (and Parent shall cause the Surviving Corporation

to) maintain in effect provisions in the certificate

incorporation, bylaws or other organizational documents of the Surviving Corporation and its Subsidiaries (or in such documents of any

successor to the business of the Surviving Corporation or any such Subsidiary) regarding elimination of liability of directors, indemnification

of directors, officers, employees, fiduciaries and agents and advancement of fees, costs and expenses that are no less advantageous to

the intended beneficiaries than the corresponding provisions in existence on the date of this Agreement.

(c)

From and after the Effective Time, Parent shall, and shall cause the Surviving Corporation and its Subsidiaries to, honor and

comply with their respective obligations under any indemnification agreement with any Indemnified Person that exists as of the date hereof,

and not, without the written agreement of the Indemnified Person, amend, repeal or otherwise modify any such agreement in any manner

that would adversely affect any right of any Indemnified Person thereunder.

(d)

Prior to the Effective Time, (x) the Company shall, (y) if Parent elects, Parent shall, or (z) if the Company is unable to, the

Surviving Corporation shall (and Parent shall cause the Surviving Corporation to) as of the Effective Time, purchase (and fully pay the

premium for), and maintain in full force and effect, a prepaid, noncancellable “tail policy” on terms and conditions (in

both amount and scope) no less favorable than the current directors’ and officers’ liability coverage of the Company’s

existing directors’ and officers’ insurance policies and the Company’s existing fiduciary liability insurance policies

(collectively, “D&O Insurance”), which D&O Insurance shall (i) be

for a claims reporting or discovery period of at least six years from and after the Effective Time with respect to any claim related

to any period of time at or prior to the Effective Time, (ii) be from an insurance carrier with the same or better credit rating as the

Company’s current insurance carrier with respect to D&O Insurance and (iii) have terms, conditions, retentions and limits of

liability that are no less favorable in the aggregate than the coverage provided under the Company’s existing policies as of the

date hereof. If the Company or the Surviving Corporation for any reason fails to obtain such “tail” insurance

policies as of the Effective Time, the Surviving Corporation shall continue to maintain in effect, for a period of at least six years

from and after the Effective Time, the D&O Insurance in place as of the date hereof with the Company’s current insurance carrier

or with an insurance carrier with the same or better credit rating as the Company’s current insurance carrier with respect to D&O

Insurance with terms, conditions, retentions and limits of liability that are no less favorable than the coverage provided under the

Company’s existing policies as of the date hereof, or the Surviving Corporation shall purchase from the Company’s current

insurance carrier or from an insurance carrier with the same or better credit rating as the Company’s current insurance carrier

with respect to D&O Insurance comparable D&O Insurance for such six-year period with terms, conditions, retentions and limits

of liability that are no less favorable than as provided in the Company’s existing policies as of the date hereof; provided

that in no event shall Parent or the Surviving Corporation be required to expend for such policies pursuant to this sentence an aggregate

annual premium amount in excess of 400% of the amount per annum for the Company’s existing policies, which amount is set forth

in ‎Section 7.02(d) of the Company Disclosure

Schedule; and provided, further, that if the aggregate premiums of such insurance coverage exceed such amount, the Surviving

Corporation shall be obligated to obtain a policy with the greatest coverage available, with respect to matters occurring prior to the

Effective Time, for a cost not exceeding such amount.

(e)

If Parent, the Surviving Corporation or any of its successors or assigns (i) consolidates with or merges into any other Person

and is not the continuing or surviving corporation or entity of such consolidation or merger or (ii) transfers or conveys all or substantially

all of its properties and assets to any Person, then, and in each such case, to the extent necessary, Parent and the Surviving Corporation

shall cause proper provision to be made so that the successors and assigns of Parent or the Surviving Corporation, as the case may be,

shall assume the obligations set forth in this ‎Section 7.02.

(f)

The rights of each Indemnified Person under this ‎Section 7.02

will be in addition to any rights such Person may have under the certificate of incorporation or bylaws of the Company or any of its

Subsidiaries, under the DGCL or any other Applicable Law or under any agreement of any Indemnified Person with the Company or any of

its Subsidiaries. These rights will survive consummation of the Merger and are intended to benefit, and shall be enforceable

by, each Indemnified Person.

Section 7.03.

Employee Matters. (a) The Company and Parent hereby acknowledge and agree that a “Change in Control”

(or similar phrase) within the meaning of any Company Plan will occur as of the Effective Time. From and after the Effective Time, Parent

shall, or shall cause the Surviving Corporation (or one or more of its Subsidiaries, as applicable) to, assume and honor all the Company

Plans in accordance with their terms.

(b)

For the period commencing at the Effective Time and ending on the date that is 12 months thereafter (or, if earlier, on the

date of the employee’s termination of employment), Parent shall cause the Surviving Corporation and/or its Subsidiaries to provide

each Company Employee as of immediately prior to the Effective Time whose employment continues with the Surviving Corporation or any

of its Subsidiaries after the Effective Time (each, a “Continuing Employee”)

(i) an annual rate of base salary or base hourly wage, as applicable, that is no less favorable than the annual rate of base salary

or base hourly wage provided to such Continuing Employee as of immediately prior to the Effective Time, (ii) target annual cash

bonus or other short-term cash incentive opportunities that are no less favorable than the target annual cash bonus or other short-term

cash incentive opportunities provided to such Continuing Employee as of immediately prior to the Effective Time (excluding any discretionary,

one-time, signing, change in control, transaction, retention, long-term incentive or equity-or-equity-based compensation or opportunities),

(iii) employee benefits that, on an aggregate basis, are substantially comparable to the employee benefits (other than any long-term

incentive, equity or equity-based compensation, nonqualified deferred compensation, severance, defined benefit pension, post-employment

welfare benefits, retention or change in control plans, agreements, programs, policies or arrangements (collectively, “Excluded

Benefits”)) provided to such Continuing Employee as of immediately prior to the Effective Time and (iv) severance protections

no less favorable than those set forth on Section 7.03(a) of the Company Disclosure Schedule, taking into account all service

with the Company, Parent and their respective Affiliates in determining the amount of severance benefits payable.

(c)

Parent shall, or shall cause the Surviving Corporation and any applicable Subsidiary to use commercially reasonable efforts to

(i) waive all limitations as to any pre-existing condition or waiting periods with respect to participation and coverage requirements

applicable to each Continuing Employee under any employee benefit plan that is a “group health plan” within the

meaning

of Section 5000(b)(1) of the Code (including any flexible spending account or similar arrangement) and in which such Continuing Employees

may be eligible to participate for the plan year which includes the Effective Time to the extent such pre-existing condition or waiting

period was not applicable as of immediately prior to the Effective Time under any similar Company Plan that is a “group health

plan” within the meaning of Section 5000(b)(1) of the Code (including any flexible spending account or similar arrangement), and

(ii) credit each Continuing Employee for any copayments, deductibles, offsets or similar payments made under the Company Plan that is

a “group health plan” within the meaning of Section 5000(b)(1) of the Code (including any flexible spending account or similar

arrangement) for the plan year which includes the Effective Time for purposes of satisfying any applicable copayment, deductible, offset

or similar requirements under the similar group health plans of Parent, the Surviving Corporation or any of their respective Subsidiaries

within the meaning of Section 5000(b)(1) of the Code (including any flexible spending account or similar arrangement) for the plan year

which includes the Effective Time.

(d)

As of the Effective Time, Parent shall, and shall cause the Surviving Corporation and any applicable Subsidiary to, give all Continuing

Employees full credit for such Continuing Employees’ service with the Company or any of its Subsidiaries prior to the Effective

Time for purposes of eligibility, vesting (other than vesting of future equity awards) and benefit accrual under any employee benefit

plans, programs, policies, agreements and arrangements maintained by Parent, the Surviving Corporation or an applicable Subsidiary in

which any Continuing Employee may be eligible to participate after the Effective Time, to the same extent that such service was credited

under any similar Company Plan immediately prior to the Effective Time; provided that such credit for service shall not apply

(i) to the extent it would result in a duplication of benefits or compensation or (ii) for any purpose with respect to the Excluded Benefits.

(e)

With respect to annual short-term cash incentive bonuses set forth on Section 7.03(e) of the Company Disclosure Schedule

relating to the performance year in which the Effective Time occurs, Parent shall, or shall cause its Affiliates (including the Surviving

Corporation) to continue the applicable annual bonus plan following the Closing in good faith and in the ordinary course of business

substantially consistent in all respects with the Company’s or its applicable Subsidiary’s past practice and shall cause

each Continuing Employee who remains employed through the date that such bonuses would be paid in the ordinary course of business to

receive an amount in respect of such bonus equal to the greater of (i) the target bonus opportunity under such plan and (ii) the amount

determined based on the level of achievement of the applicable performance goals (the “Closing

Year Bonus”). Notwithstanding the foregoing, in the event that the employment of any Continuing Employee is terminated

by Parent or its Subsidiaries, including the Surviving Corporation, without Cause or by any Continuing Employee for Good Reason, in each

case, between July 1 and December 31 of the year in which the Closing occurs, Parent shall, and shall cause its Subsidiaries, including

the Surviving Corporation, to, pay to such Continuing Employee, at such time set forth in the preceding sentence, a prorated amount of

the Closing Year Bonus based on the number of days that such Continuing Employee was employed during such year.

(f)

Prior to making any written or broad-based oral communications to any current or former Company Service Provider pertaining to

compensation or benefits matters described in this Agreement or to compensation or benefits that will be provided by Parent or any of

its Affiliates following the Closing, the Company shall provide Parent with a copy of the intended

communication,

Parent shall have a reasonable period of time to review and comment on the communication and the Company shall consider any such comments

in good faith.

(g)

Without limiting the generality of ‎‎‎Section 11.06,

the provisions of this ‎‎Section 7.03 are

solely for the benefit of the parties to this Agreement, and no Company Employee, Continuing Employee, Company Service Provider or any

other individual associated therewith shall be regarded for any purpose as a third-party beneficiary of this ‎‎‎Section 7.03. Nothing

herein shall, or shall be deemed to, (i) establish, terminate, amend or modify any Company Plan or any other compensation or benefit

plan, program, policy or agreement maintained or sponsored by Parent, the Surviving Corporation, the Company or any of their respective

Affiliates; (ii) alter or limit Parent’s, the Surviving Corporation’s or any of their respective Affiliates’ ability

to establish, terminate, amend or modify any particular benefit plan, program, policy, agreement or arrangement; (iii) be treated as

an amendment to any Company Plan or any compensation or benefit plan, program, policy or agreement maintained or sponsored by Parent,

the Surviving Corporation, or any of their respective Affiliates, or obligate Parent, the Surviving Corporation or any of their respective

Affiliates to maintain any particular benefit plan, program, policy or agreement; or (iv) confer upon any Continuing Employee any right

to employment or continued employment for any period of time by reason of this Agreement, or any right to a particular term or condition

of employment.

(h)

Prior to the Closing, Parent shall, or shall cause the Surviving Corporation and any applicable Subsidiary to, fully and timely

satisfy all notice, information, consultation, bargaining or consent obligations owed to any Union which is representing any Company

Employee, or any applicable labor tribunal, in connection with the transactions contemplated by this Agreement.

(i)

Notwithstanding anything contained herein to the contrary, Parent and its Affiliates’ obligations under this ‎Section 7.03

shall not apply with respect to any Continuing Employees who are covered by a CBA.

Section 7.04.

Debt Financing Covenants. (a) Parent and Merger Sub shall (and shall cause their Subsidiaries to) use

their reasonable best efforts to arrange and obtain the Debt Financing, including using their reasonable best efforts to (i) maintain

in effect the Debt Commitment Letter (subject to any amendment, supplement, replacement, substitution, termination or other modification

or waiver that is not prohibited by clause ‎(c) below), (ii) negotiate and enter into definitive agreements with respect

thereto on the terms and conditions contained in the Debt Commitment Letter (including the flex provisions) or on other terms taken as

a whole, not materially less favorable to Parent and Merger Sub, (iii) satisfy, or obtain a waiver thereof, on a timely basis all conditions

to funding the Debt Commitment Letter and such definitive agreements related thereto that are within their control and (iv) assuming

that all conditions contained in the Debt Commitment Letter have been satisfied, consummate the Debt Financing at or prior to the Closing.

(b)

Parent shall keep the Company reasonably informed with respect to all material activity concerning the status of the Debt Financing

contemplated by the Debt Commitment Letter and shall give the Company notice of any material adverse change with respect to the Debt

Financing as promptly as practicable. Parent and Merger Sub shall give the Company prompt notice (i) of the termination, repudiation,

rescission, cancellation or expiration of the Debt

Commitment

Letter or the definitive agreements related to the Debt Financing, (ii) of any breach or default (or any event or circumstance that,

with or without notice, lapse or time or both, would reasonably be expected to give rise to any breach or default) by any party to the

Debt Commitment Letter, or any definitive agreements related to the Debt Financing, in each case of which Parent or Merger Sub becomes

aware, (iii) of the receipt of any written notice or other written communication, in each case received from any Debt Financing Source

with respect to any (A) actual or threatened breach of Parent’s or Merger Sub’s (or any of their respective Subsidiaries’)

obligations under the Debt Commitment Letter or definitive agreements related to the Debt Financing, or actual or potential default,

termination or repudiation by any party to any of the Debt Commitment Letter or definitive agreements related to the Debt Financing (including

any proposal by any Debt Financing Source, lender or other Person to withdraw, terminate, repudiate, rescind or make a material change

in the terms of the Debt Commitment Letter) or (B) material dispute between or among any parties to the Debt Commitment Letter or definitive

agreements related to the Debt Financing and (iv) of the receipt of any written notice or other written communication on the basis of

which Parent expects that a party to the Debt Financing will fail to fund the Debt Financing or is reducing the amount of the Debt Financing. As

soon as reasonably practicable, but in any event within three Business Days of the date the Company delivers to Parent or Merger Sub

a written request, Parent and Merger Sub shall provide any information reasonably requested by the Company relating to any circumstance

referred to in clauses ‎(i), ‎(ii),

‎(iii) or ‎(iv)

of the immediately preceding sentence.

(c)

For the avoidance of doubt, Parent shall have the right from time to time to amend, supplement or otherwise modify or waive its

rights under the Debt Commitment Letter, including to add lenders, lead arrangers, bookrunners, syndication agents or similar entities

who had not executed the Debt Commitment Letter as of the date of this Agreement; provided that no such amendment, supplement,

modification or waiver shall (A) reduce the aggregate amount of available Debt Financing (including by increasing the amount of

fees to be paid or original issue discount (except as set forth in any “market flex” provisions existing on the date of this

Agreement)) to less than the amount required to consummate the transactions contemplated by this Agreement (taking into account amounts

to be provided pursuant to the Equity Financing), (B) impose new or additional conditions precedent or expand upon the conditions precedent

to the Debt Financing as set forth in the existing Debt Commitment Letter, (C) adversely change the timing of the funding of the

Debt Financing thereunder in a manner that is reasonably expected to impair, delay or prevent the availability of all or a portion of

the Debt Financing or the consummation of the transactions contemplated by this Agreement or (D) otherwise adversely affect the

ability of Parent to consummate the transactions contemplated by this Agreement. Parent shall furnish to the Company a copy

of any executed written amendment, supplement, modification or waiver of the Debt Commitment Letter. Parent shall not permit or consent

to or agree to any amendment, restatement, supplement or other modification or waiver of any provision or remedy under, the Equity Commitment

Letter (other than to increase the amount of Equity Financing available thereunder). Parent shall furnish to the Company a copy of any

executed written amendment, restatement, supplement, modification, waiver or consent of or relating to the Equity Commitment Letter or

the promptly upon execution definitive agreements related to the Equity Financing thereof. For purposes of this Agreement (other than

with respect to representations in this Agreement made by or with respect to Parent or Merger Sub that speak as of the date hereof or

another specified date), references to the “Equity Commitment Letters” and the “Financing Commitment Letters”

shall include any such document as permitted or required by this

‎Section 7.04

to be amended, supplemented, replaced, substituted, terminated or otherwise modified or waived, in each case from and after such amendment,

supplement, replacement, substitution, termination or other modification or waiver and, for the avoidance of doubt, references to “Equity

Financing” and “Financing” shall include, in whole or in part (as applicable), any supplemental, replacement or substitute

financing provided for thereunder.

(d)

In the event that any portion of the Debt Financing necessary for Parent to consummate the Closing becomes unavailable on the

terms and conditions contemplated by the Debt Commitment Letter (including the flex provisions) (other than as a result of the Company’s

breach of any provision of this Agreement or failure to satisfy the conditions set forth in ‎‎Section 9.03),

(i) Parent shall promptly notify the Company and (ii) Parent and Merger Sub shall use their reasonable best efforts to (A) arrange and

obtain, as promptly as practicable following the occurrence of such event, any such portion from alternative sources (an “Alternative

Financing”) on terms that (1) taken as whole, are no more adverse to Parent and Merger Sub than the existing Debt Commitment

Letter (including after giving effect to the market flex provisions), (2) do not impose new or additional conditions precedent or expand

upon the conditions precedent to the Debt Financing set forth in the existing Debt Commitment Letter and (3) do not reduce the aggregate

amount of available Debt Financing to less than the amount required to consummate the transactions contemplated by this Agreement (taking

into account amounts to be provided pursuant to the Equity Financing) and (B) provide the Company with a copy of the new financing commitment

that provides for such Alternative Financing (including all related exhibits, schedules, annexes, supplements and term sheets thereto,

and including any related fee letter, which may be redacted in a manner consistent with ‎‎Section 5.09,

as each of the foregoing may be amended, supplemented, replaced, substituted, terminated or otherwise modified or waived from time to

time thereafter in compliance with this ‎‎Section 7.04,

the “Alternative Financing Commitment Letter”). Notwithstanding

anything to the contrary contained in this Agreement, in no event shall Parent or its Affiliates be required to pay any fees or any interest

rates applicable to the Alternative Financing materially in excess of those contemplated by the Debt Commitment Letter as in effect on

the date hereof (including the market flex provisions).

(e)

For purposes of this Agreement (other than with respect to representations in this Agreement made by or with respect to Parent

or Merger Sub that speak as of the date hereof or another specified date), references to the “Debt Commitment Letter” and

the “Financing Commitment Letters” shall include such document as permitted or required by this ‎‎Section 7.04

to be amended, supplemented, replaced, substituted, terminated or otherwise modified or waived, in each case from and after such amendment,

supplement, replacement, substitution, termination or other modification or waiver and, for the avoidance of doubt, references to “Debt

Financing” and “Financing” shall include, in whole or in part (as applicable), any supplemental, replacement or substitute

financing provided for thereunder.

Article 8

Covenants of Parent and the Company

Section 8.01.

Regulatory Undertakings.

(a)

Subject to the terms and conditions of this Agreement (including, for the avoidance of doubt, any actions taken by the Company

permitted by ‎Section 6.02 or ‎Section 6.04

and the

terms

of Section 8.01(b) through Section 8.01(f)), the Company and Parent shall use reasonable best efforts (except where a different

standard is specifically contemplated, in which case such different standard shall apply) to take, or cause to be taken, all actions

(including instituting or defending any Proceeding), and to do, or cause to be done, all things necessary, proper or advisable under

Applicable Law to consummate the transactions contemplated by this Agreement as soon as reasonably practicable (and in any event, at

least five Business Days prior to the Outside Date), including (i) preparing and filing as promptly as reasonably practicable with any

Governmental Authority or other third party all documentation to effect all necessary, proper or advisable filings, notices, petitions,

statements, registrations, submissions of information, applications, and other documents; and (ii) obtaining and maintaining all

approvals, consents, registrations, permits, authorizations, and other confirmations required to be obtained from any Governmental Authority

or other third party that are necessary, proper, or advisable to consummate the transactions contemplated by this Agreement as soon as

practicable (and in any event, at least five Business Days prior to the Outside Date).

(b)

In furtherance and not in limitation of the foregoing, each of the Company and Parent shall (and Parent shall cause its Affiliates

to) make (i) an appropriate filing of a Notification and Report Form pursuant to the HSR Act with respect to the transactions contemplated

hereby with the United States Federal Trade Commission (the “FTC”) and the

Antitrust Division of the United States Department of Justice (the “Antitrust Division”)

as promptly as reasonably practicable and in any event within 20 Business Days after the date hereof, and such filings shall request

early termination of any applicable waiting period under the HSR Act, and (ii) any other required filings pursuant to applicable

Competition Laws as promptly as practicable after the date hereof. To facilitate these filings, each of the Company and Parent

shall (and Parent shall cause its Affiliates to) furnish to the other party as promptly as practicable all information within its (or

its Affiliates’) control requested by such other party and required for such other party to make any application or other filing

to be made by it pursuant to any Applicable Law in connection with the transactions contemplated by this Agreement (other than copies

of HSR Act filings, which need not be shared). Each of Parent and the Company shall appropriately respond as promptly as practicable

to any inquiries received from the FTC or the Antitrust Division or any other Governmental Authority for additional information or documentary

material that may be requested pursuant to the HSR Act or any other applicable Competition Laws and shall use reasonable best efforts

to promptly take all other actions necessary, proper or advisable to cause the expiration or termination of the applicable waiting periods

under the HSR Act and, if applicable, any other Competition Laws as promptly as practicable.

(c)

If any objections are asserted by any Governmental Authority with respect to the transactions contemplated by this Agreement under

the HSR Act, or any other applicable Competition Law, or if any Proceeding is instituted or threatened by any Governmental Authority

under the HSR Act or any other applicable Competition Law challenging any of the transactions contemplated by this Agreement, Parent

and the Company shall take, or cause to be taken, all actions necessary to resolve such objections or Proceedings as promptly as practicable

and obtain any needed authorization, consent or approval of a Governmental Authority or avoid or eliminate any impediments under the

HSR Act or any such other Competition Law. In furtherance of and without limiting the foregoing, in connection with any such

objection or Proceeding (including solely for the purposes of clause ‎(G)

of this Section ‎8.01(c), any Proceeding instituted or threatened

by a Third Party that is not a Governmental Authority), Parent shall, and shall cause its Subsidiaries

to,

take any such actions as may be necessary to obtain any authorization, consent or approval of a Governmental Authority or to avoid or

eliminate any impediments under the HSR Act or any such other Competition Law so as to enable the consummation of the transactions hereby

to occur no later than 5 Business Days prior to the Outside Date, including (A) agreeing to hold separate, sell, license, divest or otherwise

dispose of any of the businesses or properties or assets of the Company or any of the Company’s Subsidiaries, (B) terminating,

amending or assigning any existing relationships and contractual rights and obligations of the Company or any of its Subsidiaries, (C)

terminating any venture or other arrangement of the Company or any of its Subsidiaries, (D) having the Company or any of its Subsidiaries

grant any right or commercial or other accommodation to, or entering into any contractual or other commercial relationship with, any

Third Party, (E) imposing limitations on the Company or any of the Company’s Subsidiaries with respect to how they own, retain,

conduct or operate all or any portion of their respective businesses or assets, (F) effectuating any other change to, or restructuring

of, the Company or any of the Company’s Subsidiaries, and (G) opposing (1) any administrative or judicial Proceeding that is initiated

or threatened to be initiated challenging this Agreement or the consummation of the transactions contemplated hereby (including seeking

to have any stay or temporary restraining order entered by any court or other Governmental Authority vacated or reversed) and (2) any

request for, the entry of, and seek to have vacated or terminated, any Order that could reasonably be expected to restrain, prevent or

materially delay the consummation of the transactions contemplated hereby, including in the case of either ‎(1)

or ‎‎(2), by defending through litigation any Proceeding brought

by any Person in any court or before any Governmental Authority, and pursuing all available avenues of administrative and judicial appeal,

in each case, as may be required (x) by the applicable Governmental Authority in order to resolve such objections as such Governmental

Authority may have to such transactions under the HSR Act or any such other Competition Law or (y) by any domestic or foreign court or

other tribunal in any Proceeding challenging such transactions as violative of any Competition Law, in order to avoid the entry of, or

to effect the dissolution, vacating, lifting, altering or reversal of, any Order that has the effect of restricting, preventing or prohibiting

the consummation of the transactions contemplated by this Agreement; provided, however, that nothing in this ‎‎Section 8.01(c)

shall require Parent or the Company or its Subsidiaries to take any action contemplated in this ‎Section 8.01(c)

that is not conditioned upon consummation of the Merger and the other transactions contemplated hereby; provided, further,

that nothing in this Agreement shall require any portfolio company (as such term is commonly understood in the private equity industry)

or investment of KKR or its Affiliates, to take any action with respect to any of their respective businesses, assets, operations or

otherwise.

(d)

Each party shall, subject to Applicable Law, (i) promptly notify the other parties of any substantive communication to that party

from the FTC, the Antitrust Division, any State Attorney General or any other Governmental Authority regarding this Agreement or the

transactions contemplated hereby and permit the other parties to review, reasonably in advance, any substantive written communication

or presentation proposed to be submitted to any Governmental Authority with respect to the foregoing and consider in good faith any comments

such other may party may provide thereto; (ii) not agree to participate in any substantive meeting or discussion with any Governmental

Authority in respect of any filings, investigation or inquiry concerning any competition or antitrust matters in connection with this

Agreement or the Merger and the other transactions contemplated hereby unless in each case it consults with the other parties in advance

and, to the extent permitted by such Governmental Authority, gives the other parties the opportunity to attend and participate thereat;

and (iii) furnish the other parties with copies of

all

filings and material correspondences and communications between them, on the one hand, and any Governmental Authority or members or their

respective staffs, on the other hand, with respect to any Competition Laws in connection with this Agreement; provided, however,

that materials required to be provided pursuant to the foregoing clauses (i) – (iii) may be redacted to (A) to remove

references concerning the valuation of Parent, Company or any of their respective Subsidiaries, (B) as necessary to comply with contractual

arrangements existing as of the date hereof, and (C) as necessary to address reasonable privilege or confidentiality concerns; provided,

further, that each party may, as each deems advisable and necessary, reasonably designate any competitively sensitive material

provided to the other under this ‎Section 8.01(d)

as “Outside Counsel Only Material;” provided, further, however, that neither party shall be required to share

its HSR filing with the other party. Subject to Applicable Law, the parties hereto will consult and cooperate with one another in connection

with any analyses, appearances, presentations, memoranda, briefs, arguments, opinions and proposals made or submitted by or on behalf

of any party hereto relating to proceedings under any Competition Law. Subject to compliance with its obligations under this

‎‎‎‎Section 8.01, Parent shall have

the right to lead the regulatory strategy for securing approvals and expiration of relevant waiting periods under the HSR Act and Competition

Laws, including with respect to the timing and content of any filings, submissions and communications with or to any Governmental Authority

in connection therewith; provided that Parent shall consult with, and consider in good faith the views of, the Company; provided,

further, that no party shall extend any waiting periods under the HSR Act or any other Competition Law without the prior written

consent of the other party (not to be unreasonably withheld, conditioned or delayed).

(e)

Parent shall not, and shall cause KKR Core Investments Fund II SCSp (excluding any portfolio company of KKR Core Investments Fund

II SCSp) not to, enter into, facilitate or consummate any contracts or arrangements for an acquisition, however structured, of any ownership

interest, assets or rights in any Person, if such action would (A) reasonably be expected to make it materially more likely that there

would arise any material impediments under any Competition Law or any other Applicable Laws that may be asserted by any Governmental

Authority to the consummation of the Merger and the other transactions contemplated hereby as promptly as practicable or (B) impose any

material delay in the expiration or termination of any waiting period or obtaining of any approval from any Governmental Authority applicable

to the transactions contemplated by this Agreement.

(f)

Parent shall pay and be responsible for all HSR filing fees and any other filing fees under any Competition Laws incurred in connection

with the matters contemplated by this ‎‎‎‎Section 8.01.

Section 8.02.

Certain Filings. (a) As promptly as practicable following the date of this Agreement (but in no event

later than 35 days following the date of this Agreement), the Company shall prepare (with the assistance and cooperation of Parent as

reasonably requested by the Company) and file or cause to be filed with the SEC a preliminary proxy statement relating to the Company

Stockholders Meeting (as amended or supplemented, the “Proxy Statement”).

(b)

The Company and Parent shall reasonably cooperate with one another (i) in connection with the preparation of the Proxy Statement,

(ii) in determining whether any action by or in respect of, or filing with, any Governmental Authority is required, or any actions, consents,

approvals

or waivers are required to be obtained from parties to any material contracts, in connection with the consummation of the transactions

contemplated by this Agreement and (iii) in taking such actions or making any such filings, furnishing information required in connection

therewith or with the Proxy Statement and seeking timely to obtain any such actions, consents, approvals or waivers.

(c)

Each of Parent and Merger Sub shall, upon the Company’s request, promptly furnish to the Company all information concerning

itself, its Subsidiaries, directors and officers as may be reasonably necessary or advisable in connection with any statement, filing,

notice or application made to the SEC or NYSE in connection with the Proxy Statement. Parent and the Company shall each use reasonable

best efforts to have the Proxy Statement cleared by the SEC as promptly as reasonably practicable after filing. Prior to each filing

of the Proxy Statement, disseminating the Proxy Statement to stockholders of the Company or responding to any comments of the SEC with

respect thereto, the Company shall provide Parent and its counsel a reasonable opportunity to review and comment on such document or

response (including the proposed final version of such document or response) and give reasonable and good-faith consideration to any

comments made by Parent and its counsel in connection with any such document or response. The Company shall provide Parent and its counsel

with any comments or other communications, whether written or oral, that the Company or its counsel may receive from time to time from

the SEC or its staff with respect to the Proxy Statement promptly after receipt of those comments or other substantive communications.

None of the Company, Parent or their respective Representatives shall agree to participate in any material or substantive meeting or

conference (including by telephone) with the SEC, or any member of the staff thereof, in respect of the Proxy Statement unless it consults

with the other party in advance and, to the extent permitted by the SEC, allows the other party to participate.

(d)

The Company and Parent each agrees, as to itself and its Subsidiaries, that none of the information supplied or to be supplied

by it or its Subsidiaries for inclusion or incorporation by reference in the Proxy Statement and any amendment or supplement thereto

will, at the date the Proxy Statement is first mailed to the stockholders of the Company or at the date the Proxy Statement (or any amendment

or supplement thereto) is filed with the SEC or at the times of the meeting of the Company’s stockholders to be held in connection

with the Merger, contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements

therein, in light of the circumstances under which they were made, not misleading.

(e)

If at any time prior to the receipt of the Company Stockholder Approval, any information relating to the Company, Parent, or any

of their respective Affiliates, officers or directors, should be discovered by the Company or Parent that should be set forth in an amendment

or supplement to the Proxy Statement, so that it would not include any misstatement of a material fact or omit to state any material

fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, the

party which discovers such information shall promptly notify the other parties and an appropriate amendment or supplement describing

(or correcting) such information shall promptly be prepared and, following a reasonable opportunity for the other party (and its counsel)

to review and comment on such amendment or supplement, filed with the SEC and, to the extent required under Applicable Law, disseminated

to the stockholders of the Company.

Section 8.03.

Public Announcements. The initial press release relating to this Agreement shall be a joint press release

mutually agreed and issued by the Company and Parent. Except in connection with the matters contemplated by ‎‎‎Section 6.04

or in connection with any dispute between the parties regarding this Agreement, the Merger or the other transactions contemplated hereby,

Parent and the Company (a) shall consult with each other before issuing any further press release, having any communication with the

press (whether or not for attribution) or making any other public statement (including any announcement to officers or employees of the

Company or its Subsidiaries), or scheduling any press conference or conference call with investors or analysts, with respect to this

Agreement or the transactions contemplated hereby (other than any press release, communication, public statement, press conference or

conference call which has a bona fide purpose that does not relate to this Agreement or the transactions contemplated hereby and

in which this Agreement and the transactions contemplated hereby are mentioned only incidentally and in a manner consistent with previous

press releases, public disclosures or public statements made jointly by the parties (or individually, if approved by the other party))

and (b) except in respect of any public statement or press release as may be required by Applicable Law or any listing agreement with

or rule of any national securities exchange or association (provided, in such case, such party has given advance notice (and an

opportunity to review and comment to the extent practicable) to the other party), shall not issue any such press release or make any

such other public statement or schedule any such press conference or conference call before such consultation. Notwithstanding

the foregoing, after the issuance of any press release or the making of any public statement with respect to which the foregoing consultation

procedures have been followed, (a) either party may issue such additional publications or press releases and make such other customary

announcements without consulting with any other party hereto so long as such additional publications, press releases and announcements

do not disclose any nonpublic information regarding the transactions contemplated by this Agreement beyond the scope of the disclosure

included in a previous press release or public statement and such additional publications, press releases or announcements are otherwise

consistent with those with respect to which the other party had consented (or been consulted) in accordance with the terms of this ‎‎‎Section 8.03

and (b) Parent and its Affiliates may provide information regarding this Agreement and the transactions contemplated hereby to their

respective existing or prospective limited partners and other investors on a confidential basis to the extent such recipients are subject

to customary confidentiality obligations prior to the receipt of such information.

Section 8.04.

Merger Sub Approval. Parent shall take all action necessary to cause Merger Sub to perform its obligations

under this Agreement and to consummate the Merger in accordance with and subject to the terms and conditions of this Agreement. Immediately

following the execution of this Agreement, Parent, as sole stockholder of Merger Sub, shall adopt this Agreement.

Section 8.05.

Further Assurances. At and after the Effective Time, the officers and directors of the Surviving Corporation

shall be authorized to execute and deliver, in the name and on behalf of the Company or Merger Sub, any deeds, bills of sale, assignments

or assurances and to take and do, in the name and on behalf of the Company or Merger Sub, any other actions and things to vest, perfect

or confirm of record or otherwise in the Surviving Corporation any and all right, title and interest in, to and under any of the rights,

properties or assets of the Company acquired or to be acquired by the Surviving Corporation as a result of, or in connection with, the

Merger.

Section 8.06.

Section 16 Matters. Prior to the Effective Time, the Company shall take all such steps as may be required

to cause any dispositions of Company Common Shares (as well as Company Equity Awards and other derivative securities of Company Common

Shares) in connection with the transactions contemplated by this Agreement by each individual who is subject to the reporting requirements

of Section 16(a) of the 1934 Act with respect to the Company to be exempt under Rule 16b-3 promulgated under the 1934 Act.

Section 8.07.

Notices of Certain Events. Each of the Company and Parent shall promptly notify the other of any of the

following: (a) any written notice or other written communication from any Person alleging that the consent of such Person

is or may be required in connection with the transactions contemplated by this Agreement, (b) any written notice or other written communication

from any Governmental Authority in connection with the transactions contemplated by this Agreement (other than communications pursuant

to ‎‎‎Section 8.01, which shall be governed by ‎Section 8.01), (c) the discovery of any fact

or circumstance, or the occurrence or non-occurrence of any event, which would reasonably be expected to cause or result in any of the

conditions to the Merger contained in ‎Article 9 not being satisfied or the satisfaction of those conditions being materially

delayed and (d) any Proceedings commenced or, to its Knowledge, threatened in writing against, relating to or involving or otherwise

affecting the Company or any of its Subsidiaries or Parent or any of its Subsidiaries, as the case may be, that relate to the consummation

of the transactions contemplated by this Agreement; provided that a party’s failure to comply with this ‎‎‎Section 8.07

shall not, absent Willful Breach, constitute a breach of this ‎‎‎Section 8.07 for purposes of ‎Article 9,

and shall not provide any other party the right not to effect, or the right to terminate, the transactions contemplated by this Agreement,

except to the extent that any other provision of this Agreement independently provides such right.

Section 8.08.

Litigation and Proceedings. The Company shall promptly notify Parent of any action brought by stockholders

of the Company against the Company and/or its directors or officers relating to this Agreement, the Merger or the other transactions

contemplated by this Agreement (whether directly or on behalf of the Company and its Subsidiaries or otherwise), including by providing

copies of all pleadings with respect thereto. Prior to the Effective Time, the Company shall control the defense or settlement of any

litigation or other Proceedings against the Company or any of its directors or officers relating to this Agreement, the Merger or the

other transactions contemplated by this Agreement; provided that, other than Proceedings between or among the parties hereto,

the Company shall (i) give Parent the opportunity to consult with the Company prior to the Effective Time and keep Parent reasonably

apprised on a reasonably prompt basis with respect to the defense or settlement of any litigation or other Proceedings against the Company

or any of its directors or officers relating to this Agreement, the Merger and the other transactions contemplated by this Agreement

and (ii) give Parent a reasonable opportunity to participate, at Parent’s expense, in the defense, settlement or prosecution of

any Proceedings; provided further that that the Company agrees that it shall not settle or offer to settle any Proceedings without

the prior written consent of Parent, which shall not be unreasonably withheld, delayed or conditioned.

Section 8.09.

Takeover Statutes. If any “control share acquisition,” “fair price,” “moratorium,”

“business combination” or other similar antitakeover statute or regulation shall become applicable to the transactions contemplated

by this Agreement, each of the Company, Parent and Merger Sub and the respective members of their boards of directors shall, to the extent

permitted

by Applicable Law, use reasonable best efforts to grant such approvals and to take such actions as are reasonably necessary so that the

transactions contemplated by this Agreement may be consummated as promptly as practicable on the terms contemplated herein and otherwise

to take all such other actions as are reasonably necessary to eliminate or minimize the effects of any such statute or regulation on

the transactions contemplated hereby.

Section 8.10.

Convertible Notes; Capped Calls. (a) At or prior to the Effective Time, the Company shall cooperate

with Parent and take all actions required under the Indentures, the Convertible Notes and the Capped Call Transactions, including in

connection with the Merger and the other transactions contemplated by this Agreement, and all Applicable Laws in connection therewith,

including for the avoidance of doubt as a result of the Merger constituting a “Fundamental Change” and/or “Make-Whole

Fundamental Change” (as such terms are defined in the applicable Indenture), in each case, applicable to the Company, including,

without limitation, (i) preparing, executing and delivering, and using reasonable best efforts to cause the applicable Trustee to execute

and deliver, any supplemental indenture(s) to the Indentures in connection with the Merger, and (ii) preparing, delivering, issuing and

entering into any notices, certificates, opinions of counsel or other documents or instruments required to comply with the Indentures,

the Convertible Notes or the Capped Call Transactions; provided, that prior to the Effective Time, the Company shall not, except

as otherwise set forth in this ‎Section 8.10, amend, modify, supplement or terminate the Indentures, in each case, without

the prior written consent of Parent.

(b)

Prior to the Effective Time, the Company shall (i) take all actions reasonably requested by Parent in connection with making elections

under, amending, negotiating adjustments, obtaining waivers or unwinding the Capped Call Transactions or otherwise settling the Capped

Call Transactions effective as of or after the Effective Time, (ii) reasonably promptly advise Parent of any notices or other material

communications with the counterparties to the Capped Call Transactions in respect of any settlement or termination thereof or adjustment

thereto (including notices of adjustments received by the Company arising out of an Announcement Event (as defined in the Capped Call

Transactions)), and (iii) reasonably cooperate with Parent with respect to its efforts to settle, terminate or amend the Capped Call

Transactions effective as of or after the Effective Time and the negotiation of any adjustment, termination or settlement payment or

valuation related thereto or the negotiation of any amendment thereto, as applicable; provided, that the Company shall not agree

to amend, modify or supplement the terms relating to any Capped Call Transaction, or affirmatively agree to any adjustment thereto or

amount due upon the termination or settlement thereof, in each case, without the prior written consent of Parent.

(c)

The Company shall provide Parent and its counsel as promptly as possible prior to issuance, delivery or execution an opportunity

to review and comment on any notices, certificates, press releases, supplemental indentures or other documents or instruments deliverable

pursuant to or in connection with the Indentures, the Convertible Notes or the Capped Call Transactions, and the Company shall respond

as promptly as reasonably practicable to any questions from, and incorporate all reasonable comments provided by, Parent and its counsel

with respect thereto prior to the issuance, delivery or execution.

(d)

Notwithstanding the foregoing, nothing in this ‎Section 8.10

shall require the Company to (i) pay any fees, incur or reimburse any costs or expenses, or make any payment in connection with the Indentures

or any Capped Call Transaction prior to the occurrence of the

Effective

Time (other than to the extent expressly required under the Indentures or any Capped Call Transaction or for which Parent agrees to concurrently

reimburse the Company), (ii) enter into or effect any settlement, termination, instrument or agreement, or agree to any settlement, termination

or any other change or modification to any instrument or agreement, in each case with respect to the Indentures or any Capped Call Transaction,

that is effective prior to the occurrence of the Effective Time, or (iii) refrain from delivering, or delay the delivery of, any notice

required by the terms of the Indentures or the Capped Call Transactions (it being understood that the Company will provide Parent with

prior notice of any such delivery with a reasonable opportunity to comment on the relevant notice).

Article 9

Conditions to the Merger

Section 9.01.

Conditions to the Obligations of Each Party. The obligations of the Company, Parent and Merger Sub to consummate

the Merger are subject to the satisfaction of the following conditions:

(a)

the Company Stockholder Approval shall have been obtained in accordance with the DGCL;

(b)

no Order issued by any Governmental Authority (whether temporary, preliminary or permanent) of competent jurisdiction, or Applicable

Law prohibiting, rendering illegal or enjoining the consummation of the Merger shall be in effect; and

(c)

any applicable waiting period (including any extension thereof) under the HSR Act relating to the Merger, and any agreement between

a Governmental Authority, on the one hand, and the Company and Parent, on the other hand, prohibiting the consummation of the Merger,

shall have expired or been terminated and each consent, approval, waiver, clearance, authorization or permission of a Governmental Authority

set forth on ‎ ‎Section 9.01(c) of the Company

Disclosure Schedule shall have been made, obtained or received (or, as applicable, the waiting periods with respect thereto shall have

expired or been terminated).

Section 9.02.

Conditions to the Obligations of Parent and Merger Sub. The obligations of Parent and Merger Sub to consummate

the Merger are subject to the satisfaction of the following additional conditions:

(a)

the Company shall have performed and complied with in all material respects all of the covenants, obligations and agreements hereunder

required to be performed or complied with by it prior to the Closing;

(b)

(i) the representations and warranties of the Company contained in ‎‎‎Section 4.01(a)

(Corporate Existence and Power), ‎‎Section 4.02

(Corporate Authorization), ‎Section 4.05(a)

(other than the first two sentences) (Capitalization), Section 4.05(b) (Capitalization) and ‎Section 4.24

(Finders’ Fees)‎ shall be true and correct in

all material respects as of the Closing Date as if made at and as of the Closing Date (in each case, other than representations and warranties

that by their terms address matters only as of another specified time, which shall be so true only as of such time), (ii) the representations

and warranties of the Company contained in the first two sentences

‎Section 4.05(a) (Capitalization) shall

be true and correct in all respects, except for de minimis inaccuracies, as of the Closing Date as if made at and as of the Closing

Date (other than representations and warranties that by their terms address matters only as of another specified time, which shall be

so true only as of such time), (iii) the representations and warranties of the Company contained in ‎‎Section 4.10(b)

(Absence of Certain Changes) shall be true and correct in all respects as of the Closing Date as if made at and as of the Closing

Date and (iv) the other representations and warranties of the Company contained in this Agreement (disregarding all materiality

and Company Material Adverse Effect qualifications contained therein) shall be true and correct in all respects as of the Closing Date

as if made at and as of the Closing Date (other than representations and warranties that by their terms address matters only as of another

specified time, which shall be so true only as of such time), with only such exceptions in the case of this clause ‎(iv)

as have not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect;

(c)

since the date hereof, there shall not have occurred a Company Material Adverse Effect; and

(d)

Parent shall have received a certificate signed by an executive officer of the Company to the effect that the conditions set forth

in foregoing clauses ‎(a) – ‎(c)

have been satisfied.

Section 9.03.

Conditions to the Obligations of the Company. The obligation of the Company to consummate the Merger is

subject to the satisfaction of the following additional conditions:

(a)

each of Parent and Merger Sub shall have performed and complied with in all material respects all of the covenants, obligations

and agreements hereunder required to be performed or complied with by it prior to the Closing;

(b)

(i) the representations and warranties of Parent and Merger Sub contained in ‎Section 5.01(a)

(Corporate Existence and Power) and ‎‎‎Section 5.02

(Corporate Authorization) shall be true and correct in all material respects as of the Closing Date as if made at and as of the

Closing Date (in each case, other than representations and warranties that by their terms address matters only as of another specified

time, which shall be so true only as of such time) and (ii) the other representations and warranties of Parent and Merger Sub contained

in this Agreement (disregarding all materiality and Parent Material Adverse Effect qualifications contained therein) shall be true and

correct in all respects as of the Closing Date as if made at and as of the Closing Date (other than representations and warranties that

by their terms address matters only as of another specified time, which shall be so true only as of such time), with only such exceptions

in the case of this clause ‎(ii) as have not had and would

not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect; and

(c)

the Company shall have received a certificate signed by an executive officer of Parent to the effect that the conditions set forth

in foregoing clauses ‎(a) – ‎(b)

have been satisfied.

Article 10

Termination

Section 10.01.

Termination. This Agreement may be terminated and the Merger may be abandoned at any time prior to the Effective

Time (notwithstanding any approval of this Agreement by the stockholders of the Company and with any termination by Parent also being

an effective termination by Merger Sub):

(a)

by mutual written agreement of the Company and Parent;

(b)

by either the Company or Parent, if:

(i)

the Merger has not been consummated on or before 5:00 p.m. Eastern time on May 2, 2027 (the “Outside

Date”); provided that the right to terminate this Agreement pursuant to this ‎‎‎Section 10.01(b)(i)

shall not be available to any party who is in breach of, or has breached, its obligations under this Agreement, where such breach has

primarily caused or resulted in the failure of the Closing to occur on or before the Outside Date;

(ii)

there shall be any Order issued by any Governmental Authority of competent jurisdiction rendering illegal, or restraining, enjoining

or otherwise prohibiting the consummation of the Merger and such Order shall have become final and nonappealable; provided that,

at the time at which such Person would otherwise exercise such termination right, the material breach by such Person (and, in the case

of Parent, Merger Sub’s) of its (or their) obligations under this Agreement has not been the primary cause of, or resulted in,

the events specified in this ‎‎‎Section 10.01(b)(ii);

(iii)

at the Company Stockholders Meeting (including any adjournment or postponement thereof), the Company Stockholder Approval shall

not have been obtained; or

(c)

by Parent:

(i)

prior to receipt of the Company Stockholder Approval, if an Adverse Recommendation Change shall have occurred; or

(ii)

if a breach of any representation or warranty or failure to perform any covenant or agreement on the part of the Company set forth

in this Agreement shall have occurred that (A) would cause any of the conditions set forth in ‎‎Section 9.02

not to be satisfied and (B) is incapable of being cured or, if curable, has not been cured by the date that is 20 Business Days after

its receipt of written notice thereof from Parent (or, if earlier, five Business Days prior to the Outside Date); provided that

the right to terminate this Agreement pursuant to this ‎‎‎Section 10.01(c)(ii)

shall not be available if at such time there is any breach or inaccuracy, of any of Parent’s or Merger Sub’s representations,

warranties, covenants or agreements contained in this Agreement and such breach or inaccuracy would cause or result in the failure of

a condition set forth in ‎‎Section 9.03;

(d)

by the Company, if:

(i)

prior to receipt of the Company Stockholder Approval, the Board of Directors authorizes the Company to enter into a written definitive

agreement concerning a Superior Proposal; provided that (x) concurrently with such termination, the Company pays the Company Termination

Fee payable pursuant to ‎‎Section 11.04

and (y) the Company and the Board of Directors shall have complied in all material respects with ‎Section 6.04

with respect to such Superior Proposal;

(ii)

a breach of any representation or warranty or failure to perform any covenant or agreement on the part of Parent or Merger Sub

set forth in this Agreement shall have occurred (A) that would cause any of the conditions set forth in ‎‎Section 9.03

not to be satisfied and (B) that is incapable of being cured or, if curable, has not been cured by the date that is 20 Business Days

after its receipt of written notice thereof from the Company (or, if earlier, five Business Days prior to the Outside Date); provided

that the right to terminate this Agreement pursuant to this ‎‎‎Section 10.01(d)(ii)

shall not be available if there is any breach or inaccuracy of any of the Company’s representations, warranties, covenants or agreements

contained in this Agreement and such breach or inaccuracy would cause or result in the failure of a condition set forth in ‎‎Section 9.02;

(iii)

(A) all of the conditions set forth in ‎‎Section 9.01

and ‎‎Section 9.02 have been

satisfied (other than those conditions which by their terms or nature are to be satisfied at the Closing (assuming the satisfaction of

those conditions at such time if Closing were to occur at such time)), (B) the Company has, after the failure in clause (C) below,

irrevocably confirmed to Parent in writing that it is ready, willing and able to consummate the Closing on such date of confirmation

and at all times during the three Business Day period immediately thereafter, and (C) Parent has failed to consummate the Closing on

or prior to the date on which the Closing should have occurred pursuant to ‎Section 2.01.

The party desiring

to terminate this Agreement pursuant to this ‎Section 10.01

(other than pursuant to ‎Section 10.01(a)) shall

give written notice of such termination to the other parties specifying the provision of this ‎Section 10.01

pursuant to which this Agreement is being terminated.

Section 10.02.

Effect of Termination. If this Agreement is terminated pursuant to ‎‎‎Section 10.01,

this Agreement shall become void and of no effect without liability of any party to the other parties hereto (or any stockholder, director,

officer, employee, agent, consultant or representative of such party); provided that, subject to ‎Section 11.04(c)‎

and ‎ ‎Section 11.04(d) in all respects, no party shall be relieved of liability to the extent such termination shall

result from the fraud or any Willful Breach of this Agreement by a party prior to termination, and in each such case, such party shall

be fully liable for any and all liabilities and damages that were incurred or suffered by the other parties as a result of such fraud

or Willful Breach (which the parties acknowledge and agree will not be limited to reimbursement of expenses or out-of-pocket costs and

will include the benefit of the bargain lost by a party’s stockholders, which may be deemed in such event to be damages of such

party as determined by the trier of fact). The Confidentiality Agreement, the Guarantee and the provisions of ‎‎ ‎Section 6.03(b),

this ‎ ‎Section 10.02 and ‎‎ ‎Article 11 shall survive any termination hereof pursuant to

‎‎Section 10.01. For purposes of this Agreement, “Willful Breach”

means any material breach of this Agreement that is the consequence of an action

omission by any party if such party knew or should have known that the taking of such action or the failure to take such action would

be a breach of this Agreement.

Article 11

Miscellaneous

Section 11.01.

Notices. All notices, requests and other communications to any party hereunder shall be in writing (including

e-mail, so long as a receipt of such e-mail is requested and received) and shall be given,

if to Parent

or Merger Sub, to:

c/o

Kohlberg Kravis & Roberts & Co. L.P.

Hudson Yards

New

York, New York 10001

Attention:

Max Lin

Hunter Craig

with a

copy, which shall not constitute notice, to:

Kirkland

& Ellis LLP

601

Lexington Avenue

New

York, New York 10022

Attention:

Jennifer S.

Perkins, P.C.

David M. Klein,

P.C.

Daniel A.

Guerin, P.C.

Steven M.

Choi

E-mail:

jennifer.perkins@kirkland.com

dklein@kirkland.com

daniel.guerin@kirkland.com

steven.choi@kirkland.com

if to the

Company, to:

Integer

Holdings Corporation

5830

Granite Parkway, Suite 1150

Plano,

Texas 75024

Attention:

Diron Smith

Lindsay Blackwood

with copies,

which shall not constitute notice, to:

Davis

Polk & Wardwell LLP

450

Lexington Avenue

New

York, New York 10017

Attention:

James P. Dougherty

E-mail:

james.dougherty@davispolk.com

or to such other

address or e-mail address as such party may hereafter specify for the purpose by notice to the other parties hereto. All such

notices, requests and other communications shall be deemed received on the date of receipt by the recipient thereof if received prior

to 5:00 p.m. New York City time on a business day in the place of receipt. Otherwise, any such notice, request or communication

shall be deemed to have been received on the next succeeding business day in the place of receipt.

Section 11.02.

No Survival of Representations and Warranties. The representations and warranties contained herein and in

any certificate or other writing delivered pursuant hereto shall not survive the Effective Time.

Section 11.03.

Amendments and Waivers. (a) Any provision of this Agreement may be amended or waived prior to the Effective

Time if, but only if, such amendment or waiver is in writing and is signed, in the case of an amendment, by each party to this Agreement

or, in the case of a waiver, by each party against whom the waiver is to be effective; provided that, after the Company Stockholder

Approval has been obtained, there shall be no amendment or waiver that would require the further approval of the stockholders of the

Company under the DGCL without such approval having first been obtained.

(b)

No failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall

any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The

rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by Applicable Law.

Section 11.04.

Expenses & Fees. (a) General. Except as otherwise expressly provided herein, all costs

and expenses incurred in connection with this Agreement shall be paid by the party incurring such cost or expense.

(b)

Termination Fee.

(i)

If this Agreement is terminated by the Company pursuant to ‎

‎Section 10.01(d)(i) (Superior Proposal) or by Parent pursuant to ‎Section 10.01(c)(i)

(Adverse Recommendation Change), the Company shall pay or cause to be paid to Parent in immediately available funds $154,000,000

(in each case, such fee, the “Company Termination Fee”), in the case of a

termination by Parent, within two Business Days after such termination and, in the case of a termination by the Company, concurrently

with and as a condition to such termination.

(ii)

If (A) this Agreement is terminated by (x) Parent or the Company pursuant to ‎

‎Section 10.01(b)(i) (Outside Date) and at the time of such termination the Company Stockholder

Approval has not been received, (y) Parent or the Company pursuant to

‎

‎Section 10.01(b)(iii) (Company

No Vote) or (z) Parent pursuant to ‎Section 10.01(c)(ii)

(Company Breach), (B) following the execution and delivery of this Agreement and prior to such termination of this Agreement,

a bona fide Acquisition Proposal shall have been publicly announced or publicly disclosed and not publicly withdrawn or otherwise

abandoned at least five Business Days prior to such termination of this Agreement or the date of the Company Stockholders Meeting, in

the case of termination pursuant to Section 10.01(b)(iii) (Company No Vote) and (C) within 12 months following such termination

of this Agreement, either an Acquisition Proposal is consummated or the Company enters into a definitive agreement providing for

the consummation of an Acquisition Proposal, then the Company shall concurrently with such consummation or entry into a definitive agreement,

pay, or cause to be paid, to Parent the Company Termination Fee by wire transfer of immediately available funds to an account or accounts

designated in writing by Parent. For purposes of this ‎‎

‎Section 11.04(b)(ii)(C), all references to “20%” in the definition of “Acquisition

Proposal” shall be deemed to be references to “50%.”

(iii)

If this Agreement is terminated by the Company pursuant to ‎‎Section 10.01(d)(ii)

(Parent Breach) or ‎ ‎Section 10.01(d)(iii)

(Parent Failure to Close) (or by Parent pursuant to ‎ ‎Section 10.01(b)(i)

(Outside Date), at a time when the Company had the right to terminate the Agreement pursuant to ‎Section 10.01(d)(ii)

(Parent Breach) or ‎ ‎Section 10.01(d)(iii)

(Parent Failure to Close) (in each case, without giving effect to any notice requirement or cure period or right set forth therein)),

then Parent shall pay or cause to be paid to the Company in immediately available funds $307,000,000 (the “Parent

Termination Fee”), in the case of a termination by the Company, within two Business Days after such termination and,

in the case of a termination by Parent, concurrently with and as a condition to such termination.

(c)

Each party agrees that (i) the agreements contained in this ‎Section 11.04

are an integral part of the transactions contemplated by this Agreement and that, without these agreements, the other parties would not

enter into this Agreement and (ii) in light of the difficulty of accurately determining actual damages with respect to the foregoing,

the right to payment of the Company Termination Fee or the Parent Termination Fee, as applicable, constitutes a reasonable estimate of

the losses, damages, claims, costs or expenses that will be suffered by reason of any such termination of this Agreement and constitutes

liquidated damages (and not a penalty) (and that neither such amount is excessive or unreasonably large, given the parties’ intent

and dealings with each other) and hereby irrevocably waives, and agrees not to assert in any Proceeding arising out of or relating to

this Agreement, any claim to the contrary.

(d)

Notwithstanding anything herein to the contrary (but subject to ‎Section 10.02

and ‎ ‎Section 11.04(e)), Parent and Merger

Sub agree that, except in the case of fraud or any Willful Breach of this Agreement, upon any valid termination of this Agreement under

circumstances where the Company Termination Fee is payable pursuant to this ‎Section 11.04‎

and such Company Termination Fee is paid in full, the receipt by Parent of the Company Termination Fee shall be deemed to be liquidated

damages and the sole and exclusive remedy of such party in connection with this Agreement or the transactions contemplated hereby and

neither Parent nor Merger Sub shall seek to obtain any recovery, judgment, or damages of any kind, including consequential, indirect,

or punitive damages, against the other parties or any of their Subsidiaries or any of their respective directors, officers, employees,

partners, managers, members, stockholders, Affiliates or

Representatives

of the Company (the “Company Related Parties”) in connection with this Agreement or the transactions contemplated

hereby, including any breach of this Agreement (other than a Willful Breach). Notwithstanding the foregoing, this ‎Section 11.04(d)

shall not relieve the Company from any liability for fraud or Willful Breach. Notwithstanding anything to the contrary in

this Agreement, other than the Company’s injunctive, specific performance and equitable relief rights, as and only to the extent

expressly permitted by ‎Section 11.13, (i) the

Company’s right to terminate this Agreement pursuant to ‎Section 10.01(d)(iii)

or ‎Section 10.01(d)(iii) and receive payment

of the Parent Termination Fee, the Reimbursement Obligations (subject to the Reimbursement Cap) and the Collection Obligations (subject

to the Collection Cap) from Parent (or the Sponsor under and in accordance with the Guarantee) shall be deemed to be liquidated damages

and the sole and exclusive remedy of the Company and any of its Affiliates against Parent, Merger Sub, Sponsor and any of its or their

Affiliates or any of its or their respective former, current or future shareholders, assignees, controlling persons, directors, officers,

employees, agents, attorneys, partners, members, managers, general or limited partners or Representatives (the “Parent Related

Parties”), or any Debt Financing Sources for any and all losses, liabilities and damages that may be suffered based upon, resulting

from, arising out of, or relating to this Agreement and the Financing, including the breach of any representation, warranty, covenant,

or agreement in this Agreement, the termination of this Agreement, or the failure to consummate the Merger and (ii) other than the payment

of the Parent Termination Fee, the Reimbursement Obligations (subject to the Reimbursement Cap) and the Collection Obligations (subject

to the Collection Cap) to the Company by Parent (or Sponsor under the Guarantee) if and when due, no Parent Related Party shall have

any further liability or obligation relating to or arising out of this Agreement or the Financing, including the breach of any representation,

warranty, covenant, or agreement in this Agreement, the termination of this Agreement, or failure to consummate the Merger. Notwithstanding

the foregoing, in the event that this Agreement is terminated without the Closing having occurred, this Section 11.04(d) will

not relieve Parent or Merger Sub from any liability for any fraud or any Willful Breach of this Agreement, except that under no circumstances

will the amount payable by Parent and Merger Sub under this Agreement (for clarity, including the Parent Termination Fee, if payable)

whether payable hereunder or by Sponsor under the Guarantee exceed, in the aggregate, the amount of the Parent Termination Fee plus the

Reimbursement Obligations (subject to the Reimbursement Cap) and the Collection Obligations (subject to the Collection Cap). Each party

acknowledges and agrees that in no event shall the Company be required to pay the Company Termination Fee or Parent be required to pay

the Parent Termination Fee on more than one occasion. Notwithstanding anything to the contrary in this Agreement, other than

the Company’s injunctive, specific performance and equitable relief rights, the Company acknowledges and agrees that in no event

will the Company or any Company Related Party seek or obtain, nor will any Person be entitled to seek or obtain, any monetary recovery

or monetary award or damages (including consequential, special, indirect or punitive damages) against any Parent Related Party with respect

to this Agreement, the Financing Commitment Letters, the Guarantee or the Merger (including any breach by any Parent Related Party),

the termination of this Agreement, the failure to consummate the Merger or any Proceedings under Applicable Law arising out of any such

breach, termination or failure (including in the event of any Willful Breach), other than the Company seeking the Parent Termination

Fee, the Reimbursement Obligations (subject to the Reimbursement Cap) and the Collection Obligations (subject to the Collection Cap)

from Parent or Merger Sub to the extent expressly provided for in this Agreement or the Company seeking the Parent Termination Fee, the

Reimbursement

Obligations (subject to the Reimbursement Cap) and the Collection Obligations (subject to the Collection Cap) from the Sponsor to the

extent expressly provided for in the Guarantee. For the avoidance of doubt, nothing in this ‎

‎Section 11.04(d) shall (i) limit any remedies of Parent prior to any such termination of this Agreement under

circumstances where the Company Termination Fee is payable pursuant to this ‎

‎Section 11.04, including specific performance pursuant to ‎

‎Section 11.13 or (ii) shall restrict the Company’s entitlement to seek and obtain specific performance

(1) hereunder as and to the extent permitted by ‎ ‎Section 11.13,

(2) against the Sponsor under the Guarantee or (3) under the Equity Commitment Letter to the extent expressly permitted under, and in

accordance with, the terms and conditions set forth therein and herein. In no event will any party be entitled to receive

both (A) a grant of specific performance which results in the consummation of the Closing as contemplated in this Agreement and (B) payment

of the Company Termination Fee or the Parent Termination Fee, as applicable.

(e)

If the Company or Parent fails to promptly pay any amount due pursuant to this ‎

‎Section 11.04 and, in order to obtain such payment, Parent or the Company, as applicable, commences a Proceeding

that results in a judgment against the other for such amount or any portion thereof, the responsible party will pay the other its reasonable

out-of-pocket fees, costs and expenses (including reasonable attorneys’ fees) in connection with such Proceeding, together with

interest on such amount due or portion thereof at the annual rate of 5% plus the prime rate as published in The Wall

Street Journal in effect on the date that such payment or portion thereof was required to be made through the date that such payment

or portion thereof was actually received, or a lesser rate that is the maximum permitted by Applicable Law (the foregoing obligations,

the “Collection Obligations”); provided that (i) the Collection Obligations payable pursuant to this ‎Section 11.04(e)

shall not exceed $5,000,000 in the aggregate (the “Collection Cap”).

(f)

Except as expressly set forth in ‎Section 2.03(c),

all transfer, documentary, sales, use, stamp, registration, value-added and other similar Taxes and fees incurred in connection with

the transactions contemplated by this Agreement shall be paid by Parent when due. Parent shall file, or cause to be filed, all Tax Returns

and other documentation required to be filed with respect to such Taxes and fees.

Section 11.05.

Disclosure Schedule and SEC Document References. The parties hereto agree that any reference in a particular

section of the Company Disclosure Schedule or Parent Disclosure Schedule shall be deemed to be an exception to (or, as applicable, a

disclosure for purposes of) (a) the representations and warranties (or covenants, as applicable) of the Company or either Parent or Merger

Sub, as applicable, that are contained in the corresponding section of this Agreement and (b) any other representations and warranties

(or covenants, as applicable) of the Company or either Parent or Merger Sub, as applicable, that are contained in this Agreement, but

only if the relevance of that reference as an exception to (or a disclosure for purposes of) such representations and warranties (or

covenants, as applicable) is reasonably apparent on its face. The mere inclusion of an item in the Company Disclosure Schedule

or Parent Disclosure Schedule will not be deemed an admission that such item represents a material exception or material fact, event

or circumstance or that such item has had or would reasonably be expected to have a Company Material Adverse Effect or Parent Material

Adverse Effect, and the disclosure therein of any allegations with respect to any alleged breach, violation or default under any contractual

or other obligation, or any law, is not an admission that such breach, violation or default has occurred. Headings and subheadings

have been inserted in certain sections of the Company Disclosure

Schedule

or Parent Disclosure Schedule for convenience of reference only and will not be considered a part of or affect the construction or interpretation

of such sections. The information provided in the Company Disclosure Schedule or Parent Disclosure Schedule is being provided

solely for the purpose of making disclosures under this Agreement. In disclosing such information, the disclosing party does

not waive, and expressly reserves any rights under, any attorney-client privilege associated with such information or any protection

afforded by the work-product doctrine with respect to any of the matters disclosed or discussed therein.

Section 11.06.

Binding Effect; Third Party Beneficiaries; Assignment. (a) Subject to ‎‎ ‎Section 11.06(b),

the provisions of this Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors

and assigns and no provision of this Agreement is intended to confer any rights, benefits, remedies, obligations or liabilities hereunder

upon any Person other than the parties hereto and their respective successors and assigns, other than: (i) with respect to

‎Section 7.02, which shall insure to the benefit of the Persons benefiting therefrom who are intended to be third-party

beneficiaries thereof; (ii) the right of any holders of Company Common Shares and Company Equity Awards to receive the Merger Consideration

following the Effective Time in accordance with, and subject to, the terms and conditions of this Agreement and (iii) the right of the

Company, on behalf of the holders of Company Common Shares and Company Equity Awards (each of which are third party beneficiaries of

this Agreement to the extent required for this clause ‎(iii) to be enforceable), to pursue specific performance as set forth

in ‎ ‎Section 11.13 or, if specific performance is not sought or granted as a remedy, damages (which damages the

parties acknowledge and agree will not be limited to reimbursement of expenses or out of pocket costs and may include the benefit of

the bargain lost by such holders) in the event of a Willful Breach hereof by Parent of this Agreement, it being agreed that in no event

shall any such holder be entitled to enforce any of their rights, or any of Parent’s or Merger Sub’s obligations, under this

Agreement in the event of any such breach, but rather the Company shall have the sole and exclusive right to do so, as agent for such

holders.

(b)

No party may assign, delegate or otherwise transfer any of its rights or obligations under this Agreement without the consent

of each other party hereto. relieve Parent or Merger Sub of its obligations under this Agreement or enlarge, alter or change any obligation

of any party hereto or due to Parent or Merger Sub. Any purported assignment, delegation or other transfer without such consent

or otherwise consistent with the foregoing sentence shall be void.

Section 11.07.

Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State

of Delaware, without regard to the conflicts of law rules or other rules that would result in the application of the laws of a different

jurisdiction. Any and all claims, controversies, causes of action, or other Proceedings arising out or relating to this Agreement,

whether sounding in contract, tort, or statute, shall be governed by the laws of the State of Delaware, without giving effect to any

conflicts of law rules or other rules that would result in the application of the laws of a different jurisdiction.

Section 11.08.

Jurisdiction. The parties hereto agree that any Proceeding seeking to enforce any provision of, relating

to, or in connection with, this Agreement shall be brought exclusively in the Delaware Chancery Court or, if such court shall not have

or declines jurisdiction, any federal court or other Delaware state courts, in each case, located in New Castle County in the State of

Delaware (collectively, the “Chosen Courts”), and each of the parties hereby

irrevocably

consents

and submits to the exclusive jurisdiction of such Chosen Courts (and of the appropriate appellate courts therefrom) in any such Proceeding

and irrevocably waives, to the fullest extent permitted by Applicable Law, any objection that it may now or hereafter have to the laying

of the venue of any such Proceeding in any such Chosen Court or that any such Proceeding brought in any such Chosen Court has been brought

in an inconvenient forum. Process in any such Proceeding may be served on any party anywhere in the world, whether within

or without the jurisdiction of any such court. Without limiting the foregoing, each party agrees that service of process on

such party as provided in ‎‎ ‎Section 11.01 shall be deemed effective service of process on such party.

Section 11.09.

WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE

UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE, EACH PARTY HERETO HEREBY IRREVOCABLY AND UNCONDITIONALLY

WAIVES ANY AND ALL RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN ANY PROCEEDING ARISING OUT OF, RELATED TO, OR IN CONNECTION WITH THIS

AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE,

AGENT OR ATTORNEY OF ANY OTHER PARTY HERETO HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF

LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C)

SUCH PARTY MAKES THIS WAIVER VOLUNTARILY AND (D) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS,

THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION ‎ ‎11.09.

Section 11.10.

Counterparts; Effectiveness. This Agreement may be signed in any number of counterparts, each of which shall

be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement

shall become effective when each party hereto shall have received a counterpart hereof signed by all of the other parties hereto. Until

and unless each party has received a counterpart hereof signed by each other party hereto, this Agreement shall have no effect and no

party shall have any right or obligation hereunder (whether by virtue of any other oral or written definitive agreement or other communication).

Section 11.11.

Entire Agreement. This Agreement, the Confidentiality Agreement, the Equity Commitment Letter and the Guarantee

constitute the entire agreement between the parties with respect to the subject matter of this Agreement and supersede all prior agreements

and understandings, both oral and written, between the parties with respect to the subject matter of this Agreement. Notwithstanding

anything in this Agreement to the contrary, the parties acknowledge and agree that, solely for purposes of Section 251 of the DGCL, the

Company Disclosure Schedule is not incorporated by reference into, and shall not be deemed to constitute a part of, this Agreement or

the “agreement of merger.”

Section 11.12.

Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent

jurisdiction or other Governmental Authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants

and restrictions of this Agreement shall remain in full force and effect and shall in no way be affected, impaired

invalidated so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially

adverse to any party. Upon such a determination, the parties shall negotiate in good faith to modify this Agreement so as

to effect the original intent of the parties as closely as possible in an acceptable manner in order that the transactions contemplated

hereby be consummated as originally contemplated to the fullest extent possible.

Section 11.13.

Specific Performance.

(a) The

parties hereto agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with its

terms, and that monetary damages, even if available, would not be an adequate remedy therefor. Accordingly, the parties hereto

agree that, subject to ‎Section 11.13(b), the parties shall be entitled to an injunction or injunctions, or any other

appropriate form of equitable relief, to prevent or restrain breaches or threatened breaches of this Agreement, the Guarantee and/or

the Equity Commitment Letter, or to enforce specifically the performance of the terms and provisions hereof, without the necessity of

proving that irreparable damage would occur or the inadequacy of money damages as a remedy (and each party hereby waives any requirement

for the securing or posting of any bond in connection with such remedy), in addition to any other remedy to which they are entitled at

law or in equity. The parties hereto hereby waive any defense, and agree not to assert (or interpose as a defense or in opposition),

that a remedy of speciﬁc performance or other equitable relief is unenforceable, invalid, contrary to law or inequitable for any

reason, that a remedy of monetary damages would provide an adequate remedy or that the parties otherwise have an adequate remedy at law. Each

of Parent and Merger Sub acknowledges and agrees that the Company may pursue a grant of specific performance under this ‎Section 11.13,

the payment of the Parent Termination Fee and damages; provided that in no event shall the Company be permitted or entitled to

receive both (i) a grant of specific performance resulting in the consummation of the transactions contemplated by this Agreement

in accordance with the terms hereof and (ii) the Parent Termination Fee or damages.

(b)

Notwithstanding anything to the contrary in this Agreement, it is acknowledged and agreed that the right of the Company to specific

performance in connection with enforcing the obligations of Parent and Merger Sub hereunder and under the Equity Commitment Letter to

effect the Closing or cause the Equity Financing to be funded will be subject to the requirements that (i) all of the conditions in ‎Section 9.01

and ‎‎Section 9.02 (other than those conditions

which by their terms or nature are to be satisfied at the Closing (but subject to such conditions being satisfied or, to the extent permissible,

waived at Closing)) have been satisfied or waived and remain so satisfied or waived at the time specific performance is granted, and

Parent failed to consummate the Closing on or prior to the date the Closing should have occurred pursuant to ‎Section 2.01,

(ii) after such failure referenced in clause (i), the Company has irrevocably notified Parent in writing that the Company is ready,

willing and able to consummate the Closing on such date of confirmation and at all times during the three Business Day period immediately

thereafter and will consummate the Closing if specific performance is granted, (iii) the Debt Financing (or any Alternative Financing

in accordance with ‎Section 7.04) has been funded

or will be funded in full at the Closing if the Equity Financing is funded at the Closing, and (iv) Parent fails to consummate the Closing

within three Business Days after receipt of such irrevocable notice. In no event shall Parent be obligated to both (x) specifically perform

the obligation to cause the Equity Financing to be funded and consummate the Closing and (y) pay the Parent Termination Fee or any other

monetary damages whatsoever.

Section 11.14.

Debt Financing Sources. Notwithstanding anything in this Agreement to the contrary, the Company and Parent,

on behalf of themselves and their Subsidiaries and Affiliates, hereby: (a) (i) agree that any action, whether in law or in

equity, whether in contract or in tort or otherwise, involving any Debt Financing Sources Related Party, arising out of or relating to,

this Agreement, the Debt Financing or any of the agreements entered into in connection with the Debt Financing or any of the transactions

contemplated hereby or thereby or the performance of any services thereunder shall be subject to the exclusive jurisdiction of any federal

or state court in the Borough of Manhattan, New York, New York, so long as such forum is and remains available, and any appellate court

thereof; and (ii) irrevocably submits itself and its property with respect to any such action to the exclusive jurisdiction of such court,

and such action (except to the extent relating to the interpretation of any provisions in this Agreement) shall be governed by the laws

of the State of New York (without giving effect to any conflicts of law principles that would result in the application of the laws of

another jurisdiction), (b) agree not to bring or support any action of any kind or description, whether in law or in equity, whether

in contract or in tort or otherwise, against any Debt Financing Sources Related Party in any way arising out of or relating to, this

Agreement, the Debt Financing or any of the transactions contemplated hereby or thereby or the performance of any services thereunder

in any forum other than any federal or state court in the Borough of Manhattan, New York, New York, (c) agree that service of process

upon the Company or Parent, or any of their Subsidiaries in any such action or proceeding shall be effective if notice is given in accordance

with ‎ ‎Section 11.01, (d) waive, to the fullest extent that it may effectively do so, the defense of an inconvenient

forum to the maintenance of such action in any such court, (e) waive, to the fullest extent permitted by Applicable Law, all rights of

trial by jury in any action brought against the Debt Financing Sources Related Parties in any way arising out of or relating to this

Agreement, the Debt Financing or any of the transactions contemplated hereby or thereby or the performance of any services thereunder,

(f) agree that no Debt Financing Sources Related Party will have any liability to the Company or any of its Subsidiaries in connection

with this Agreement, the Debt Financing or any of the transactions contemplated hereby or thereby or the performance of any services

thereunder, whether in law or in equity, whether in contract or in tort or otherwise (provided that, notwithstanding the foregoing,

nothing herein shall affect the rights of Parent against the Debt Financing Sources Related Parties with respect to the Debt Financing

or any of the transactions contemplated hereby or any services thereunder), and (g) agree that that (i) the Debt Financing Sources Related

Parties are express third party beneficiaries of, and may enforce, this ‎ ‎Section 11.14 and ‎Section 11.04(d)

and (ii) such provisions (and any other provision of this Agreement to the extent an amendment, supplement, waiver or other modification

of such provision would modify the substance of this ‎ ‎Section 11.14 and ‎Section 11.04(d)) together

with ‎Section 11.07 shall not be amended in any way materially adverse to any Debt Financing Source Related Parties without

the prior written consent of the Debt Financing Sources.

Section 11.15.

No Recourse.

(a)

This Agreement may only be enforced against, and any claims or causes of action that may be based upon, arise out of or relate

to this Agreement, or the negotiation, execution or performance of this Agreement may only be made against the Parent Related Parties

that are expressly identified as parties hereto and no Parent Related Parties (other than Parent, Merger Sub and the Sponsor to the extent

set forth in the Guarantee or Equity Commitment Letter) shall have any liability for any obligations or liabilities of the parties to

this Agreement (whether for indemnification or otherwise) or for any claim (whether in tort, contract or otherwise) based on, in

respect

of, or by reason of, the transactions contemplated hereby or in respect of any oral representations made or alleged to be made in connection

herewith. It is further understood that any certificate contemplated by this Agreement and executed by an officer of a party will be

deemed to have been delivered only in such officer’s capacity as an officer of such party (and not in his or her individual capacity)

and will not entitle any party to assert a claim against such officer in his or her individual capacity.

(b)

The Company (on behalf of itself and any Person claiming by through or on behalf of the Company) agrees that it shall not institute,

and shall not permit any of its Representatives or Affiliates to bring, make or institute any action, claim or Proceeding (whether based

in contract, tort, fraud, strict liability, other Applicable Laws or otherwise, at law or in equity) arising under or in connection with

this Agreement or any other agreement executed or delivered in connection herewith or any of the transactions contemplated hereby or

thereby against any of the Parent Related Parties and none of the Parent Related Parties shall have any liability or obligations (whether

based in contract, tort, fraud, strict liability, other Applicable Laws or otherwise) to the Company, the Company’s Subsidiaries,

any of their respective Representatives or Affiliates (or any Person claiming by, through or on behalf of the Company or its Affiliates)

or any of their respective successors, heirs or representatives thereof arising out of or relating to this Agreement or any other agreement

executed or delivered in connection herewith or any of the transactions contemplated hereby or thereby, other than, in each case, Parent

and Merger Sub to the extent provided herein, or the Sponsor pursuant to the Equity Commitment Letter or the Guarantee (in each case,

in accordance with the terms set forth therein).

[The remainder

of this page has been intentionally left blank;

the next page is the signature page.]

IN WITNESS WHEREOF, the parties hereto

have caused this Agreement to be duly executed by their respective authorized officers as of the date set forth on the cover page of

this Agreement.

INTEGER HOLDINGS CORPORATION

By:

/s/ Payman Khales

Name:

Payman Khales

Title:

President and Chief Executive Officer

[Signature Page to Merger Agreement]

ARMSTRONG PARENT, INC.

By:

/s/ Max Lin

Name:

Max Lin

Title:

President

ARMSTRONG BIDCO, INC.

By:

/s/ Max Lin

Name:

Max Lin

Title:

President

[Signature Page to Merger Agreement]

Exhibit

Certificate of Incorporation of Surviving Corporation

EX-2.2 — EXHIBIT 2.2

EX-2.2

Filename: dp251220_ex0202.htm · Sequence: 3

Exhibit 2.2

FORM OF INDEMNIFICATION

AGREEMENT

This Indemnification

Agreement (this “Agreement”), is made and entered into as of the ____ day of ______ , 20__, by and between Integer Holdings

Corporation, a Delaware corporation (the “Company”) and [•] (“Indemnitee”).

W I T N E S S E

T H:

WHEREAS, highly

competent persons have become more reluctant to serve publicly-held corporations as directors or in other capacities unless they are

provided with adequate protection through insurance or adequate indemnification against risks of claims and actions against them arising

out of their service to and activities on behalf of the corporation.

WHEREAS, the Board

of Directors of the Company (the “Board”) has determined that, in order to attract and retain qualified individuals,

the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company

and its subsidiaries from certain liabilities. Although the furnishing of such insurance has been a customary and widespread

practice among United States-based corporations and other business enterprises, the Company believes that, given current market conditions

and trends, such insurance may be available to it in the future only at higher premiums and with more exclusions. At the same

time, directors, officers, and other persons in service to corporations or business enterprises are being increasingly subjected to expensive

and time-consuming litigation relating to, among other things, matters that traditionally would have been brought only against the Company

or business enterprise itself.

WHEREAS, the By-laws

of the Company provide that the Company shall indemnify and advance expenses to all directors and officers of the Company in the manner

set forth therein and to the fullest extent permitted by applicable law, and the Company’s Certificate of Incorporation provides

for limitation of liability for directors. In addition, Indemnitee may be entitled to indemnification pursuant to the General

Corporation Law of the State of Delaware (“DGCL”). The By-laws and the DGCL expressly provide that the indemnification

provisions set forth therein are not exclusive, and thereby contemplate that contracts may be entered into between the Company and members

of the Board, officers and other persons with respect to indemnification.

WHEREAS, the uncertainties

relating to such insurance and to indemnification have increased the difficulty of attracting and retaining such persons.

WHEREAS, the Board

has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests of the Company’s

stockholders and that the Company should act to assure such persons that there will be increased certainty of such protection in the

future.

WHEREAS, it is reasonable,

prudent and necessary for the Company to contractually obligate itself to indemnify, and to advance expenses on behalf of, such persons

to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company free from undue concern that

they will not be so indemnified.

WHEREAS, this Agreement

is a supplement to and in furtherance of the Certificate of Incorporation and By-laws of the Company and any resolutions adopted pursuant

thereto and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder.

WHEREAS, Indemnitee

is willing to serve, continue to serve and to take on additional service for or on behalf of the Company on the condition that he or

she be so indemnified hereunder.

NOW, THEREFORE,

in consideration of the premises and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as follows:

Article

Certain Definitions

(a) As used in this

Agreement:

“Change

of Control” means any one of the following circumstances occurring after the date hereof: (i) there shall have occurred an

event required to be reported with respect to the Company in response to Item 6(e) of Schedule 14A of Regulation 14A (or in response

to any similar item or any similar schedule or form) under the Exchange Act, regardless of whether the Company is then subject to such

reporting requirement; (ii) any “person” or “group” (as such terms are used in Sections 13(d) and 14(d) of the

Exchange Act) shall have become, without prior approval of the Company’s Board by approval of at least a majority of the Continuing

Directors, the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities

of the Company representing 20% or more of the combined voting power of the Company’s then outstanding voting securities (provided

that, for purposes of this clause (ii), the term “person” shall exclude (x) the Company, (y) any trustee or other fiduciary

holding securities under an employee benefit plan of the Company, and (z) any corporation owned, directly or indirectly, by the stockholders

of the Company in

substantially the

same proportions as their ownership of stock of the Company); (iii) there occurs a merger or consolidation of the Company with any other

entity, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior

to such merger or consolidation continuing to represent (either by remaining outstanding or by being converted into voting securities

of the surviving entity) more than 51% of the combined voting power of the voting securities of the surviving entity outstanding immediately

after such merger or consolidation and with the power to elect at least a majority of the board of directors or other governing body

of such surviving entity; (iv) all or substantially all the assets of the Company are sold or disposed of in a transaction or series

of related transactions; (v) the approval by the stockholders of the Company of a complete liquidation of the Company; or (vi) the Continuing

Directors cease for any reason to constitute at least a majority of the members of the Board.

“Continuing

Director” means (i) each director on the Board on the date hereof or (ii) any new director whose election or nomination for

election by the Company’s stockholders was approved by a vote of at least a majority of the directors then still in office who

were directors on the date hereof or whose election or nomination was so approved.

“Corporate

Status” means the status of a person who is or was a director, officer, trustee, general partner, managing member, fiduciary,

board of directors’ committee member, employee or agent of the Company or of any other Enterprise.

“Disinterested

Director” means a director of the Company who is not and was not a party to the Proceeding in respect of which indemnification

is sought by Indemnitee.

“Enterprise”

means the Company and any other corporation, limited liability company, partnership, joint venture, trust, employee benefit plan or other

enterprise of which Indemnitee is or was serving at the request of the Company as a director, officer, trustee, general partner, managing

member, fiduciary, board of directors’ committee member, employee or agent.

“Exchange

Act” means the Securities Exchange Act of 1934, as amended.

“Expenses”

means all means attorneys’ and experts’ fees and expenses and all other costs and expenses paid or payable in connection

with investigating, defending, being a witness in or participating in (including on appeal), or preparing to investigate, defend, be

a witness in or participate in (including on appeal), any Proceeding. Expenses also shall include Expenses incurred in connection

with any appeal resulting from any Proceeding, including the premium, security for, and other costs relating to any cost bond, supersedeas

bond, or other appeal

bond or its equivalent. For the avoidance of doubt, Expenses, however, shall not include any Liabilities.

“Independent

Counsel” means a law firm, or a member of a law firm, that is experienced in matters of corporate law and neither currently

is, nor in the five years previous to its selection or appointment has been, retained to represent (i) the Company or Indemnitee in any

matter material to either such party (other than with respect to matters concerning Indemnitee under this Agreement or of other indemnitees

under similar indemnification agreements) or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding

the foregoing, the term “Independent Counsel” shall not include any person who, under the applicable standards of professional

conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine

Indemnitee’s rights under this Agreement.

“Liabilities”

means any losses or liabilities, including any judgments, fines, excise taxes and penalties, penalties and amounts paid in settlement,

arising out of or in connection with any Proceeding (including all interest, assessments and other charges paid or payable in connection

with or in respect of any such judgments, fines, excise taxes and penalties, penalties or amounts paid in settlement).

“Proceeding”

means any threatened, pending or completed action, derivative action, suit, claim, counterclaim, cross claim, arbitration, alternate

dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding,

whether civil (including intentional and unintentional tort claims), criminal, administrative or investigative, including any appeal

therefrom, and whether instituted by or on behalf of the Company or any other party, or any inquiry or investigation that Indemnitee

in good faith believes might lead to the institution of any such action, suit or other proceeding hereinabove listed in which Indemnitee

was, is or will be involved as a party, potential party, non-party witness or otherwise by reason of any Corporate Status of Indemnitee,

or by reason of any action taken (or failure to act) by him or her or of any action (or failure to act) on his or her part while serving

in any Corporate Status.

(b)

For the purposes of this Agreement:

References to “to

the fullest extent permitted by applicable law” shall include, but not be limited to: (i) to the fullest extent permitted by any

provision of the DGCL, or the corresponding provision of any successor statute, and (ii) to the fullest extent authorized or permitted

by any amendments to or replacements of the DGCL adopted after the date of this Agreement that increase the extent to which a corporation

may indemnify its officers and directors.

References to “Company”

shall include, in addition to the resulting or surviving corporation, any constituent corporation (including any constituent of a constituent)

absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify

its directors, officers, employees or agents, so that if Indemnitee is or was a director, officer, employee, or agent of such constituent

corporation or is or was serving at the request of such constituent corporation as a director, officer, employee, or agent of another

corporation, partnership, joint venture, trust or other enterprise, then Indemnitee shall stand in the same position under the provisions

of this Agreement with respect to the resulting or surviving corporation as Indemnitee would have with respect to such constituent corporation

if its separate existence had continued.

Reference to “other

enterprise” shall include employee benefit plans; references to “fines” shall include any excise tax assessed with

respect to any employee benefit plan; references to “serving at the request of the Company” shall include any service as

a director, officer, employee or agent of the Company which imposes duties on, or involves services by, such director, officer, employee

or agent with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner

he or she reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan shall be

deemed to have acted in a manner “not opposed to the best interests of the Company” as referred to in this Agreement.

Reference to “including”

shall mean “including, without limitation,” regardless of whether the words “without limitation” actually appear.

Article

Services By Indemnitee

Section 2.01. Services

By Indemnitee. Indemnitee hereby agrees to serve or continue to serve, at the will of the Company, as a director of the

Company, for so long as Indemnitee is duly elected or appointed or until Indemnitee tenders his or her resignation or is removed.

Article

Indemnification

Section 3.01.(a)

Indemnity in Third-Party Proceedings. The Company will indemnify Indemnitee in accordance with the provisions of this Section

3.01(a) if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding, other than a Proceeding by or in

the right of the Company to procure

a judgment in its

favor. Pursuant to this Section 3.01(a), the Company will indemnify Indemnitee to the fullest extent permitted by applicable law against

all Expenses and Liabilities, in each case, actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection

with such Proceeding or any claim, issue, or matter therein, if Indemnitee acted in good faith and in a manner Indemnitee reasonably

believed to be in or not opposed to the best interests of the Company and, in the case of a criminal Proceeding had no reasonable cause

to believe that Indemnitee’s conduct was unlawful.

(b) Indemnity

in Proceedings by or in the Right of the Company. The Company will indemnify Indemnitee in accordance with the provisions of this

Section 3.01(b) if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding by or in the right of the

Company to procure a judgment in its favor. Pursuant to this Section 3.01(b), the Company will indemnify Indemnitee to the fullest extent

permitted by applicable law against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection

with such Proceeding or any claim, issue, or matter therein, if Indemnitee acted in good faith and in a manner Indemnitee reasonably

believed to be in or not opposed to the best interests of the Company. The Company will not indemnify Indemnitee for Expenses under this

Section 3.01(b) related to any claim, issue, or matter in a Proceeding for which Indemnitee has been finally adjudged by a court to be

liable to the Company, unless, and only to the extent that, the Court of Chancery of the State of Delaware (the “Delaware Court”)

or any court in which the Proceeding was brought determines upon application by Indemnitee that, despite the adjudication of liability

but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification.

any other provision of this Agreement, to the extent that Indemnitee is, by reason of his or her Corporate Status, a witness in any Proceeding

to which Indemnitee is not a party, he or she shall be indemnified against all Expenses actually and reasonably incurred by Indemnitee

or on his or her behalf in connection therewith.

(d) Expenses

as a Party Where Wholly or Partly Successful. Notwithstanding any other provisions of this Agreement, to the fullest extent

permitted by applicable law, to the extent that Indemnitee is a party to (or a participant in) and is successful, on the merits or otherwise,

in any Proceeding or in defense of any claim, issue or matter therein, in whole or in part, the Company shall indemnify Indemnitee against

all Expenses actually and reasonably incurred by him or her in connection therewith. If Indemnitee is not wholly successful

in such Proceeding, but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such

Proceeding, the Company shall, to the fullest extent permitted by applicable law, indemnify Indemnitee against all Expenses actually

and reasonably incurred by Indemnitee or on his or her behalf

in connection with

each successfully resolved claim, issue or matter. For purposes of this Section 3.01(d) and without limitation, the

termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful

result as to such claim, issue or matter.

Section 3.02.

Exclusions. Notwithstanding any provision of this Agreement the Company shall not be obligated under this Agreement to

make any indemnity in connection with any Proceeding (or any part of any Proceeding):

(a)

for which payment has actually been made to or on behalf of Indemnitee under any statute, insurance policy, indemnity provision,

vote or otherwise, except with respect to any excess beyond the amount paid;

(b)

for an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company

within the meaning of Section 16(b) of the Exchange Act or similar provisions of state statutory law or common law;

(c)

for any reimbursement of the Company by Indemnitee of any bonus or other incentive-based or equity-based compensation or of any

profits realized by Indemnitee from the sale of securities of the Company, as required in each case under the Exchange Act (including

any such reimbursements that arise from an accounting restatement of the Company pursuant to Section 304 of the Sarbanes-Oxley Act of

2002 (the “Sarbanes-Oxley Act”), or the payment to the Company of profits arising from the purchase and sale by Indemnitee

of securities in violation of Section 306 of the Sarbanes-Oxley Act);

(d)

for any Proceeding initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against

the Company or its directors, officers, employees, agents or other indemnitees, unless (x) the Board authorized the Proceeding (or the

relevant part of the Proceeding) prior to its initiation, (y) the Company provides the indemnification, in its sole discretion, pursuant

to the powers vested in the Company under applicable law, (z) the Proceeding or part of any Proceeding is to enforce Indemnitee’s

rights to indemnification or advancement, of Expenses, including a Proceeding (or any part of any Proceeding) initiated pursuant to Section

6.01(e) of this Agreement; or

(e)

if prohibited by applicable law.

Article

Advancement Of Expenses; Defense of Claims

Section 4.01. Advances. Notwithstanding

any provision of this Agreement to the contrary, the Company shall advance any Expenses actually and reasonably incurred by Indemnitee

in connection with any Proceeding within fifteen (15) days after the receipt by the Company of each statement requesting such advance

from time to time, whether prior to or after final disposition of any Proceeding. Advances shall be unsecured and interest

free. Advances shall be made without regard to Indemnitee’s ability to repay such amounts and without regard to Indemnitee’s

ultimate entitlement to indemnification under the other provisions of this Agreement. Advances shall include any and all reasonable

Expenses incurred pursuing an action to enforce this right of advancement, including Expenses incurred preparing and forwarding statements

to the Company to support the advances claimed.

Section 4.02. Repayment

of Advances or Other Expenses. Indemnitee agrees that Indemnitee shall reimburse the Company for all Expenses advanced

by the Company pursuant to ‎Section 4.01, in the event and only to the extent that it shall be determined by final judgment or other

final adjudication under the provisions of any applicable law (as to which all rights of appeal therefrom have been exhausted or lapsed)

that Indemnitee is not entitled to be indemnified by the Company for such Expenses.

Section 4.03. Defense

of Claims. The Company shall be entitled to assume the defense of any Proceeding with counsel consented to by Indemnitee

(such consent not to be unreasonably withheld) upon the delivery by the Company to Indemnitee of written notice of the Company’s

election to do so. After delivery of such notice, consent to such counsel by Indemnitee and the retention of such counsel

by the Company, the Company will not be liable to Indemnitee under this Agreement for any fees or expenses of counsel subsequently incurred

by Indemnitee with respect to such Proceeding; provided that (i) Indemnitee shall have the right to employ separate counsel in

respect of any Proceeding at Indemnitee’s expense and (ii) if (A) the employment of counsel by Indemnitee has been previously authorized

in writing by the Company or (B) Indemnitee shall have reasonably concluded upon the advice of counsel that there is a conflict of interest

between the Company and Indemnitee in the conduct of the defense of such Proceeding, (C) the Company shall not continue to retain such

counsel to defend such Proceeding, or (D) a Change of Control shall have occurred, then in each such case the fees and expenses of Indemnitee’s

counsel shall be at the Company’s expense. The Company shall not settle any action, claim or Proceeding (in whole or

in part) which would impose any Expense, judgment, fine, penalty or limitation on Indemnitee without Indemnitee’s prior written

consent, such consent not to be unreasonably withheld. Indemnitee shall not settle any action, claim or Proceeding (in whole

or in part) which would impose

any Expense, judgment,

fine, penalty or limitation on the Company without the Company’s prior written consent, such consent not to be unreasonably withheld.

The Company shall not be liable to indemnify Indemnitee for any settlement of any Proceeding (or any part thereof) without the Company’s

prior written consent.

Article

Procedures For Notification of and Determination of Entitlement To Indemnification

Section 5.01. Notification;

Request For Indemnification. (a) As soon as reasonably practicable after receipt by Indemnitee of written notice that

he or she is a party to or a participant (as a witness or otherwise) in any Proceeding or of any other matter in respect of which Indemnitee

intends to seek indemnification or advancement of Expenses hereunder, Indemnitee shall provide to the Company written notice thereof,

including the nature of and the facts underlying the Proceeding. The omission by Indemnitee to so notify the Company will

not relieve the Company from any liability which it may have to Indemnitee hereunder or otherwise.

(b)

To obtain indemnification under this Agreement, Indemnitee shall deliver to the Company a written request for indemnification,

including therewith such information as is reasonably available to Indemnitee and reasonably necessary to determine Indemnitee’s

entitlement to indemnification hereunder. Such request(s) may be delivered from time to time and at such time(s) as Indemnitee

deems appropriate in his or her sole discretion. Indemnitee’s entitlement to indemnification shall be determined according

to Section 5.02 of this Agreement and applicable law.

Section 5.02. Determination

of Entitlement. (a) Where there has been a written request by Indemnitee for indemnification pursuant to ‎Section

5.01(b), then as soon as is reasonably practicable (but in any event not later than 60 days) after final disposition of the relevant

Proceeding, a determination, if required by applicable law, with respect to Indemnitee’s entitlement thereto shall be made in the

specific case: (i) if a Change of Control shall not have occurred, (A) by a majority vote of the Disinterested Directors, even though

less than a quorum of the Board, (B) by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors,

even though less than a quorum of the Board, (C) if there are no such Disinterested Directors or, if such Disinterested Directors so

direct, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee; or (ii) if a Change

of Control shall have occurred, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee. If

it is so determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within thirty

(30) days after such

determination. Indemnitee shall reasonably cooperate with the person, persons or entity making such determination with respect

to Indemnitee’s entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request

any documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably available to

Indemnitee and reasonably necessary to such determination. Any costs or expenses (including attorneys’ fees and disbursements)

actually and reasonably incurred by Indemnitee in so cooperating with the person, persons or entity making such determination shall be

borne by the Company (irrespective of the determination as to Indemnitee’s entitlement to indemnification).

(b)

If entitlement to indemnification is to be determined by Independent Counsel pursuant to ‎Section 5.02(a)(ii), such Independent

Counsel shall be selected by Indemnitee, and Indemnitee shall give written notice to the Company advising it of the identity of the Independent

Counsel so selected. If entitlement to indemnification is to be determined by Independent Counsel pursuant to ‎Section

5.02(a)(i)(C) (or if Indemnitee requests that such selection be made by the Board), such Independent Counsel shall be selected by the

Company in which case the Company shall give written notice to Indemnitee advising him or her of the identity of the Independent Counsel

so selected. In either event, Indemnitee or the Company, as the case may be, may, within 10 days after such written notice

of selection shall have been received, deliver to the Company or to Indemnitee, as the case may be, a written objection to such selection;

provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the

requirements of “Independent Counsel” as defined in Article 1 of this Agreement, and the objection shall set forth with particularity

the factual basis of such assertion. Absent a proper and timely objection, the person so selected shall act as Independent

Counsel. If such written objection is so made and substantiated, the Independent Counsel so selected may not serve as Independent

Counsel unless and until such objection is withdrawn or a court of competent jurisdiction has determined that such objection is without

merit. If, within 20 days after the later of submission by Indemnitee of a written request for indemnification pursuant to

‎Section 5.01(b) hereof and the final disposition of the Proceeding, no Independent Counsel shall have been selected and not objected

to, either the Company or Indemnitee may petition a court of competent jurisdiction for resolution of any objection which shall have

been made by the Company or Indemnitee to the other’s selection of Independent Counsel and/or for the appointment as Independent

Counsel of a person selected by the court or by such other person as the court shall designate, and the person with respect to whom all

objections are so resolved or the person so appointed shall act as Independent Counsel under ‎Section 5.02(a) hereof. Upon the due

commencement of any judicial proceeding or arbitration pursuant to ‎Section 6.01(a) of this Agreement, the Independent Counsel shall

be discharged and relieved of any further

responsibility in

such capacity (subject to the applicable standards of professional conduct then prevailing).

(c)

The Company agrees to pay the reasonable fees and expenses of any Independent Counsel serving under this Agreement.

Section 5.03. Presumptions

and Burdens of Proof; Effect of Certain Proceedings. (a) In making any determination with respect to entitlement to indemnification

hereunder, the person or persons or entity making such determination shall, to the fullest extent not prohibited by law, presume that

Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance

with ‎Section 5.01(b) of this Agreement, and the Company shall, to the fullest extent not prohibited by law, have the burden of proof

to overcome that presumption in connection with the making by any person, persons or entity of any determination contrary to that presumption. Neither

the failure of any person, persons or entity to have made a determination prior to the commencement of any action pursuant to this Agreement

that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination

by any person, persons or entity that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or

create a presumption that Indemnitee has not met the applicable standard of conduct.

(b)

If the person, persons or entity empowered or selected under ‎Section 5.02 of this Agreement to determine whether Indemnitee

is entitled to indemnification shall not have made a determination within the sixty (60) day period referred to in Section 5.02(a), the

requisite determination of entitlement to indemnification shall, to the fullest extent not prohibited by law, be deemed to have been

made and Indemnitee shall be entitled to such indemnification , absent (i) a misstatement by Indemnitee of a material fact, or an omission

of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for indemnification,

or (ii) a prohibition of such indemnification under applicable law; provided, however, that such 60-day period may be extended

for a reasonable time, not to exceed an additional thirty (30) days, if the person, persons or entity making the determination with respect

to entitlement to indemnification in good faith requires such additional time for the obtaining or evaluating of documentation and/or

information relating thereto.

(c)

The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon

a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely

affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which

he or she reasonably believed to be in or not opposed to

the best interests

of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that his or her conduct was

unlawful.

(d)

For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee’s

action is in good faith reliance on the records or books of account of any Enterprise, including financial statements, or on information

supplied to Indemnitee by the officers of such Enterprise in the course of their duties, or on the advice of legal counsel for such Enterprise

or on information or records given or reports made to such Enterprise by an independent certified public accountant or by an appraiser

or other expert selected by such Enterprise. The provisions of this ‎Section 5.03(d) shall not be deemed to be exclusive

or to limit in any way the other circumstances in which Indemnitee may be deemed or found to have met the applicable standard of conduct

set forth in this Agreement.

(e)

The knowledge and/or actions, or failure to act, of any other director, trustee, partner, managing member, fiduciary, officer,

agent or employee of any Enterprise shall not be imputed to Indemnitee for purposes of determining any right to indemnification under

this Agreement.

Article

Remedies of Indemnitee

Section 6.01. Adjudication

or Arbitration. (a) In the event of any dispute between Indemnitee and the Company hereunder as to entitlement to indemnification

or advancement of Expenses (including where (i) a determination is made pursuant to ‎Section 5.02 of this Agreement that Indemnitee

is not entitled to indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to ‎Section 4.01

of this Agreement, (iii) payment of indemnification pursuant to ‎Section 3.01 of this Agreement is not made within ten (10) days

after a determination has been made that Indemnitee is entitled to indemnification, (iv) no determination as to entitlement to indemnification

is timely made pursuant to Section 5.02 of this Agreement and no payment of indemnification is made within ten (10) days after entitlement

is deemed to have been determined pursuant to Section 5.03(b)) or (v) a contribution payment is not made in a timely manner pursuant

to Section 8.04 of this Agreement, then Indemnitee shall be entitled to an adjudication by a court of his or her entitlement to such

indemnification, contribution or advancement. Alternatively, in such case, Indemnitee, at his or her option, may seek an award in arbitration

to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association. Indemnitee

shall commence such proceeding seeking an adjudication within 180 days following the date on which Indemnitee first has the right to

commence such proceeding pursuant to this Section 6.01(a).

The Company shall

not oppose Indemnitee’s right to seek any such adjudication or award in arbitration.

(b)

In the event that a determination shall have been made pursuant to ‎Section 5.02(a) of this Agreement that Indemnitee is not

entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this ‎Section 6.01 shall be conducted in

all respects as a de novo trial, or arbitration, on the merits, and Indemnitee shall not be prejudiced by reason of that adverse

determination. In any judicial proceeding or arbitration commenced pursuant to this ‎Section 6.01 the Company shall have

the burden of proving Indemnitee is not entitled to indemnification or advancement of Expenses, as the case may be, and the Company may

not refer to or introduce into evidence any determination pursuant to ‎Section 5.02(a) of this Agreement adverse to Indemnitee for

any purpose. If Indemnitee commences a judicial proceeding or arbitration pursuant to this ‎Section 6.01, Indemnitee shall

not be required to reimburse the Company for any advances pursuant to ‎Section 4.02 until a final determination is made with respect

to Indemnitee’s entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed).

(c)

If a determination shall have been made pursuant to ‎Section 5.02(a) of this Agreement that Indemnitee is entitled to indemnification,

the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this ‎Section 6.01,

absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement

not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable

law.

(d)

The Company shall be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this ‎Section

6.01 that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court

or before any such arbitrator that the Company is bound by all the provisions of this Agreement.

(e)

The Company shall indemnify Indemnitee to the fullest extent permitted by law against all Expenses and, if requested by Indemnitee,

shall (within twenty (20) days after the Company’s receipt of such written request) advance such Expenses to Indemnitee, which

are reasonably incurred by Indemnitee in connection with any judicial proceeding or arbitration brought by Indemnitee for (i) indemnification

or advances of Expenses by the Company (or otherwise for the enforcement, interpretation or defense of his or her rights) under this

Agreement or any other agreement, including any other indemnification, contribution or advancement agreement, or any provision of the

Company’s Certificate of Incorporation or By-laws now or hereafter in effect or (ii) recovery or advances under any directors’

and officers’ liability insurance policy

maintained by the

Company, regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification, contribution, advancement

or insurance recovery, as the case may be.

(f)

Notwithstanding anything in this Agreement to the contrary, no determination as to entitlement to indemnification under this Agreement

shall be required to be made prior to the final disposition of the Proceeding, including any appeal therein.

Article

Directors’ and Officers’ Liability Insurance

Section 7.01. D&O

Liability Insurance. To the extent that the Company maintains a policy or policies of insurance providing liability insurance

for directors and officers of the Company in their capacities as such (and for any capacity in which any director or officer of the Company

serves any other Enterprise at the request of the Company), in respect of acts or omissions occurring while serving in such capacity,

Indemnitee shall be covered by such policy or policies, in accordance with its or their terms, to the maximum extent of the coverage

available for any other director or officer under such policy or policies.

Article

Miscellaneous

Section 8.01. Nonexclusivity

of Rights. The rights of indemnification, contribution and advancement of Expenses as provided by this Agreement shall

not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled to under applicable law, the Company’s

Certificate of Incorporation, the Company’s Bylaws, any agreement, a vote of stockholders or a resolution of directors, or otherwise. No

right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be

cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The

assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any

other right or remedy.

Section 8.02. Insurance

and Subrogation. (a) Indemnitee shall be covered by the Company’s D&O Liability Insurance in accordance with

its or their terms to the maximum extent of the coverage available for any director or officer under such policy or policies. If,

at the time the Company receives notice of a claim hereunder, the Company has director and officer liability insurance in

effect, the Company

shall give prompt notice of such Proceeding to the insurers in accordance with the procedures set forth in the respective policies. The

Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable

as a result of such Proceeding in accordance with the terms of such policies. The failure or refusal of any such insurer to

pay any such amount shall not affect or impair the obligations of the Company under this Agreement.

(b)

In the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the

rights of recovery of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including

execution of such documents as are necessary to enable the Company to bring suit to enforce such rights.

(c)

The Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable (or for which advancement

is provided) hereunder if and to the extent that Indemnitee has actually received such payment under any insurance policy or other indemnity

provision.

Section 8.03 Indemnification

from Other Sources. The Company’s obligation to indemnify or advance Expenses hereunder to Indemnitee who is or was serving

at the request of the Company as a director, officer, trustee, partner, managing member, fiduciary, board of directors’ committee

member, employee or agent of any other Enterprise shall be reduced by any amount Indemnitee has actually received as indemnification

or advancement of Expenses from such Enterprise.

Section 8.04. Contribution. To

the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to Indemnitee

for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee, whether

for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for Expenses, in connection with any claim

relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances

of such Proceeding in order to reflect (i) the relative benefits received by the Company and Indemnitee as a result of the event(s) and/or

transaction(s) giving rise to such Proceeding; and/or (ii) the relative fault of the Company (and its directors, officers, employees

and agents) and Indemnitee in connection with such event(s) and/or transaction(s).

Section 8.05. Amendment. This

Agreement may not be modified or amended except by a written instrument executed by or on behalf of each of the parties hereto. No

amendment, alteration or repeal of this Agreement or of any provision hereof shall limit, restrict or reduce any right of Indemnitee

under this Agreement in respect of any act or omission, or any event occurring, prior to such

amendment, alteration

or repeal. To the extent that a change in applicable law, whether by statute or judicial decision, (i) permits greater indemnification,

contribution or advancement of Expenses than would be afforded currently under the Company’s By-Laws and this Agreement, it is

the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change or (ii)

limits rights with respect to indemnification, contribution or advancement of Expenses, it is the intent of the parties hereto that the

rights with respect to indemnification, contribution or advancement of Expenses in effect prior to such change shall remain in full force

and effect to the extent permitted by applicable law.

Section 8.06. Waivers. The

observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively)

by the party entitled to enforce such term only by a writing signed by the party against which such waiver is to be asserted. Unless

otherwise expressly provided herein, no delay on the part of any party hereto in exercising any right, power or privilege hereunder shall

operate as a waiver thereof, nor shall any waiver on the part of any party hereto of any right, power or privilege hereunder operate

as a waiver of any other right, power or privilege hereunder nor shall any single or partial exercise of any right, power or privilege

hereunder preclude any other or further exercise thereof or the exercise of any other right, power or privilege hereunder.

Section 8.07. Entire

Agreement. This Agreement and the documents referred to herein constitute the entire agreement between the parties hereto

with respect to the matters covered hereby, and any other prior or contemporaneous oral or written understandings or agreements with

respect to the matters covered hereby are superseded by this Agreement, provided that this Agreement is a supplement to and in furtherance

of the Certificate of Incorporation and By-Laws of the Company and applicable law, and shall not be deemed a substitute therefor, nor

to diminish or abrogate any rights of Indemnitee thereunder.

Section 8.08. Severability. If

any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a)

the validity, legality and enforceability of the remaining provisions of this Agreement (including each portion of any Section of this

Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable)

shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted by law; (b) such provision

or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent

of the parties hereto; and (c) to the fullest extent possible, the provisions of this Agreement (including each portion of any Section

of this Agreement containing any such provision held to be invalid, illegal or

unenforceable, that

is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby.

Section 8.09. Notices. All

notices, requests, demands and other communications under this Agreement shall be in writing (which may be email or other electronic

transmission including PDFs). All such notices, requests and other communications shall be deemed received on the date of

receipt by the recipient thereof if received prior to 5:00 p.m. in the place of receipt and such day is a business day in the place of

receipt. Otherwise, any such notice, request or communication shall be deemed not to have been received until the next succeeding

business day in the place of receipt. The address for notice to a party is as shown on the signature page of this Agreement,

or such other address as any party shall have given by written notice to the other party as provided above.

Section 8.10. Binding

Effect. (a) The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations

imposed on it hereby in order to induce Indemnitee to serve as a director or officer of the Company, and the Company acknowledges that

Indemnitee is relying upon this Agreement in serving as a director or officer of the Company.

(b)

This Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective

successors, assigns, including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially

all of the business and/or assets of the Company, spouses, heirs, and executors, administrators, personal and legal representatives. The

Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all or

substantially all, or a substantial part of the business or assets of the Company, by written agreement in form and substance satisfactory

to Indemnitee, expressly to assume and agree to perform this Agreement in the manner and to the same extent that the Company would be

required to perform if no such succession had taken place.

(c)

The indemnification, contribution and advancement of Expenses provided by, or granted pursuant to this Agreement shall continue

as to a person who has ceased to be a director or officer and shall inure to the benefit of the heirs, executors, administrators, legatees

and assigns of such a person.

Section 8.11. Governing

Law. This Agreement and the legal relations among the parties shall be governed by, and construed and enforced in accordance

with, the laws of the State of Delaware, without regard to its conflict of laws rules.

Section 8.12. Consent

To Jurisdiction. Except with respect to any arbitration commenced by Indemnitee pursuant to ‎Section 6.01(a) of this

Agreement, the Company and Indemnitee hereby irrevocably and unconditionally

(i) agree that any

action or proceeding arising out of or in connection with this Agreement shall be brought only in the Delaware Court, and not in any

other state or federal court in the United States of America or any court in any other country, (ii) consent to submit to the exclusive

jurisdiction of the Delaware Court for purposes of any action or proceeding arising out of or in connection with this Agreement, (iii)

waive any objection to the laying of venue of any such action or proceeding in the Delaware Court, and (iv) waive, and agree not to plead

or to make, any claim that any such action or proceeding brought in the Delaware Court has been brought in an improper or inconvenient

forum.

Section 8.13. Headings. The

Article and Section headings in this Agreement are for convenience of reference only, and shall not be deemed to alter or affect the

meaning or interpretation of any provisions hereof.

Section 8.14. Counterparts. This

Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which

together shall constitute one and the same Agreement. Only one such counterpart signed by the party against whom enforceability

is sought needs to be produced to evidence the existence of this Agreement. The words “execution,” “signed,”

“signature,” “delivery,” and words of like import in or relating to this Agreement or any document to be signed

in connection with this Agreement shall be deemed to include electronic signatures, deliveries or the keeping of records in electronic

form.

Section 8.15. Use

of Certain Terms. As used in this Agreement, the words “herein,” “hereof,” and “hereunder”

and other words of similar import refer to this Agreement as a whole and not to any particular paragraph, subparagraph, section, subsection,

or other subdivision. Whenever the context may require, any pronoun used in this Agreement shall include the corresponding masculine,

feminine or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural and vice versa.

IN WITNESS WHEREOF,

this Agreement has been duly executed and delivered to be effective as of the date first above written.

INTEGER HOLDINGS CORPORATION

By:

Name:

Title:

Address:

E-Mail:

Attention:

With a copy to:

Address:

E-Mail:

Attention:

INDEMNITEE

Address:

E-Mail:

With a copy to:

Address:

E-Mail:

Attention:

EX-3.1 — EXHIBIT 3.1

EX-3.1

Filename: dp251220_ex0301.htm · Sequence: 4

Exhibit 3.1

BY-LAWS

INTEGER HOLDINGS CORPORATION

(A DELAWARE CORPORATION)

(Amended and

Restated as of August 2, 2026)

ARTICLE

Stockholders

Section 1.01.

Annual Meetings. (a) The annual meeting of the holders of such classes or series of capital stock as are entitled to notice

thereof and to vote thereat pursuant to the provisions of the restated certificate of incorporation (the “Certificate of Incorporation”)

of Integer Holdings Corporation (the “Corporation”) for the election of directors and for the transaction of such

other business as may properly be brought before the meeting shall be held on such date as may be designated by resolution of the Board

of Directors or, in the event that no such date is so designated, on the fourth Thursday in May of each year, at such hour (within ordinary

business hours) as shall be stated in the notice of the meeting. If the day so designated shall be a legal holiday, then such meeting

shall be held on the next succeeding business day. Each annual meeting of stockholders shall be held at such place, within or without

the State of Delaware, as shall be determined by the Board of Directors.

(b)

An annual meeting of stockholders may be adjourned by the presiding officer of the meeting for any reason (including, if the presiding

officer determines that it would be in the best interests of the Corporation, to extend the period of time for the solicitation of proxies)

from time to time and place to place until such presiding officer shall determine that the business to be conducted at the meeting is

completed, which determination shall be conclusive.

(c)

The only business that shall be conducted at an annual meeting of stockholders shall be that which shall have been properly brought

before the annual meeting. To be properly brought before an annual meeting, business must be (i) specified in the notice of meeting (or

any supplements or addenda thereto) given by or at the direction of the Board of Directors, (ii) brought before the annual meeting by

or at the direction of the Board of Directors, or (iii) brought before the annual meeting by a stockholder that (A) is a stockholder

of record at the time of giving of notice provided for in this ‎Section 1.01 of these By-laws and at the time of the annual

meeting, (B) is entitled to vote at the annual meeting, (C) proposes the business be conducted at the annual meeting pursuant to timely

notice in proper written form to the Secretary of the Corporation, and (D) otherwise complies with the procedures set forth in this ‎Section

1.01 of these By-laws.

(d)

To be timely, a stockholder’s notice must be delivered to, or mailed and received by, the Secretary at the principal executive

offices of the Corporation not less than 90 calendar days nor more than 120 calendar days prior to the anniversary date of the previous

year’s annual meeting of stockholders (or if there was no such prior annual

meeting, not less

than 90 calendar days nor more than 120 calendar days prior to the date that represents the fourth Thursday in May of the current year);

PROVIDED, HOWEVER, that in the event that the date of the annual meeting is advanced by more than 20 calendar days, or delayed by more

than 60 calendar days, from such anniversary date, then, to be considered timely, notice by the stockholder must be received not later

than the close of business on the later of (x) the 90th calendar day prior to the annual meeting or (y) the seventh calendar day following

the date on which notice of the date of the annual meeting was mailed to stockholders or public disclosure thereof was otherwise made.

In no event shall any postponement or adjournment of an annual meeting commence a new time period for the giving of a stockholder’s

notice as described above.

(e)

To be in proper written form, a stockholder’s notice to the Secretary shall set forth as to each matter the stockholder

proposes to bring before the annual meeting: (i) a description in reasonable detail of the business desired to be brought before

the annual meeting and the reasons for transacting such business at the annual meeting; (ii) the text of the proposal or business

(including the text of any resolution for consideration and in the event that such business includes a proposal to amend these Bylaws,

the language of the proposed amendment); (iii) the name and address, as they appear on the Corporation’s most recent stockholder

lists, of the stockholder proposing such proposal and any Stockholder Related Person (as defined below); (iv) a representation that the

stockholder giving the notice is a holder of record of stock of the Corporation entitled to vote at such annual meeting and intends (A)

to be a holder of record of stock of the Corporation at the time of the annual meeting and (B) to appear in person or by proxy at the

annual meeting to propose the business specified in the notice; (v) the class and number of shares of any securities of the Corporation

that are beneficially owned or held of record by the stockholder giving the notice or any Stockholder Related Person; (vi) a description

of (A) any derivative positions in any securities of the Corporation directly or indirectly held or beneficially owned by the stockholder

or any Stockholder Related Person and (B) any hedging or other transaction or series of transactions, agreement, arrangement or understanding

with respect to any of the Corporation’s securities entered into or made by such stockholder or any Stockholder Related Person;

(vii) a description of all contracts, arrangements, relationships or understandings between or among such stockholder, any Stockholder

Related Person and any other person(s) (including their names) in connection with the proposal of such business, and any material interest

of the stockholder or any Stockholder Related Person in such business; (viii) any other information relating to the stockholder that

would be required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies

for the proposal pursuant to Section 14 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (whether

or not such stockholder intends to deliver a proxy statement or conduct its own proxy solicitation); and (ix) a statement as to whether

either such stockholder, beneficial owner or Stockholder Related Person intends to deliver a proxy statement and form of proxy to the

holders of at least the percentage of shares of the Corporation entitled to vote that is required to approve such proposal. Notwithstanding

the foregoing, in order to include information relating to a stockholder proposal in the Corporation’s proxy statement and form

of proxy for an annual meeting of stockholders, a stockholder must provide notice as required by, and otherwise comply with, all of the

content, procedural and other

requirements of Rule

14a-8 of Regulation 14A under the Exchange Act, irrespective of whether the Corporation is then subject to such Rule or the Exchange

Act. In addition, if the stockholder’s ownership of shares of the Corporation, as set forth in the notice, is solely beneficial

(and not of record) documentary evidence satisfactory to the Corporation of such ownership must accompany the notice in order for such

notice to be considered validly and timely received. A “Stockholder Related Person” of any stockholder means (1) any person

controlling, directly or indirectly, or acting in concert with, such stockholder, (2) any beneficial owner of shares of stock of the

Corporation owned of record or beneficially by such stockholder, and (3) any person controlling, controlled by or under common control

with, such Stockholder Related Person.

(f)

A stockholder of record providing notice of business proposed to be brought before an annual meeting shall further update and

supplement such notice, if necessary, so that the information provided or required to be provided in such notice pursuant to ‎Section

1.01 of these By-laws shall be true and correct as of the record date for the annual meeting and as of the date that is 10 business days

prior to the annual meeting or any adjournment or postponement thereof, and such update and supplement shall be delivered to, or mailed

and received by, the Secretary at the principal executive offices of the Corporation not later than five (5) business days after the

record date for the meeting (in the case of the update and supplement required to be made as of the record date), and not later than

five (5) business days prior to the date for the annual meeting, if practicable (or, if not practicable, on the first practicable date

prior to) any adjournment or postponement thereof (in the case of the update and supplement required to be made as of 10 business days

prior to the meeting or any adjournment or postponement thereof).

(g)

The presiding officer at an annual meeting shall, if the facts warrant, determine and declare to the meeting that any business

which was not properly brought before the meeting is out of order and shall not be transacted at the meeting.

Section 1.02.

Special Meetings. Special meetings of stockholders for the transaction of such business as may properly come before the

meeting may be called by order of the Board of Directors, the Chairman of the Board, or the Chief Executive Officer of the Corporation,

and shall be held at such place, date and time, within or without the State of Delaware, as may be specified by such order. Whenever

the directors shall fail to fix the place of a special meeting, the meeting shall be held at the principal executive office of the Corporation.

To be properly brought before a special meeting, business must be (i) specified in the notice of the meeting (or any supplements or addenda

thereto) given in accordance with Article ‎1, ‎Section 1.03 of these By-laws or (ii) otherwise properly brought

before the meeting by the presiding officer or by or at the direction of a majority of the Board of Directors. The presiding officer

at a special meeting shall, if the facts warrant, determine and declare to the meeting that any business that was not properly brought

before the meeting is out of order and shall not be transacted at the meeting. A special meeting of stockholders may be adjourned by

the presiding officer of the meeting for any reason (including, if the presiding officer determines that it would be in the best interests

of the Corporation, to extend the period of time for the solicitation of proxies) from time to time and place to place until such

presiding officer

shall determine that the business to be conducted at the meeting is completed, which determination shall be conclusive.

Section 1.03.

Notice of Meetings. Written notice of all meetings of the stockholders, stating the place, date and hour of the meeting

and the place within the city or other municipality or community at which the list of stockholders may be examined, shall be mailed or

delivered to each stockholder not less than 10 nor more than 60 days prior to the meeting. Notice of any special meeting shall state

with reasonable specificity the purpose or purposes for which the meeting is to be held and the business proposed to be transacted thereat.

When a meeting is adjourned to another time or place, notice need not be given of the adjourned meeting if the time and place thereof

are announced at the meeting at which the adjournment is taken; provided, however, that if the date of any adjourned meeting is more

than 30 days after the date for which the meeting was originally noticed, or if a new record date is fixed for the adjourned meeting,

notice of the place, if any, date, and time of the adjourned meeting shall be given in conformity herewith.

Section 1.04.

Stockholder Lists. The officer who has charge of the stock ledger of the Corporation shall prepare and make, at least 10

days before every meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting, arranged in alphabetical

order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder. Such list shall

be open to the examination of any stockholder, for any purpose germane to the meeting, for a period of at least 10 calendar days prior

to the meeting, (i) on a reasonably accessible electronic network, provided that the information received to gain access to such list

is provided with the notice of the meeting or (ii) during ordinary business hours either at a place within the city where the meeting

is to be held, which place shall be specified in the notice of the meeting, or, if not so specified, at the place where the meeting is

to be held. The list shall also be produced and kept at the time and place of the meeting during the whole time thereof, and may be inspected

by any stockholder who is present in person thereat.

Section 1.05.

Quorum. Except as otherwise provided by law or the Corporation’s Certificate of Incorporation, a quorum for the transaction

of business at any meeting of stockholders shall consist of the holders of record of a majority of the issued and outstanding shares

of the capital stock of the Corporation entitled to vote at the meeting, present in person or by proxy. If there be no such quorum, the

holders of a majority of such shares so present or represented may adjourn the meeting from time to time, without further notice, until

a quorum shall have been obtained. At such adjourned meeting at which a quorum shall be present or represented, any business may be transacted

that might have been transacted at the meeting as originally notified. If the adjournment is for more than 30 days, or if after the adjournment

a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record

entitled to vote at the meeting. When a quorum is once present it is not broken by the subsequent withdrawal from the meeting of any

stockholder.

Section 1.06.

Organization.

(a)

Meetings of stockholders shall be presided over by the Chairman, if any, or if none or in the Chairman’s absence the Vice-Chairman,

if any, or if none or in the Vice-Chairman’s absence the President, if any, or if none or in the President’s absence a Vice-President,

or, if none of the foregoing is present, by a chairman to be chosen by the stockholders entitled to vote who are present in person or

by proxy at the meeting. The Secretary of the Corporation, or in the Secretary’s absence an Assistant Secretary, shall act as secretary

of every meeting, but if neither the Secretary nor an Assistant Secretary is present, the presiding officer of the meeting shall appoint

any person present to act as secretary of the meeting.

(b)

The order of business and all other matters of procedure at every meeting of the stockholders may be determined by the presiding

officer of the meeting. The presiding officer shall have all the powers and authority vested in a presiding officer by law or practice

without restriction, including, without limitation, the authority, in order to conduct an orderly meeting, to announce the date and time

of the opening and closing of the polls, to impose reasonable limits on the amount of time at the meeting taken up in remarks by any

one stockholder and to declare any business not properly brought before the meeting to be out of order. The Board of Directors may adopt

by resolution such rules and regulations for the conduct of the meeting of stockholders as it shall deem appropriate. Such rules, regulations

or procedures, whether adopted by the Board of Directors or prescribed by the presiding officer of the meeting, may include, without

limitation, the following: (i) the establishment of an agenda or order of business for the meeting; (ii) rules and procedures for maintaining

order at the meeting and the safety of those present; (iii) limitations on attendance at or participation in the meeting to stockholders

entitled to vote at the meeting, their duly authorized and constituted proxies or such other persons as the presiding person of the meeting

shall determine; (iv) restrictions on entry to the meeting after the time fixed for the commencement thereof; and (v) limitations on

the time allotted to questions or comments by participants. The presiding officer at any meeting of stockholders, in addition to making

any other determinations that may be appropriate to the conduct of the meeting, shall, if the facts warrant, determine and declare to

the meeting that a matter or business was not properly brought before the meeting and if such presiding officer should so determine,

such presiding person shall so declare to the meeting and any such matter or business not properly brought before the meeting shall not

be transacted or considered. Unless and to the extent determined by the Board of Directors or the presiding officer, meetings of stockholders

shall not be required to be held in accordance with the rules of parliamentary procedure.

Section 1.07.

Voting; Proxies; Required Vote. (a) Each stockholder of record shall be entitled at every meeting of stockholders to one

vote for each share having voting power standing in his or her name on the record of stockholders of the Corporation on the record date

fixed pursuant to ‎Section 6.03(a) of Article ‎6 of these By-laws. No stockholder shall be entitled to exercise

any right of cumulative voting.

(b)

Each stockholder entitled to vote at a meeting of stockholders may vote in person, or may authorize another person or persons

to act for him or her by proxy. Any proxy may be signed by such stockholder or his or her duly authorized attorney-in-fact, including

by facsimile signature, and shall be delivered to the secretary of the meeting, or may be authorized by electronic transmission provided

that it can be reasonably determined from such electronic transmission that such proxy was authorized by the stockholder. The signature

of a stockholder on any proxy, including without limitation an electronic transmission, may be printed, stamped or written, or provided

by other reliable reproduction, provided such signature is executed or adopted by the stockholder with intention to authenticate the

proxy. No proxy shall be valid after the expiration of 11 months from the date of its execution unless otherwise provided in the proxy.

Every proxy shall be revocable at the pleasure of the stockholder executing it, except as otherwise provided by law or pursuant to these

By-laws in respect of each matter properly presented to the meeting.

(c)

At all elections of directors, the voting may, but need not be by, ballot and a plurality of the votes cast there shall elect

directors. Except as otherwise required by law, the Certificate of Incorporation or the rules and regulations of any stock exchange on

which the capital stock of the Corporation is quoted or traded, in which case such express provision shall govern and control the decision

of the matter, any other action shall be authorized by a majority of the votes cast. In the case of a matter submitted for a vote of

the stockholders as to which a stockholder approval requirement is applicable under the stockholder approval policy of the stock exchange

or quotation system on which the capital stock of the Corporation is quoted or traded, the requirements of Rule 16b-3 under the Exchange

Act or any provision of the Internal Revenue Code, in each case for which no higher voting requirement is specified by law, the Certificate

of Incorporation or these By-laws, the vote required for approval shall be the requisite vote specified in such stockholder approval

policy, Rule 16b-3 or Internal Revenue Code provision, as the case may be (or the highest such requirement if more than one is applicable).

Broker non-votes and abstentions will be considered for purposes of establishing a quorum with respect to a particular proposal but will

not be considered as votes cast for, against or withheld with respect to any proposal or director nominee.

Section 1.08.

Inspectors. The Board of Directors shall, in advance of any meeting, appoint one or more inspectors of election to act

at the meeting or any adjournment thereof and make a written report thereof. If an inspector or inspectors are not so appointed, the

person presiding at the meeting shall appoint one or more inspectors. In case any person who may be appointed as an inspector fails to

appear or act, the vacancy may be filled by appointment made by the directors in advance of the meeting or at the meeting by the person

presiding thereat. Each inspector, before entering upon the discharge of his or her duties, shall take and sign an oath faithfully to

execute the duties of inspector at such meeting with strict impartiality and according to the best of his ability. The inspectors shall

(i) ascertain the number of shares outstanding and the voting power of each, (ii) determine the shares represented at a meeting, the

existence of a quorum and the validity of proxies and ballots, (iii) count all votes and ballots, (iv) determine and retain for a reasonable

period a record of the disposition of any challenges made to any determination by the inspectors and (v) certify their determination

of the

number of shares represented

at the meeting, and their count of all votes and ballots. The inspectors may appoint or retain other persons or entities to assist the

inspectors in the performance of the duties of the inspectors.

Section 1.09.

Action by Written Consent. Any action which is required to be or may be taken at any annual or special meeting of stockholders

of the Corporation may be taken without a meeting, without prior notice to stockholders and without a vote if consents in writing, setting

forth the action so taken, shall have been signed by the holders of outstanding stock having not less than the minimum number of votes

that would be necessary to authorize or to take such action at a meeting at which all shares entitled to vote thereto were present and

voted.

(a)

In order that the Corporation’s stockholders shall have an opportunity to receive and consider the information germane to

an informed judgment as to whether to give a written consent and in accordance with the procedures contained in the New York Stock Exchange

policies and rules, any corporate action to be taken by written consent shall not be effective until, and the stockholders of the Corporation

shall be able to give or revoke written consents for, at least twenty (20) days from the date of the commencement of a solicitation (as

such term is defined in Rule 14a-1(k) promulgated under the Exchange Act) of consents, other than corporate action by written consent

taken pursuant to solicitations of not more than ten (10) persons. For purposes of this ‎Section 1.09, a consent solicitation

shall be deemed to have commenced when a proxy statement or information statement containing the information required by law is first

furnished to the Corporation’s stockholders.

(b)

Consents to corporate action shall be valid for a maximum of sixty (60) days after the date of the earliest dated consent delivered

to the Corporation in the manner provided in Section 228(c) of the General Corporation Law of the State of Delaware (the “DGCL”).

Consents may be revoked by written notice (i) to the Corporation, (ii) to the stockholder or stockholders soliciting consents or soliciting

revocations in opposition to action by consent proposed by the Corporation (the “Soliciting Stockholders”), or (iii)

to a proxy solicitor other agent designated by the Corporation or the Soliciting Stockholders.

(c)

Notwithstanding the foregoing, if independent counsel to the Corporation delivers to the Corporation a written opinion stating,

or a court of competent jurisdiction determines, that this ‎Section 1.09, or any portion thereof, is illegal with respect

to any corporate action to be taken by written consent for which a consent has theretofore been delivered to the Corporation, in the

manner provided in Section 228(c) of the DGCL, whether prior or subsequent to the date of the adoption of this ‎Section 1.09,

then this ‎Section 1.09, or such portion thereof, as the case may be, shall after the date of such delivery of such opinion

or such determination be null and void and of no effect with respect to any other corporate action to be taken by written consent.

(d)

Within three (3) business days after receipt of the earliest dated consent delivered to the Corporation in the manner provided

in Section 228(c) of the DGCL or the determination by the Board of Directors of the Corporation that the Corporation

should seek corporate

action by written consent, as the case may be, the Secretary shall engage independent inspectors of elections for the purpose of performing

a ministerial review of the validity of the consents and revocations. The cost of retaining inspectors of election shall be borne by

the Corporation.

(e)

Consents and revocations shall be delivered to the inspectors upon receipt by the Corporation, the Soliciting Stockholders or

their proxy solicitors or other designated agents. As soon as consents and revocations are received, the inspectors shall review the

consents and revocations and shall maintain a count of the number of valid and unrevoked consents. The inspectors shall keep such count

confidential and shall not reveal the count to the Corporation, the Soliciting Stockholder or their representatives or any other entity.

As soon as practicable after the earlier of (i) sixty (60) days after the date of the earliest dated consent delivered to the Corporation

in the manner provided in Section 228(c) of the DGCL or (ii) a written request therefor by the Corporation or the Soliciting Stockholders

(whichever is soliciting consents) (which request may be made no earlier than twenty (20) days after the commencement of the applicable

solicitation of consents, except in the case of corporate action by written consent taken pursuant to solicitations of not more than

ten (10) persons), notice of which request shall be given to the party opposing the solicitation of consents, if any, which request shall

state that the Corporation or Soliciting Stockholders, as the case may be, have a good faith belief that the requisite number of valid

and unrevoked consents to authorize or take the action specified in the consents has been received in accordance with these By-laws,

the inspectors shall issue a preliminary report to the Corporation and the Soliciting Stockholders stating: (i) the number of valid consents;

(ii) the number of valid revocations; (iii) the number of valid and unrevoked consents; (iv) the number of invalid consents; (v) the

number of invalid revocations; (vi) whether, based on their preliminary count, the requisite number of valid and unrevoked consents has

been obtained to authorize or take the action specified in the consents.

(f)

Unless the Corporation and the Soliciting Stockholders shall agree to a shorter or longer period, the Corporation and the Soliciting

Stockholders shall have 48 hours to review the consents and revocations and to advise the inspectors and the opposing party in writing

as to whether they intend to challenge the preliminary report of the inspectors. If no written notice of an intention to challenge the

preliminary report is received within 48 hours after the inspectors’ issuance of the preliminary report, the inspectors shall issue

to the Corporation and the Soliciting Stockholders their final report containing the information from the inspectors’ determination

with respect to whether the requisite number of valid and unrevoked consents was obtained to authorize and take the action specified

in the consents. If the Corporation or the Soliciting Stockholders issue written notice of an intention to challenge the inspectors’

preliminary report within 48 hours after the issuance of that report, a challenge session shall be scheduled by the inspectors as promptly

as practicable. A transcript of the challenge session shall be recorded by a certified court reporter. Following completion of the challenge

session, the inspectors shall as promptly as practicable issue their final report to the Soliciting Stockholders and the Corporation,

which report shall contain the information included in the preliminary report, plus all changes in the vote totals as a result of the

challenge and a certification of whether the requisite number of valid and unrevoked consents was

obtained to authorize

or take the action specified in the consents. A copy of the final report of the inspectors shall be included in the book in which the

proceedings of meetings of stockholders are recorded.

(g)

The Corporation shall give prompt notice to the stockholders of the results of any consent solicitation or the taking of any corporate

action without a meeting and by less than unanimous written consent.

ARTICLE

Board of Directors

Section 2.01.

General Powers. The business, property and affairs of the Corporation shall be managed by, or under the direction of, the

Board of Directors.

Section 2.02.

Qualification; Number; Term; Remuneration; Chairman. (a) Each director shall be at least 18 years of age. A director need

not be a stockholder, a citizen of the United States, or a resident of the State of Delaware. The number of directors constituting the

entire Board shall be no fewer than one (1) and no more than twelve (12), or such other number as may be fixed from time to time by action

of the Board of Directors. The use of the phrase “entire Board” herein refers to the total number of directors which the

Corporation would have if there were no vacancies.

(b)

Directors who are elected at an annual meeting of stockholders, and directors who are elected in the interim to fill vacancies

and newly created directorships, shall hold office until the next annual meeting of stockholders and until their successors are elected

and qualified or until their earlier death, resignation or removal.

(c)

Directors may be paid their expenses, if any, of attendance at each meeting of the Board of Directors and may be paid a fixed

sum for attendance at each meeting of the Board of Directors or a stated salary as director. No such payment shall preclude any director

from serving the Corporation in any other capacity and receiving compensation therefor. Members of special or standing committees may

be allowed like compensation for attending committee meetings.

(d)

The Board of Directors shall annually, at the first meeting of the Board after the annual meeting of stockholders, select from

among its members a Chairman of the Board who shall have such authority and perform such duties as the Board of Directors may from time

to time prescribe. The Chairman of the Board shall, unless otherwise determined by the Board of Directors, hold office until the first

meeting of the Board following the next annual meeting of stockholders and until his or her successor has been elected or appointed and

qualified. The Chairman of the Board of Directors shall preside at all meetings of the stockholders and at all meetings of the Board

of Directors and shall see that all orders and resolutions of the Board of Directors are carried into effect. The Chairman of the Board

of Directors, as such, shall not be an officer of the Corporation.

Section 2.03.

Nomination of Directors. (a) Nominations for the election of directors may be made by the Board of Directors or a committee

appointed by the Board

of Directors or, to

the extent permitted by this ‎Section 2.03 of these By-laws, by a stockholder that (i) is a stockholder of record at the time

of giving of notice provided for in this ‎Section 2.03 of these By-laws and at the time of the meeting at which directors

will be elected, (ii) is entitled to vote at such meeting, (iii) makes the nomination pursuant to timely notice in proper written form

to the Secretary, and (iv) otherwise complies with the procedures set forth in this ‎Section 2.03 of these By-laws.

(b)

To be timely, a stockholder’s notice of intent to make a nomination or nominations must be delivered to, or mailed and received

by, the Secretary at the principal executive offices of the Corporation not later than (i) with respect to an election to be held at

an annual meeting of stockholders, not less than 90 calendar days nor more than 120 calendar days prior to the anniversary date of the

date of the previous year’s annual meeting (or if there was no such prior annual meeting, not less than 90 calendar days nor more

than 120 calendar days prior to the date which represents the fourth Thursday in May of the current year), PROVIDED, HOWEVER, that in

the event that the date of the annual meeting is advanced by more than 20 calendar days, or delayed by more than 60 calendar days, from

such anniversary date, then, to be considered timely, notice by the stockholder must be received not later than the close of business

on the later of (x) the 90th calendar day prior to the annual meeting or (y) the seventh calendar day following the date on which notice

of the date of the annual meeting was mailed to stockholders or public disclosure thereof was otherwise made, and (ii) with respect to

an election to be held at a special meeting of stockholders for the election of directors, the close of business on the fifth calendar

day following the date on which notice of such meeting is first delivered to stockholders. In no event shall any postponement or adjournment

of a meeting commence a new time period for the giving of a stockholder’s notice as described above.

(c)

To be in proper written form, a stockholder’s notice to the Secretary shall set forth: (i) the name and address, as they

appear on the Corporation’s most recent stockholder lists, of the stockholder who intends to make the nomination, any Stockholder

Related Person and of the person or persons to be nominated, and of the beneficial owner(s), if any, on whose behalf the nomination is

made; (ii) a representation that the stockholder giving the notice is a holder of record of capital stock of the Corporation entitled

to vote at such meeting and intends (A) (1) to be a holder of record of stock of the Corporation at the time of the meeting and (2) to

appear in person or by proxy at the meeting to nominate the person or persons specified in the notice; (iii) the class and number of

shares of any securities of the Corporation that are beneficially owned or held of record by the stockholder giving the notice, any Stockholder

Related Person, any person to be nominated and any beneficial owner(s), if any, on whose behalf the nomination is made; (iv) a description

of (A) any derivative positions in any securities of the Corporation directly or indirectly held or beneficially owned by the stockholder,

any Stockholder Related Person or any person to be nominated and (B) any hedging or other transaction or series of transactions, agreement,

arrangement or understanding with respect to any of the Corporation’s securities entered into or made by such stockholder, any

Stockholder Related Person or any person to be nominated; (v) a description of all contracts, arrangements, relationships or understandings

between or among the stockholder giving the notice, any Stockholder Related Person, any person to be

nominated, any beneficial

owner(s), if any, on whose behalf the nomination is made, or any other person or persons (naming such person or persons) pursuant to

which the nomination or nominations are to be made by the stockholder; (vi) whether either such stockholder or Stockholder Related Person

intends to deliver a proxy statement and form of proxy to the holders of at least the percentage of shares of the Corporation entitled

to vote that is required to elect such person(s) to be nominated; (vii) such other information regarding each person to be nominated

as would be required to be included in a proxy or information statement filed pursuant to the Exchange Act and the rules and regulations

promulgated thereunder (or any subsequent provisions replacing such Exchange Act, rules or regulations); (viii) any other information

relating to the stockholder giving the notice that would be required to be disclosed in a proxy statement or other filings required to

be made in connection with solicitations of proxies for the proposal pursuant to Section 14 of the Exchange Act (whether or not such

stockholder intends to deliver a proxy statement or conduct its own proxy solicitation); (ix) a description of all direct and indirect

compensation and other material monetary agreements, arrangements and understandings during the past three years, and any other material

relationships, between or among the stockholder giving the notice, any Stockholder Related Person, any beneficial owner(s), if any, on

whose behalf the nomination is made, or any other person or persons (naming such person or persons) pursuant to which the nomination

or nominations are to be made by the stockholder, on the one hand, and each proposed nominee, and his or her respective affiliates and

associates, or others acting in concert therewith, on the other hand, including, without limitation, all information that would be required

to be disclosed pursuant to Item 404 of Regulation S-K if the stockholder giving the notice, any Stockholder Related Person, any beneficial

owner(s), if any, on whose behalf the nomination is made, or any other person or persons (naming such person or persons) pursuant to

which the nomination or nominations are to be made by the stockholder were the “registrant” for purposes of such rule and

the nominee were a director or executive officer of such registrant; (x) the consent of each person to be nominated to be named as a

nominee and to serve as a director of the Corporation if elected; and (xi) a nominee questionnaire, representation and agreement in the

form provided by the Secretary upon request. The Corporation may also require any proposed nominee to furnish such other information

as it may reasonably require (i) to determine the eligibility of such proposed nominee to serve as a director of the Corporation, including

with respect to qualifications established by any committee of the Board of Directors; (ii) to determine whether such nominee qualifies

as an “independent director” or “audit committee financial expert” under applicable law, securities exchange

rule or regulation, or any publicly-disclosed corporate governance guideline or committee charter of the Corporation; and (iii) that

could be material to a reasonable stockholder’s understanding of the independence and qualifications, or lack thereof, of such

nominee.

(d)

A stockholder of record providing notice of a nomination of director shall further update and supplement such notice, if necessary,

so that the information provided or required to be provided in such notice pursuant to this ‎Section 2.03 of these By-laws

shall be true and correct as of the record date for the annual meeting and as of the date that is 10 business days prior to the annual

meeting or any adjournment or postponement thereof, and such update and supplement shall be delivered to, or mailed and received by,

the Secretary at the principal executive offices of the Corporation not later than five (5)

business days after

the record date for the meeting (in the case of the update and supplement required to be made as of the record date), and not later than

five (5) business days prior to the date for the annual meeting, if practicable (or, if not practicable, on the first practicable date

prior to) any adjournment or postponement thereof (in the case of the update and supplement required to be made as of 10 business days

prior to the meeting or any adjournment or postponement thereof).

(e)

The presiding officer of a meeting of stockholders shall, if the facts warrant, refuse to acknowledge the nomination of any person

not made in compliance with the provisions of this ‎Section 2.03 of these By-laws.

Section 2.04.

Quorum and Manner Of Voting. Except as otherwise provided by law, a majority of the entire Board shall constitute a quorum.

A majority of the directors present, whether or not a quorum is present, may adjourn a meeting from time to time to another time and

place without notice. The vote of the majority of the directors present at a meeting at which a quorum is present shall be the act of

the Board of Directors.

Section 2.05.

Places of Meetings. Meetings of the Board of Directors may be held at any place within or without the State of Delaware,

as may from time to time be fixed by resolution of the Board of Directors, or as may be specified in the notice of meeting.

Section 2.06.

Annual Meeting. Following the annual meeting of stockholders, the newly elected Board of Directors shall meet for the purpose

of the election of officers and the transaction of such other business as may properly come before the meeting. Such meeting may be held

without notice immediately after the annual meeting of stockholders at the same place at which such stockholders’ meeting is held.

Section 2.07.

Regular Meetings. Regular meetings of the Board of Directors shall be held at such times and places as the Board of Directors

shall from time to time by resolution determine. Notice need not be given of regular meetings of the Board of Directors held at times

and places fixed by resolution of the Board of Directors.

Section 2.08.

Special Meetings. Special meetings of the Board of Directors shall be held whenever called by the Chairman of the Board,

President or by a majority of the directors then in office.

Section 2.09.

Notice of Meetings. A notice of the place, date and time and the purpose or purposes of each meeting of the Board of Directors

shall be given to each director by mailing the same at least two days before the special meeting, or by telegraphing, telephoning or

sending by other means of electronic transmission the same or by delivering the same personally not later than the day before the day

of the meeting.

Section 2.10.

Organization. At all meetings of the Board of Directors, the Chairman, if any, or if none or in the Chairman’s absence

or inability to act the President, if such President is a member of the Board of Directors, or in the President’s absence or inability

to act, any Vice-President who is a member of the Board of Directors, or in such Vice-President’s absence or inability to act a

chairman chosen by the directors, shall

preside. The Secretary

of the Corporation shall act as secretary at all meetings of the Board of Directors when present, and, in the Secretary’s absence,

the presiding officer may appoint any person to act as secretary.

Section 2.11.

Resignation and Removal. Any director may resign at any time by giving notice in writing or by electronic transmission

to the Corporation and such resignation shall take effect upon receipt thereof by the President or Secretary, unless otherwise specified

in the resignation. Subject to the rights of the holders of any series of Preferred Stock or any other class of capital stock of the

Corporation (other than the Common Stock) then outstanding, any director may be removed, with or without cause, by the holders of a majority

of the shares of stock outstanding and entitled to vote for the election of directors.

Section 2.12.

Vacancies. Unless otherwise provided in these By-laws, vacancies on the Board of Directors, whether caused by resignation,

death, disqualification, removal, an increase in the authorized number of directors or otherwise, may be filled only by the affirmative

vote of a majority of the remaining directors, although less than a quorum, or by a sole remaining director, and any directors so chosen

shall hold office until their successors are elected and qualified.

Section 2.13.

Participation in Meetings by Conference Phone. Members of the Board of Directors, or of any committee thereof, may participate

in a meeting of such Board of Directors or committee by means of conference telephone or other communications equipment by means of which

all persons participating in the meeting can speak and hear each other and such participation shall constitute presence in person at

such meeting.

Section 2.14.

Action by Written Consent. Any action required or permitted to be taken at any meeting of the Board of Directors may be

taken without a meeting if all the directors consent thereto in writing or by electronic transmission (as that term is defined in Section

232 of the DGCL), and the writing or writings or electronic transmissions are filed with the minutes of proceedings of the Board of Directors.

ARTICLE

Indemnification

Section 3.01.

Indemnification. The Corporation shall indemnify, to the fullest extent permitted by Section 145 of the DGCL, as amended

from time to time, any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action,

suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the Corporation),

by reason of the fact that the person is or was a director, officer, employee or agent of the Corporation, or is or was serving at the

request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other

enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably

incurred by the person in connection with such action, suit or proceeding if the person acted in good faith and in a manner the person

reasonably

believed to be in

or not opposed to the best interests of the Corporation, and, with respect to any criminal action or proceeding, had no reasonable cause

to believe his or her conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction,

or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith

and in a manner which the person reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect

to any criminal action or proceeding, have reasonable cause to believe that his or her conduct was unlawful.

Section 3.02.

Actions by or in the Right of the Corporation. The Corporation shall indemnify any person who was or is a party or is threatened

to be made a party to any threatened, pending or completed action or suit by or in the right of the Corporation to procure a judgment

in its favor by reason of the fact that the person is or was a director, officer, employee or agent of the Corporation, or is or was

serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture

or trust or other enterprise, against expenses (including attorneys’ fees) actually and reasonably incurred by the person in connection

with the defense or settlement of such action or suit if the person acted in good faith and in a manner the person reasonably believed

to be in or not opposed to the best interests of the Corporation and except that no indemnification shall be made in respect of any claim,

issue or matter as to which such person shall have been adjudged to be liable to the Corporation unless and only to the extent that the

Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication

of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses

which the Court of Chancery or such other court shall deem proper.

Section 3.03.

Indemnification Against Expenses. To the extent that a present or former director or officer of the Corporation has been

successful on the merits or otherwise in defense of any action, suit or proceeding referred to in Sections ‎3.01 and ‎3.02

hereof, or in defense of any claim, issue or matter therein, such person shall be indemnified against expenses (including attorneys’

fees) actually and reasonably incurred by such person in connection therewith.

Section 3.04.

Board Determinations. Any indemnification under Sections ‎3.01 and ‎3.02 hereof (unless

ordered by a court) shall be made by the Corporation only as authorized in the specific case upon a determination that indemnification

of the present or former director, officer, employee or agent is proper in the circumstances because the person has met the applicable

standard of conduct set forth in Sections ‎3.01 and ‎3.02 hereof. Such determination shall be made, with respect

to a person who is a director or officer at the time of such determination, (i) by a majority vote of the directors who were not parties

to such action, suit or proceeding, even though less than a quorum, or (ii) by a committee of such directors designated by majority vote

of such directors, even though less than a quorum, or (iii) if there are no such disinterested directors or if such directors so direct,

by independent legal counsel in a written opinion, or (iv) by the stockholders.

Section 3.05.

Advancement of Expenses. Expenses including attorneys’ fees incurred by an officer or director in defending a civil

or criminal action, suit or proceeding may be paid by the Corporation in advance of the final disposition of such action, suit or proceeding

upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it shall ultimately be determined

that such person is not entitled to be indemnified by the Corporation as authorized by law or in this section. Such expenses incurred

by former directors and officers or other employees and agents may be so paid upon such terms and conditions, if any, as the Corporation

deems appropriate.

Section 3.06.

Nonexclusive. The indemnification and advancement of expenses provided by, or granted pursuant to, this section shall not

be deemed exclusive of any other rights to which any director, officer, employee or agent of the Corporation seeking indemnification

or advancement of expenses may be entitled under any other bylaw, agreement, vote of stockholders or disinterested directors or otherwise,

both as to action in such person’s official capacity and as to action in another capacity while holding such office, and shall,

unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director, officer, employee or

agent of the Corporation and shall inure to the benefit of the heirs, executors and administrators of such a person.

Section 3.07.

Insurance. The Corporation may purchase and maintain insurance on behalf of any person who is or was a director, officer,

employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent

of another corporation, partnership, joint venture, trust or other enterprise, against any liability asserted against such person and

incurred by such person in any such capacity or arising out of such person’s status as such, whether or not the Corporation would

have the power to indemnify such person against such liability under the provisions of applicable statutes, the certificate of incorporation

or this section.

Section 3.08.

Certain Definitions. For purposes of this Article ‎3, (i) references to “the Corporation” shall

include, in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed

in a consolidation or merger that, if its separate existence had continued, would have had power and authority to indemnify its directors,

officers and employees or agents, so that any person who is or was a director, officer, employee or agent of such constituent corporation,

or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation,

partnership, joint venture, trust or other enterprise, shall stand in the same position under the provisions of this section with respect

to the resulting or surviving corporation as such person would have with respect to such constituent corporation if its separate existence

had continued; (ii) references to “other enterprises” shall include employee benefit plans; (iii) references to “fines”

shall include any excise taxes assessed on a person with respect to an employee benefit plan; and (iv) references to “serving at

the request of the Corporation” shall include any service as a director, officer, employee or agent of the Corporation that imposes

duties on, or involves services by, such director, officer, employee or agent with respect to any employee benefit plan, its participants,

or beneficiaries; and a person who acted in good faith and in a manner such person reasonably believed to be in the interest of the participants

and

beneficiaries of an

employee benefit plan shall be deemed to have acted in a manner “not opposed to the best interests of the Corporation” as

referred to in this section.

Section 3.09.

Change in Governing Law. In the event of any amendment or addition to Section 145 of the DGCL or the addition of any other

section to such law that limits indemnification rights thereunder, the Corporation shall, to the extent permitted by the DGCL, indemnify

to the fullest extent authorized or permitted hereunder, any person who was or is a party or is threatened to be made a party to any

threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (including an action

by or in the right of the Corporation), by reason of the fact that he or she is or was a director, officer, employee or agent of the

Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation,

partnership, joint venture, trust or other enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts

paid in settlement actually and reasonably incurred by him or her in connection with such action, suit or proceeding, indemnify, to the

fullest extent permitted by Section 145 of the DGCL as amended from time to time, all persons whom it may indemnify pursuant thereto

and in the manner prescribed thereby.

ARTICLE

Committees

Section 4.01.

Appointment. From time to time, the Board of Directors by a resolution adopted by a majority of the entire Board may appoint

any committee or committees for any purpose or purposes, to the extent lawful, which shall have powers as shall be determined and specified

by the Board of Directors in the resolution of appointment. The Board of Directors shall have the power at any time to increase or decrease

the number of members of any committee, to fill vacancies thereon, to change any member thereof and to change the functions or terminate

the existence thereof. The Board of Directors may appoint a chair from among the members of the committee. If the Board of Directors

does not appoint a chair of the committee, the committee members may designate a chair from among the members of the committee. The Board

of Directors may designate one or more directors as alternate members of each committee who may replace any absent or disqualified member

at any meeting of the committee. Any member of any such committee elected or appointed by the Board of Directors may be removed by the

Board of Directors whenever in its judgment the best interests of the Corporation will be served thereby. No member of any committee

shall continue to be a member thereof after ceasing to be a director of the Corporation.

Section 4.02.

Procedures, Quorum And Manner of Acting. Each committee shall fix its own rules of procedure, and shall meet where and

as provided by such rules or by resolution of the Board of Directors. Except as otherwise provided by law, the presence of a majority

of the then appointed members of a committee shall constitute a quorum for the transaction of business by that committee, and in every

case where a quorum is present the affirmative vote of a majority of the members of the committee present shall be the act of the committee.

Each committee shall keep minutes of its proceedings, and actions taken by a committee shall be reported to the Board of Directors.

Section 4.03.

Action by Written Consent. Any action required or permitted to be taken at any meeting of any committee of the Board of

Directors may be taken without a meeting if all the members of the committee consent thereto in writing, and the writing or writings

are filed with the minutes of proceedings of the committee.

Section 4.04.

Term; Termination. In the event any person shall cease to be a director of the Corporation, such person shall simultaneously

therewith cease to be a member of any committee appointed by the Board of Directors.

ARTICLE

Officers

Section 5.01.

Election and Qualifications. The Board of Directors shall elect the officers of the Corporation, which shall include a

Chief Executive Officer, a President and a Secretary, and may include, by election or appointment, a Chief Financial Officer, one or

more Vice-Presidents (any one or more of whom may be given an additional designation of rank or function), a Controller, a Treasurer

and such Assistant Secretaries, Assistant Controllers and Assistant Treasurers and such other officers as the Board may from time to

time deem proper. Each officer shall have such powers and duties as may be prescribed by these By-laws and as may be assigned by the

Board of Directors or the President. Any two or more offices may be held by the same person except the offices of President and Secretary.

Section 5.02.

Term of Office and Remuneration. The term of office of all officers shall be one year and until their respective successors

have been elected and qualified, but any officer may be removed from office, either with or without cause, at any time by the Board of

Directors. Any vacancy in any office arising from any cause may be filled for the unexpired portion of the term by the Board of Directors.

The remuneration of all officers of the Corporation may be fixed by the Board of Directors or in such manner as the Board of Directors

shall provide.

Section 5.03.

Resignation; Removal. Any officer may resign at any time upon written notice to the Corporation and such resignation shall

take effect upon receipt thereof by the President or Secretary, unless otherwise specified in the resignation. Any officer shall be subject

to removal, with or without cause, at any time by vote of a majority of the entire Board.

Section 5.04.

President and Chief Executive Officer. The President shall be the chief executive officer of the Corporation, and shall

have such duties as customarily pertain to that office. The President shall have general management and supervision of the property,

business and affairs of the Corporation and over its other officers; may appoint and remove assistant officers and other agents and employees,

other than officers referred to in ‎Section 5.01; and may execute and deliver in the name of the Corporation powers of attorney,

contracts, bonds and other obligations and instruments.

Section 5.05.

Chief Financial Officer. The Chief Financial Officer shall in general have all duties incident to such position, including,

without limitation, the

organization and review

of all accounting, tax and related financial matters involving the Corporation, the implementation of appropriate Corporation financial

controls and procedures, and the supervision and assignment of the duties of all other financial officers and personnel employed by the

Corporation, and shall have such other duties as may be assigned by the Board of Directors or the President.

Section 5.06.

Vice-President. A Vice-President may execute and deliver in the name of the Corporation contracts and other obligations

and instruments pertaining to the regular course of the duties of said office, and shall have such other authority as from time to time

may be assigned by the Board of Directors or the President.

Section 5.07.

Treasurer. The Treasurer shall in general have all duties incident to the position of Treasurer and such other duties as

may be assigned by the Board of Directors or the President.

Section 5.08.

Secretary. The Secretary shall in general have all the duties incident to the office of Secretary and such other duties

as may be assigned by the Board of Directors or the President.

Section 5.09.

Controller. The Controller shall in general have all the duties incident to the office of Controller and such other duties

as may be assigned by the Board of Directors or the Chief Financial Officer.

Section 5.10.

Officers. Any assistant officer shall have such powers and duties of the officer such assistant officer assists as such

officer or the Board of Directors shall from time to time prescribe.

ARTICLE

Books and Records

Section 6.01.

Location. The books and records of the Corporation may be kept at such place or places within or outside the State of Delaware

as the Board of Directors or the respective officers in charge thereof may from time to time determine. The record books containing the

names and addresses of all stockholders, the number and class of shares of stock held by each and the dates when they respectively became

the owners of record thereof shall be kept by the Secretary or by the transfer agent or registrar as shall be designated by the Board

of Directors.

Section 6.02.

Addresses of Stockholders. Notices of meetings and all other corporate notices may be delivered personally or mailed to

each stockholder at the stockholder’s address as it appears on the records of the Corporation or may be given by means of electronic

transmission in the manner provided in Section 232 of the DGCL.

Section 6.03.

Fixing Date for Determination of Stockholders of Record. (a) In order that the Corporation may determine the stockholders

entitled to notice of or to vote at any meeting of stockholders or any adjournment thereof, the Board of Directors may fix a record date,

which record date shall not be more than 60 nor less than 10 days

before the date of

such meeting. If no record date is fixed by the Board of Directors, the record date for determining stockholders entitled to notice of

or to vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on which notice is given,

or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held. A determination of

stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting; provided,

however, that the Board of Directors may fix a new record date for the adjourned meeting.

(b)

In order that the Corporation may determine the stockholders entitled to consent to corporate action in writing without a meeting,

the Board of Directors may fix a record date, which date shall not be more than 10 days after the date upon which the resolution fixing

the record date is adopted by the Board of Directors. If no record date has been fixed by the Board of Directors, the record date for

determining stockholders entitled to consent to corporate action in writing without a meeting, when no prior action by the Board of Directors

is required, shall be the first date on which a signed written consent setting forth the action taken or proposed to be taken is delivered

to the Corporation by delivery to its registered office in this State, its principal place of business, or an officer or agent of the

Corporation having custody of the book in which proceedings of meetings of stockholders are recorded. Delivery made to the Corporation’s

registered office shall be by hand or by certified or registered mail, return receipt requested. If no record date has been fixed by

the Board of Directors and prior action by the Board of Directors is required by this chapter, the record date for determining stockholders

entitled to consent to corporate action in writing without a meeting shall be at the close of business on the day on which the Board

of Directors adopts the resolution taking such prior action.

(c)

In order that the Corporation may determine the stockholders entitled to receive payment of any dividend or other distribution

or allotment of any rights or the stockholders entitled to exercise any rights in respect of any change, conversion or exchange of stock,

or for the purpose of any other lawful action, the Board of Directors may fix a record date, which record date shall be not more than

60 days prior to such action. If no record date is fixed, the record date for determining stockholders for any such purpose shall be

at the close of business on the day on which the Board of Directors adopts the resolution relating thereto.

ARTICLE

Certificates Representing Stock

Section 7.01.

Certificates; Signatures. The shares of the Corporation shall be represented by certificates, provided that the Board of

Directors of the Corporation may provide by resolution or resolutions that some or all of any or all classes or series of its stock shall

be uncertificated shares, which uncertificated shares may be evidenced by a book-entry system maintained by the Corporation’s transfer

agent or registrar, or a combination of both. Any such resolution shall not apply to shares represented by a certificate until such certificate

is surrendered to the Corporation. Notwithstanding the adoption of such a resolution by the Board of Directors, every holder of stock

represented

by certificates and

upon request every holder of uncertificated shares shall be entitled to have a certificate, signed by or in the name of the Corporation

by the Chairman of the Board of Directors, or the President or Vice-President, and by the Treasurer or an Assistant Treasurer, or the

Secretary or an Assistant Secretary of the Corporation, representing the number of shares registered in certificate form. No certificate

shall be valid until countersigned by a transfer agent if the Corporation has a transfer agent, or until registered by a registrar if

the Corporation has a registrar. Any and all signatures on any such certificate may be facsimiles. In case any officer, transfer agent

or registrar who has signed or whose facsimile signature has been placed upon a certificate shall have ceased to be such officer, transfer

agent or registrar before such certificate is issued, it may be issued by the Corporation with the same effect as if he were such officer,

transfer agent or registrar at the date of issue. The name of the holder of record of the shares represented thereby, with the number

of such shares and the date of issue, shall be entered on the books of the Corporation.

Section 7.02.

Transfers of Shares. Upon compliance with any provisions restricting the transfer or registration of transfer of shares

of stock, including, without limitation, restrictions set forth in the Certificate of Incorporation, shares of capital stock shall be

transferable on the books of the Corporation only by the holder of record thereof in person, or by duly authorized attorney or legal

representative, upon (i) surrender and cancellation of certificates for a like number of shares (or upon compliance with the provisions

of ‎Section 7.05, if applicable), properly endorsed, and the payment of all taxes due thereon or (ii) with respect to uncertificated

shares, by delivery of duly executed instructions or in any other manner permitted by applicable law. Upon such surrender to the Corporation

or a transfer agent of the Corporation of a certificate for shares duly endorsed or accompanied by proper evidence of succession, assignment

or authority to transfer (or upon compliance with the provisions of ‎Section 7.05, if applicable) and of compliance with any

transfer restrictions applicable thereto contained in an agreement to which the Corporation is a party or of which the Corporation has

knowledge by reason of legend with respect thereto placed on any such surrendered stock certificate, it shall be the duty of the Corporation

to issue a new certificate to the person entitled thereto, cancel the old certificate and record the transaction upon its books. The

Board of Directors shall have power and authority to make all such rules and regulations as it may deem expedient concerning the issue,

transfer and registration of certificated or uncertificated shares of the Corporation, and may appoint one or more transfer agents and

registrars of the shares of the Corporation.

Section 7.03.

Ownership of Shares. The Corporation shall be entitled to treat the holder of record of any shares or shares of capital

stock of the Corporation as the holder in fact thereof and, accordingly, shall not be bound to recognize any equitable or other claim

to or interest in such share or shares on the part of any other person, whether or not it shall have express or other notice thereof,

except as otherwise provided by law.

Section 7.04.

Fractional Shares. The Corporation may, but shall not be required to, issue certificates for fractions of a share where

necessary to effect authorized transactions, or the Corporation may pay in cash the fair value of fractions of a share as of the time

when those entitled to receive such fractions are determined, or it may issue

scrip in registered

or bearer form over the manual or facsimile signature of an officer of the Corporation or of its agent, exchangeable as therein provided

for full shares, but such scrip shall not entitle the holder to any rights of a stockholder except as therein provided.

Section 7.05.

Lost, Stolen or Destroyed Certificates. The Board of Directors may direct a new certificate of stock or uncertificated

shares to be issued in place of any certificate theretofore issued by the Corporation alleged to have been lost, stolen, destroyed or

mutilated, upon the making of an affidavit of that fact by the person claiming the certificate of stock to be lost, stolen, destroyed

or mutilated. When authorizing (a) such issue of new certificate or certificates, or (b) if the Board of Directors has provided by resolution

that the applicable stock shall be uncertificated, such issue of uncertificated shares, the Board of Directors may, in its discretion

and as a condition precedent to the issuance thereof, require any or all of the following: (i) the owner of such lost, stolen, destroyed

or mutilated certificate, or the legal representative of the owner, to give the Corporation a bond or agreement of indemnity in such

form and amount and with such surety (or without surety) sufficient in the discretion of the Board of Directors to indemnify the Corporation

against any claim that may be made against the Corporation on account of the alleged loss, theft, destruction, or mutilation of such

certificate or the issuance of such new certificate or certificates or uncertificated shares, (ii) additional evidence of the loss,

theft, destruction or mutilation claimed, (iii) advertisement of the loss in such a manner as the Board of Directors may direct

or approve, and (iv) the order or approval of a court.

ARTICLE

Dividends

Subject always to

the provisions of law and the Certificate of Incorporation, the Board of Directors shall have full power to determine whether any, and,

if any, what part of any, funds legally available for the payment of dividends shall be declared as dividends and paid to stockholders;

the division of the whole or any part of such funds of the Corporation shall rest wholly within the lawful discretion of the Board of

Directors, and it shall not be required at any time, against such discretion, to divide or pay any part of such funds among or to the

stockholders as dividends or otherwise; and before payment of any dividend, there may be set aside out of any funds of the Corporation

available for dividends such sum or sums as the Board of Directors from time to time, in its absolute discretion, thinks proper as a

reserve or reserves to meet contingencies, or for equalizing dividends, or for repairing or maintaining any property of the Corporation,

or for such other purpose as the Board of Directors shall think conducive to the interest of the Corporation, and the Board of Directors

may modify or abolish any such reserve in the manner in which it was created.

ARTICLE

Corporate Seal

The corporate seal

shall have inscribed thereon the name of the Corporation and the year of its incorporation, and shall be in such form and contain such

other words and/or figures as the Board of Directors shall determine. The corporate seal may be used

by printing, engraving,

lithographing, stamping or otherwise making, placing or affixing, or causing to be printed, engraved, lithographed, stamped or otherwise

made, placed or affixed, upon any paper or document, by any process whatsoever, an impression, facsimile or other reproduction of said

corporate seal.

ARTICLE

Fiscal Year

The fiscal year

of the Corporation shall be fixed, and shall be subject to change, by the Board of Directors. Unless otherwise fixed by the Board of

Directors, the fiscal year of the Corporation shall be based on a fifty-two or fifty-three week year ending on the Friday nearest December

31st.

ARTICLE

Notice

Section 11.01.

If mailed, notice to stockholders shall be deemed given when deposited in the mail, postage prepaid, directed

to the stockholder at such stockholder’s address as it appears on the records of the Corporation. Without limiting the manner by

which notice otherwise may be given effectively to stockholders, any notice to stockholders may be given by electronic transmission in

the manner provided in Section 232 of the DGCL.

Section 11.02.

Whenever notice is required to be given by these By-laws or by the Certificate of Incorporation or by law, a written waiver thereof,

signed by the person or persons entitled to said notice, or waiver by electronic transmission from the person or persons entitled to

said notice, whether before or after the time stated therein, shall be deemed equivalent to notice. Neither the business nor the purpose

of any meeting need be specified in such a waiver. Attendance at any meeting shall constitute waiver of notice except attendance for

the express purpose of objecting, at the beginning of the meeting, to the transaction of business because the meeting is not lawfully

called or convened.

ARTICLE

Bank Accounts, Drafts, Contracts, Etc.

Section 12.01.

Bank Accounts and Drafts. In addition to such bank accounts as may be authorized by the Board of Directors, the primary

financial officer or any person designated by said primary financial officer, whether or not an employee of the Corporation, may authorize

such bank accounts to be opened or maintained in the name and on behalf of the Corporation as he may deem necessary or appropriate, payments

from such bank accounts to be made upon and according to the check of the Corporation in accordance with the written instructions of

said primary financial officer, or other person so designated by the Treasurer.

Section 12.02.

Contracts. The Board of Directors may authorize any person or persons, in the name and on behalf of the Corporation, to

enter into or execute and deliver

any and all deeds,

bonds, mortgages, contracts and other obligations or instruments, and such authority may be general or confined to specific instances.

Section 12.03.

Proxies; Powers of Attorney; Other Instruments. The Chairman, the President or any other person designated by either of

them shall have the power and authority to execute and deliver proxies, powers of attorney and other instruments on behalf of the Corporation

in connection with the rights and powers incident to the ownership of stock by the Corporation. The Chairman, the President or any other

person authorized by proxy or power of attorney executed and delivered by either of them on behalf of the Corporation may attend and

vote at any meeting of stockholders of any company in which the Corporation may hold stock, and may exercise on behalf of the Corporation

any and all of the rights and powers incident to the ownership of such stock at any such meeting, or otherwise as specified in the proxy

or power of attorney so authorizing any such person. The Board of Directors, from time to time, may confer like powers upon any other

person.

Section 12.04.

Financial Reports. The Board of Directors may appoint the primary financial officer or other fiscal officer or any other

officer to cause to be prepared and furnished to stockholders entitled thereto any special financial notice and/or financial statement,

as the case may be, which may be required by any provision of law.

ARTICLE

Amendments

The Board of Directors

shall have power to alter, adopt, amend or repeal By-laws. By-laws adopted by the Board of Directors may be repealed or changed, and

new By-laws made, by the affirmative vote of the holders of a majority of the shares of the capital stock of the Corporation issued and

outstanding and entitled to vote at any regular meeting of stockholders, or at any special meeting of stockholders, provided notice of

such alteration, adoption, amendment or repeal shall have been stated in the notice of such meeting, and the stockholders may prescribe

that any By-law made by them shall not be altered, amended or repealed by the Board of Directors.

ARTICLE

Forum Selection

Unless the Corporation

consents in writing to the selection of an alternative forum, to the fullest extent permitted by law, the sole and exclusive forum for

(i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim of breach of a fiduciary

duty owed by any current or former director, officer, other employee or stockholder of the Corporation to the Corporation or the Corporation’s

stockholders, (iii) any action asserting a claim arising pursuant to any provision of Delaware Law, the Restated Certificate of Incorporation

or these By-laws (in each case, as they may be amended from time to time) or as to which Delaware Law confers jurisdiction on the Court

of Chancery of the State of Delaware or (iv) any action asserting a claim governed by the internal affairs doctrine of the law of the

State of Delaware, shall be the Court of Chancery of the State of Delaware (or, if the Court of

Chancery of the State

of Delaware does not have jurisdiction, the federal district court for the District of Delaware); provided that the foregoing shall not

apply to claims brought to enforce a duty or liability created by the Securities Act of 1933, as amended, or any rule or regulation promulgated

thereunder (the “Securities Act”), the Exchange Act or any other claim for which the federal courts have exclusive

jurisdiction. Unless the Corporation consents in writing to the selection of an alternative forum, to the fullest extent permitted by

law, the sole and exclusive forum for any action asserting a cause of action arising under the Securities Act shall be the federal district

courts of the United States. The Court of Chancery of the State of Delaware (or if the Court of Chancery does not have jurisdiction,

another court of the State of Delaware, or if no court of the State of Delaware has jurisdiction, the federal district court for the

District of Delaware) shall have the fullest authority allowed by law to issue an anti-suit injunction to enforce this forum selection

clause and to preclude suit in any other forum. Any person or entity holding, purchasing or otherwise acquiring any interest in shares

of capital stock of the Corporation shall be deemed to consent to (i) the personal jurisdiction of the Court of Chancery of the State

of Delaware (or if the Court of Chancery does not have jurisdiction, another court of the State of Delaware, or if no court of the State

of Delaware has jurisdiction, the federal district court for the District of Delaware) in any proceeding brought to enjoin, or otherwise

enforce this ‎Article ‎14

with respect to, any action by that person or entity that is inconsistent with the exclusive jurisdiction provided for in this Article

‎14 (an “Inconsistent Action”) and (ii) having

service of process made upon such person or entity in any such proceeding by service upon such person's or entity’s counsel in

such Inconsistent Action as agent for such person or entity.

EX-3.2 — EXHIBIT 3.2

EX-3.2

Filename: dp251220_ex0302.htm · Sequence: 5

BY-LAWS

INTEGER HOLDINGS CORPORATION

(A DELAWARE CORPORATION)

(Amended and

Restated as of May 21August

2, 20252026)

ARTICLE

Stockholders

Section 1.01.

Annual Meetings. (a) The annual meeting of the holders of such classes or series of capital stock as are entitled to

notice thereof and to vote thereat pursuant to the provisions of the restated certificate of incorporation (the “Certificate

of Incorporation”) of Integer Holdings Corporation (the “Corporation”) for the election of directors and

for the transaction of such other business as may properly be brought before the meeting shall be held on such date as may be designated

by resolution of the Board of Directors or, in the event that no such date is so designated, on the fourth Thursday in May of each year,

at such hour (within ordinary business hours) as shall be stated in the notice of the meeting. If the day so designated shall be a legal

holiday, then such meeting shall be held on the next succeeding business day. Each annual meeting of stockholders shall be held at such

place, within or without the State of Delaware, as shall be determined by the Board of Directors.

(b)

An annual meeting of stockholders may be adjourned by the presiding officer of the meeting for any reason (including, if the presiding

officer determines that it would be in the best interests of the Corporation, to extend the period of time for the solicitation of proxies)

from time to time and place to place until such presiding officer shall determine that the business to be conducted at the meeting is

completed, which determination shall be conclusive.

(c)

The only business that shall be conducted at an annual meeting of stockholders shall be that which shall have been properly brought

before the annual meeting. To be properly brought before an annual meeting, business must be (i) specified in the notice of meeting

(or any supplements or addenda thereto) given by or at the direction of the Board of Directors, (ii) brought before the annual meeting

by or at the direction of the Board of Directors, or (iii) brought before the annual meeting by a stockholder that (A) is a stockholder

of record at the time of giving of notice provided for in this ‎Section 1.01 of these By-laws and at the time of the annual

meeting, (B) is entitled to vote at the annual meeting, (C) proposes the business be conducted at the annual meeting pursuant to

timely notice in proper written form to the Secretary of the Corporation, and (D) otherwise complies with the procedures set forth

in this ‎Section 1.01 of these By-laws.

(d)

To be timely, a stockholder’s notice must be delivered to, or mailed and received by, the Secretary at the principal executive

offices of the Corporation not less than 90 calendar days nor more than 120 calendar days prior to the anniversary date of the previous

year’s annual meeting of stockholders (or if there was no such prior annual meeting, not less than 90 calendar days nor more than

120 calendar days prior to the date that represents the fourth Thursday in May of the current year); PROVIDED, HOWEVER, that in the event

that the date of the annual meeting is advanced by more than 20 calendar days, or delayed by more than 60 calendar days,

from such anniversary

date, then, to be considered timely, notice by the stockholder must be received not later than the close of business on the later of

(x) the 90th calendar day prior to the annual meeting or (y) the seventh calendar day following the date on which notice of the date

of the annual meeting was mailed to stockholders or public disclosure thereof was otherwise made. In no event shall any postponement

or adjournment of an annual meeting commence a new time period for the giving of a stockholder’s notice as described above.

(e)

To be in proper written form, a stockholder’s notice to the Secretary shall set forth as to each matter the stockholder

proposes to bring before the annual meeting: (i) a description in reasonable detail of the business desired to be brought before

the annual meeting and the reasons for transacting such business at the annual meeting; (ii) the text of the proposal or business

(including the text of any resolution for consideration and in the event that such business includes a proposal to amend these Bylaws,

the language of the proposed amendment); (iii) the name and address, as they appear on the Corporation’s most recent stockholder

lists, of the stockholder proposing such proposal and any Stockholder Related Person (as defined below); (iv) a representation that

the stockholder giving the notice is a holder of record of stock of the Corporation entitled to vote at such annual meeting and intends

(A) to be a holder of record of stock of the Corporation at the time of the annual meeting and (B) to appear in person or by proxy

at the annual meeting to propose the business specified in the notice; (v) the class and number of shares of any securities of

the Corporation that are beneficially owned or held of record by the stockholder giving the notice or any Stockholder Related Person;

(vi) a description of (A) any derivative positions in any securities of the Corporation directly or indirectly held or beneficially

owned by the stockholder or any Stockholder Related Person and (B) any hedging or other transaction or series of transactions, agreement,

arrangement or understanding with respect to any of the Corporation’s securities entered into or made by such stockholder or any

Stockholder Related Person; (vii) a description of all contracts, arrangements, relationships or understandings between or among

such stockholder, any Stockholder Related Person and any other person(s) (including their names) in connection with the proposal of such

business, and any material interest of the stockholder or any Stockholder Related Person in such business; (viii) any other information

relating to the stockholder that would be required to be disclosed in a proxy statement or other filings required to be made in connection

with solicitations of proxies for the proposal pursuant to Section 14 of the Securities Exchange Act of 1934, as amended (the “Exchange

Act”) (whether or not such stockholder intends to deliver a proxy statement or conduct its own proxy solicitation); and (ix)

a statement as to whether either such stockholder, beneficial owner or Stockholder Related Person intends to deliver a proxy statement

and form of proxy to the holders of at least the percentage of shares of the Corporation entitled to vote that is required to approve

such proposal. Notwithstanding the foregoing, in order to include information relating to a stockholder proposal in the Corporation’s

proxy statement and form of proxy for an annual meeting of stockholders, a stockholder must provide notice as required by, and otherwise

comply with, all of the content, procedural and other requirements of Rule 14a-8 of Regulation 14A under the Exchange Act, irrespective

of whether the Corporation is then subject to such Rule or the Exchange Act. In addition, if the stockholder’s ownership of shares

of the Corporation, as set forth in the notice, is solely beneficial (and not of record) documentary evidence satisfactory to the Corporation

of such ownership must accompany the notice in order for such notice to be considered validly and timely received. A “Stockholder

Related Person” of any stockholder means (1) any person controlling, directly or indirectly, or acting in concert with, such

stockholder, (2) any beneficial owner of shares of stock of the Corporation owned of

record or beneficially

by such stockholder, and (3) any person controlling, controlled by or under common control with, such Stockholder Related Person.